List of Vital and Essential Drugs (VED) published by the Ministry of Health of the Russian Federation is generally similar to list of essential medicines published by the FDA in terms of necessity and immediateness of administration and ubiquitous use of listed drugs in the context of treating life-threatening and chronic conditions.
Below is a table showing the number of predicted DDI, the severity level of the predicted adverse reactions (based on ORCA classification system), and the types of effects (cardiovascular effects and isoenzyme-specific interactions) for two drugs, listed under their generic name
Drug1 | Drug2 | DDI count | The severity of DDIs | Adverse effects on the cardiovascular system | Cytochromes P450 that mediate DDI |
---|---|---|---|---|---|
Mebeverine | Trifluoperazine | 9 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Imipramine | 9 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Sotalol | 9 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Trifluoperazine | 9 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Perphenazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Haloperidol | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Procainamide | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Trifluoperazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Bupivacaine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Chlorpromazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Clomifene | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Levobupivacaine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nintedanib | Terizidone | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Trifluoperazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Benzyl benzoate | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Carvedilol | Dopamine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Fluphenazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Perphenazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Haloperidol | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Methotrimeprazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Procainamide | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Trifluoperazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Chlorpromazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Clomipramine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Imipramine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Sulpiride | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Methotrimeprazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Chlorpromazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Clomifene | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Clomipramine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Thioridazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Benzyl benzoate | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Dobutamine | Imipramine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Haloperidol | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Procainamide | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Fluphenazine | Oxybuprocaine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Metoprolol | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Norepinephrine | Procainamide | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Trifluoperazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Trifluoperazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Oxybuprocaine | Imipramine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Propafenone | Chlorpromazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Perampanel | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Procainamide | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Bupivacaine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Chlorpromazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Clomipramine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Imipramine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Levobupivacaine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Ropivacaine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Pirfenidone | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dopamine | Trifluoperazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Dopamine | Chlorpromazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Haloperidol | Phenylephrine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Procainamide | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI |
Procarbazine | Benzyl benzoate | 8 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Propranolol | Trifluoperazine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Propranolol | Clomifene | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Clomifene | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Chlorpromazine | Clomifene | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Clomifene | Imipramine | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Benzyl benzoate | Mitotane | 8 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C9 mediated DDI |
Cromoglicic acid | Dobutamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carfilzomib | Mebeverine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Hexoprenaline | Verapamil | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Bedaquiline | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Fluphenazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Ivacaftor | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Mebendazole | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hexoprenaline | Periciazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Vismodegib | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Hexoprenaline | Amiodarone | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Procarbazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Teriflunomide | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Imipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hexoprenaline | Ropivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Hexoprenaline | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Imatinib | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Lisinopril | Halothane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Acalabrutinib | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Ivabradine | Dobutamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nimodipine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Nintedanib | Dobutamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Nintedanib | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Tamsulosin | Dobutamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Terizidone | Mebeverine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Terizidone | Procaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Chlorpromazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Halothane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Verapamil | Mebeverine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Epinephrine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Bupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Verapamil | Chlorpromazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Clomipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Imipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Levobupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Verapamil | Ropivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Verapamil | Thioridazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Mitotane | 7 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cetirizine | Fenoterol | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cetirizine | Dobutamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | |
Chloramphenicol | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Drotaverine | Dobutamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Drotaverine | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Fenoterol | Hydroxyzine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Procarbazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Bupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Levobupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Thioridazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Dobutamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Levodopa | Halothane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Mebeverine | Dobutamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Mebeverine | Fluphenazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Metoclopramide | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Mebeverine | Oxybuprocaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Perphenazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Mebeverine | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Dopamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Mebeverine | Haloperidol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Procainamide | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Mebeverine | Tropicamide | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Bupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Levobupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Ropivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Tamoxifen | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nifedipine | Droperidol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Teriflunomide | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Atenolol | Fluphenazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Dopamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Chlorpromazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Imipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bedaquiline | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Fluphenazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Oxybuprocaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Propafenone | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Droperidol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Haloperidol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Methotrimeprazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Procainamide | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Procaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Procarbazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Propranolol | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Agomelatine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Bupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Chlorpromazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Clomipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Levobupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Ropivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Sertindole | 7 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Imipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Fluphenazine | Metoprolol | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Norepinephrine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fluphenazine | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fluphenazine | Dopamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoclopramide | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoclopramide | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Metoprolol | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Imipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Norepinephrine | Perphenazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | |
Norepinephrine | Haloperidol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Norepinephrine | Procarbazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Bupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Chlorpromazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Norepinephrine | Imipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Norepinephrine | Levobupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Thioridazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Norepinephrine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Oxybuprocaine | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Methotrimeprazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Bupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Oxybuprocaine | Chlorpromazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | |
Oxybuprocaine | Clomipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Oxybuprocaine | Levobupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Oxybuprocaine | Tamoxifen | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Periciazine | Sotalol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Perphenazine | Dopamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | |
Perphenazine | Phenylephrine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Perphenazine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Propafenone | Dopamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Mitotane | 7 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Sotalol | Vismodegib | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Atropine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Bisacodyl | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Dopamine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Fingolimod | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Haloperidol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Ketorolac | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Methotrimeprazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Procaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Tropicamide | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Agomelatine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Fentanyl | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Levamisole | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Lidocaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Nicotinamide | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Sotalol | Sertindole | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Tapentadol | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Thioridazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Cinacalcet | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atropine | Phenylephrine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atropine | Imipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dopamine | Mefloquine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dopamine | Methotrimeprazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Dopamine | Procainamide | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Dopamine | Procarbazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Propranolol | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dopamine | Bupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Dopamine | Levobupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Dopamine | Ropivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Dopamine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Methotrimeprazine | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Phenylephrine | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Bupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Clomipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Imipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Levobupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Procaine | Trifluoperazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Procaine | Imipramine | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI |
Procaine | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Procaine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Propranolol | Imipramine | 7 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Propranolol | Thioridazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Trifluoperazine | Agomelatine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Trifluoperazine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tropicamide | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Bupivacaine | Clomifene | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bupivacaine | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Bupivacaine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Chlorpromazine | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Chlorpromazine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomifene | Levobupivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Clomifene | Ropivacaine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Clomifene | Thioridazine | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Clomifene | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Levobupivacaine | Benzyl benzoate | 7 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Levobupivacaine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Lidocaine | Mitotane | 7 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI |
Ganirelix | Sotalol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Cromoglicic acid | Mebeverine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Oxybuprocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Cromoglicic acid | Sotalol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Cromoglicic acid | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Chlorhexidine | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Chlorhexidine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carfilzomib | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Carfilzomib | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP2D6 mediated DDI |
Carfilzomib | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hexoprenaline | Carbidopa | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Nimodipine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Terizidone | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Alectinib | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Avibactam | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI |
Hexoprenaline | Carvedilol | 6 | Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Chloramphenicol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Glyburide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Hexoprenaline | Mebeverine | 6 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Hexoprenaline | Nifedipine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Nitisinone | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Hexoprenaline | Metoclopramide | 6 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Atropine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Hexoprenaline | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Droperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Fingolimod | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Loperamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Perampanel | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Propranolol | 6 | Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Clomipramine | 6 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Fentanyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Levamisole | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Lidocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Amitriptyline | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Hexoprenaline | Pirfenidone | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ertugliflozin | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Lisinopril | Sotalol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Selexipag | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Carbidopa | Terizidone | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Mebeverine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Carbidopa | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Carbidopa | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Carbidopa | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ivabradine | Terizidone | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Ivabradine | Nifedipine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ivabradine | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Ivabradine | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | |
Ivabradine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | |
Ivabradine | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nimodipine | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nimodipine | Clomipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nimodipine | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nimodipine | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nintedanib | Fenoterol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nintedanib | Sotalol | 6 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Nintedanib | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Nintedanib | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Nintedanib | Phenylephrine | 6 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Nintedanib | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nintedanib | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nintedanib | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Piribedil | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | |
Tamsulosin | Fenoterol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Mebeverine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Norepinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Tamsulosin | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Verapamil | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Fenoterol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Methyldopa | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Epinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Norepinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Propafenone | 6 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Atropine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Methotrimeprazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Terizidone | Clomipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Urapidil | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Verapamil | Salmeterol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Verapamil | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Ivacaftor | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Metoclopramide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Verapamil | Oxybuprocaine | 6 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Verapamil | Fingolimod | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Verapamil | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Loperamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Methotrimeprazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Verapamil | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Procainamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Verapamil | Salicylic acid | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Verapamil | Tramadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Verapamil | Fluoxetine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Tamoxifen | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Amitriptyline | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Verapamil | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Vilanterol | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Amlodipine | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Avibactam | Epinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI |
Avibactam | Oxybuprocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI |
Avibactam | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Bisoprolol | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Fenoterol | 6 | Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Fluphenazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Norepinephrine | 6 | Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Procarbazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Chlorpromazine | 6 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | |
Cetirizine | Norepinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Cetirizine | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Cetirizine | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Mebendazole | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Chloramphenicol | Sotalol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Fingolimod | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Chloramphenicol | Clomipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | |
Chloramphenicol | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Chloramphenicol | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | |
Drotaverine | Mebeverine | 6 | CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Drotaverine | Fluphenazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Oxybuprocaine | 6 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Drotaverine | Periciazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Drotaverine | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Drotaverine | Procaine | 6 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Drotaverine | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Drotaverine | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Enalapril | Sotalol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Fenoterol | Glyburide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Mebeverine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Nifedipine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Bedaquiline | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Ivacaftor | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Mebendazole | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fenoterol | Periciazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Propafenone | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Sotalol | 6 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Vismodegib | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Amiodarone | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Atropine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Bisacodyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Droperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Fingolimod | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Mefloquine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Procaine | 6 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Propranolol | 6 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Umifenovir | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Fentanyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Lidocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Rivastigmine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Amitriptyline | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Fenoterol | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Oxybuprocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Sotalol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Formoterol | Atropine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Procainamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Procaine | 6 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Glyburide | Norepinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Glyburide | Sotalol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Glyburide | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Glyburide | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | |
Levodopa | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C8 mediated DDI |
Levodopa | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C8 mediated DDI |
Mebeverine | Methyldopa | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Mebeverine | Mebendazole | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Norepinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Mebeverine | Oseltamivir | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Mebeverine | Periciazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Mebeverine | Vismodegib | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Amiodarone | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Bisacodyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Flupentixol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Flutamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Mebeverine | Mefloquine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Procarbazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Mebeverine | Agomelatine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Fentanyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Mebeverine | Fluoxetine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Mebeverine | Amitriptyline | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Cinacalcet | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Methyldopa | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Sotalol | 6 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Procainamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Agomelatine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Methyldopa | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Methyldopa | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Nifedipine | Salmeterol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Epinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Nifedipine | Metoclopramide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Norepinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Periciazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Nifedipine | Cariprazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Nifedipine | Procainamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Nifedipine | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP3A4 mediated DDI |
Nifedipine | Clomipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Nifedipine | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nifedipine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Nicotinamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Cinacalcet | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nitisinone | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nitisinone | Epinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nitisinone | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Repaglinide | Dobutamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Repaglinide | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Salmeterol | Sotalol | 6 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Salmeterol | Atropine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Salmeterol | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salmeterol | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salmeterol | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Sulpiride | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Atenolol | Dobutamine | 6 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Atenolol | Oxybuprocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Tramadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Agomelatine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Fluoxetine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bedaquiline | Norepinephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Ivacaftor | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Mebendazole | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Dobutamine | Metoprolol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Oseltamivir | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Dobutamine | Periciazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Perphenazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Vismodegib | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Acetylsalicylic acid | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dobutamine | Amiodarone | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Bisacodyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dobutamine | Cariprazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Fingolimod | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Flutamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Dobutamine | Ketorolac | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dobutamine | Mefloquine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Umifenovir | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Fentanyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Fluoxetine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Levamisole | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Lidocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Rivastigmine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Tamoxifen | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Amitriptyline | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Epinephrine | Fluphenazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Atropine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Droperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Fingolimod | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Perampanel | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Procarbazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Epinephrine | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Clomipramine | 6 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Lidocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Fluphenazine | Procaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Fluphenazine | Propranolol | 6 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fluphenazine | Nicotinamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Indacaterol | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Ivacaftor | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Mebendazole | Sotalol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Metoclopramide | Oxybuprocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Metoclopramide | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Metoclopramide | Flutamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoclopramide | Agomelatine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Metoclopramide | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Metoprolol | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Norepinephrine | Periciazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Vismodegib | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Amiodarone | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Norepinephrine | Atropine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Bisacodyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Norepinephrine | Droperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Umifenovir | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Norepinephrine | Clomipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Norepinephrine | Levamisole | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Lidocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Norepinephrine | Tamoxifen | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Norepinephrine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Periciazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | |
Oxybuprocaine | Amiodarone | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Oxybuprocaine | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Flupentixol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI |
Oxybuprocaine | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI |
Oxybuprocaine | Procarbazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Agomelatine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Oxybuprocaine | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Oxybuprocaine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Periciazine | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Periciazine | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Propranolol | 6 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Perphenazine | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Propafenone | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Umifenovir | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Agomelatine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Clomifene | 6 | CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Salbutamol | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salbutamol | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salbutamol | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI |
Sotalol | Chloropyramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Flupentixol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Flutamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Sotalol | Loperamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Procarbazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Sotalol | Propranolol | 6 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Salicylic acid | 6 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Teriflunomide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Sotalol | Tramadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Umifenovir | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Betahistine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Sotalol | Fluoxetine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Piracetam | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Tamoxifen | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Amitriptyline | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Carbamazepine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Sotalol | Propofol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Sotalol | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Vismodegib | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Acetylsalicylic acid | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Amiodarone | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Amiodarone | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Amiodarone | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Atropine | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Atropine | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Atropine | Amitriptyline | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Atropine | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Dopamine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Clonidine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | |
Dopamine | Fingolimod | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dopamine | Ketorolac | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dopamine | Procaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Dopamine | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Umifenovir | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Agomelatine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dopamine | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dopamine | Clomipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Dopamine | Fentanyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Dopamine | Levamisole | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Lidocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Dopamine | Rivastigmine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Dopamine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dopamine | Amitriptyline | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Dopamine | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Ethanol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dopamine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Droperidol | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fingolimod | Loperamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fingolimod | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Lidocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Flutamide | Haloperidol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Flutamide | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Flutamide | Procaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Flutamide | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Haloperidol | Methotrimeprazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Procaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Haloperidol | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Lidocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Haloperidol | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Methotrimeprazine | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perampanel | Phenylephrine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Perampanel | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Phenobarbital | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Phenylephrine | Procarbazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Phenylephrine | Teriflunomide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Phenylephrine | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Lidocaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Phenylephrine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Procainamide | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Procainamide | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Procainamide | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | |
Procainamide | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Procaine | Procarbazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Procaine | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | |
Procaine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | |
Procaine | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | |
Procaine | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Procaine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Procarbazine | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Procarbazine | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Procarbazine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | |
Propranolol | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Chlorpromazine | 6 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Clomipramine | 6 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salicylic acid | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salicylic acid | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Sunitinib | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Teriflunomide | Trifluoperazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI |
Teriflunomide | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Tropicamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Fluoxetine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Trifluoperazine | Nicotinamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Trifluoperazine | Cinacalcet | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Tropicamide | Bupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Tropicamide | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tropicamide | Clomipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tropicamide | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tropicamide | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Tropicamide | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Tropicamide | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Umifenovir | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Umifenovir | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Agomelatine | Clomifene | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Agomelatine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Betahistine | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | |
Bupivacaine | Chlorpromazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Bupivacaine | Imipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Bupivacaine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Bupivacaine | Nicotinamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI |
Bupivacaine | Piracetam | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Bupivacaine | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Bupivacaine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Chlorpromazine | Fentanyl | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | |
Chlorpromazine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Chlorpromazine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Clomifene | Clomipramine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomifene | Tapentadol | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Clomifene | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Clomipramine | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hydroxyurea | Leflunomide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Imipramine | Levobupivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Imipramine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Imipramine | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Levobupivacaine | Nicotinamide | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI |
Levobupivacaine | Piracetam | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Levobupivacaine | Ropivacaine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Levobupivacaine | Thioridazine | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Nicotinamide | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | |
Nicotinamide | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Ropivacaine | Benzyl benzoate | 6 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Tapentadol | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Tapentadol | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Thioridazine | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clotrimazole | Halothane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Halothane | Mitotane | 6 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Etelcalcetide | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Micafungin | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Cetrorelix | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Triptorelin | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | |
Leuprolide | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Leuprolide | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | |
Lanreotide | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Lanreotide | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Lanreotide | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Lanreotide | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Lanreotide | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Lanreotide | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Lanreotide | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Octreotide | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Octreotide | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Octreotide | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Octreotide | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Octreotide | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2B6 mediated DDI |
Cromoglicic acid | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Methotrimeprazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cromoglicic acid | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Cromoglicic acid | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Benzyl benzoate | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Chlorhexidine | Sotalol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Chlorhexidine | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Glecaprevir | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Pasireotide | Terizidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Pasireotide | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Pasireotide | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Pasireotide | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Pasireotide | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Iohexol | Verapamil | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ioversol | Verapamil | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ioversol | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Ioversol | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Bosutinib | Hexoprenaline | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Bosutinib | Fenoterol | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bosutinib | Atenolol | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Dobutamine | 5 | Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Bosutinib | Epinephrine | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bosutinib | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Norepinephrine | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Bosutinib | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Bosutinib | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Phenylephrine | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Propranolol | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bosutinib | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Bosutinib | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Bosutinib | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Bosutinib | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Carfilzomib | Hexoprenaline | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Carfilzomib | Nimodipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Carfilzomib | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Carfilzomib | Formoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Carfilzomib | Levodopa | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carfilzomib | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Carfilzomib | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | CYP2D6 mediated DDI |
Carfilzomib | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Carfilzomib | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP2D6 mediated DDI |
Carfilzomib | Salbutamol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI |
Carfilzomib | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Carfilzomib | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Carfilzomib | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Carfilzomib | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Carfilzomib | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Carfilzomib | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Carfilzomib | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Delamanid | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI |
Hexoprenaline | Atazanavir | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hexoprenaline | Imatinib | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Hexoprenaline | Acalabrutinib | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C9 mediated DDI |
Hexoprenaline | Alogliptin | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Hexoprenaline | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Miglustat | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Salmeterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Ethambutol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Oseltamivir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Hexoprenaline | Paroxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Sotalol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Chloropyramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Hexoprenaline | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Hexoprenaline | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Hexoprenaline | Mefloquine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Methotrimeprazine | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hexoprenaline | Methylergometrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Hexoprenaline | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Regorafenib | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Umifenovir | 5 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Diphenhydramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Solifenacin | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Hexoprenaline | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Propofol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Iomeprol | Verapamil | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iomeprol | Fenoterol | 5 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Dobutamine | 5 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Oxybuprocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Iomeprol | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iomeprol | Levetiracetam | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Iopromide | Verapamil | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Glyburide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Iopromide | Oxybuprocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iopromide | Vismodegib | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Iopromide | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iopromide | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iopromide | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Iopromide | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iopromide | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Iopromide | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Iopromide | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iopromide | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Iopromide | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Iopromide | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Iopromide | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Sulfasalazine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Apremilast | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Apremilast | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Apremilast | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atazanavir | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Benserazide | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Darunavir | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Empagliflozin | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Ertugliflozin | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Ertugliflozin | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Gefitinib | Terizidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Verapamil | 5 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Dobutamine | 5 | CLASS 1 (from 3); Major DDI | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Gefitinib | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Gefitinib | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Gefitinib | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Gefitinib | Procaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Gefitinib | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI |
Imatinib | Fenoterol | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Imatinib | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Imatinib | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP3A4 mediated DDI |
Imatinib | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Imatinib | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Imatinib | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Imatinib | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Imatinib | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Imatinib | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2D6 mediated DDI |
Lapatinib | Metoprolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Lapatinib | Propranolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Lisinopril | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Ombitasvir | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Osimertinib | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Saquinavir | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2B6 mediated DDI |
Saquinavir | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Saquinavir | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2B6 mediated DDI |
Selexipag | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Selexipag | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Selexipag | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Selexipag | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Selexipag | Procaine | 5 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Acalabrutinib | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Acalabrutinib | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Acalabrutinib | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Acalabrutinib | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Acalabrutinib | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Acalabrutinib | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Nimodipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Amlodipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Carbidopa | Linezolid | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | |
Carbidopa | Nifedipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Bedaquiline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Carbidopa | Oxybuprocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Carbidopa | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI |
Carbidopa | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Carbidopa | Bisacodyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Carbidopa | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI |
Carbidopa | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | |
Carbidopa | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI |
Carbidopa | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Carbidopa | Ethanol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Dapagliflozin | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dapagliflozin | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Deferasirox | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Ivabradine | Nimodipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Mebeverine | 5 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Clomifene | 5 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Lumacaftor | Nifedipine | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Lumacaftor | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Lumacaftor | Sotalol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Lumacaftor | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Nimodipine | Terizidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Nimodipine | Urapidil | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Nimodipine | Formoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nimodipine | Glyburide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Nimodipine | Levodopa | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Nimodipine | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Methyldopa | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Nimodipine | Salmeterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Nimodipine | Metoclopramide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Oseltamivir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nimodipine | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Nimodipine | Salbutamol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Cariprazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Nimodipine | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Nimodipine | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Nimodipine | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nimodipine | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nimodipine | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Nimodipine | Zuclopenthixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Nimodipine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Nimodipine | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Propofol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nimodipine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nintedanib | Verapamil | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Nintedanib | Drotaverine | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nintedanib | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nintedanib | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Nintedanib | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nintedanib | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nintedanib | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nintedanib | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Nintedanib | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Nintedanib | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nintedanib | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nintedanib | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Nintedanib | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Olodaterol | Terizidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Olodaterol | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Sotalol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Atropine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Olodaterol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Olodaterol | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Piribedil | Terizidone | 5 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Piribedil | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C9 mediated DDI |
Piribedil | Propranolol | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Piribedil | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Piribedil | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Rilpivirine | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C8 mediated DDI |
Rilpivirine | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Tamsulosin | Epinephrine | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Sotalol | 5 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Tamsulosin | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Tamsulosin | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Terizidone | Vilanterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Carvedilol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Dasabuvir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Drotaverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Levodopa | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Nifedipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Salmeterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Oxybuprocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Salbutamol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Tetrabenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2D6 mediated DDI |
Terizidone | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Lacosamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Mefloquine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Propranolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Umifenovir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Acetaminophen | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Terizidone | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Rivastigmine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Terizidone | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Sevoflurane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI |
Terizidone | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Urapidil | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Nifedipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Urapidil | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Urapidil | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Urapidil | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI |
Urapidil | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Verapamil | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Formoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Levodopa | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Verapamil | Methyldopa | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Verapamil | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Verapamil | Indacaterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Verapamil | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Verapamil | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Verapamil | Sotalol | 5 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Vismodegib | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Verapamil | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Atropine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Verapamil | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Verapamil | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Verapamil | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Verapamil | Mefloquine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Perampanel | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP3A4 mediated DDI |
Verapamil | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Propranolol | 5 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Verapamil | Zuclopenthixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Verapamil | Diphenhydramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Verapamil | Rivastigmine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Sertindole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP3A4 mediated DDI |
Verapamil | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Trihexyphenidyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Verapamil | Pirfenidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Vilanterol | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Vilanterol | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vilanterol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Vilanterol | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vilanterol | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Vilanterol | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Vilanterol | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Vilanterol | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Alectinib | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Alectinib | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI |
Alectinib | Nifedipine | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Alectinib | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI |
Alectinib | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alectinib | Fosfomycin | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Alectinib | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alectinib | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Alectinib | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Alectinib | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Amlodipine | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Amlodipine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Amlodipine | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Amlodipine | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Amlodipine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Amlodipine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Apixaban | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Avibactam | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | |
Avibactam | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Avibactam | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | |
Avibactam | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Avibactam | Propranolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | |
Avibactam | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | |
Avibactam | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Bicalutamide | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Bicalutamide | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Bicalutamide | Procaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Bicalutamide | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Bisoprolol | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bisoprolol | Fingolimod | 5 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bisoprolol | Trifluoperazine | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisoprolol | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bisoprolol | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cabozantinib | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Cabozantinib | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cabozantinib | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Cabozantinib | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carvedilol | Salmeterol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Bedaquiline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Epinephrine | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Perphenazine | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Sotalol | 5 | Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Haloperidol | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Mefloquine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Methotrimeprazine | 5 | CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Phenylephrine | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Clomifene | 5 | CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Imipramine | 5 | CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Trihexyphenidyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cetirizine | Nifedipine | 5 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Cetirizine | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Cetirizine | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Cetirizine | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Cetirizine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Chloramphenicol | Fenoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Formoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | |
Chloramphenicol | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | |
Chloramphenicol | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Atropine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Chloramphenicol | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Chloramphenicol | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Drotaverine | Fenoterol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Sulpiride | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Drotaverine | Perphenazine | 5 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Lacosamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Drotaverine | Methotrimeprazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Drotaverine | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2D6 mediated DDI |
Drotaverine | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Drotaverine | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Benzyl benzoate | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Enalapril | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Enalapril | Atropine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Enalapril | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | |
Enalapril | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Fenoterol | Formoterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Methyldopa | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Nitisinone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Salmeterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Siponimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Apalutamide | 5 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Indacaterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Metoclopramide | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Oseltamivir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Fenoterol | Oxybuprocaine | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Paroxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Fenoterol | Tetrabenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Chloropyramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Fenoterol | Dexketoprofen | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Fenoterol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Fluorescein | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Ketoprofen | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Fenoterol | Ketorolac | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Methylergometrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Fenoterol | Perampanel | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Tramadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Zuclopenthixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Fenoterol | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Sertindole | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Solifenacin | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Fenoterol | Tamoxifen | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Pirfenidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Propofol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Sertraline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Methyldopa | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Formoterol | Nifedipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Salmeterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Formoterol | Bedaquiline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Formoterol | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Metoclopramide | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Formoterol | Oseltamivir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Formoterol | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Vismodegib | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Bisacodyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Formoterol | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Formoterol | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Methotrimeprazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Perampanel | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Formoterol | Propranolol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Zuclopenthixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Mebeverine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Nifedipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Glyburide | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Glyburide | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Rivastigmine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Ibrutinib | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Levodopa | Mebeverine | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Levodopa | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Levodopa | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Levodopa | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | |
Levodopa | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C8 mediated DDI |
Levodopa | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Levodopa | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Levodopa | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | CYP2C8 mediated DDI |
Levodopa | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Levodopa | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Linezolid | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | |
Losartan | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI |
Losartan | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | CYP2C9 mediated DDI |
Mebeverine | Nifedipine | 5 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Salmeterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Siponimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Mebeverine | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Mebeverine | Ketorolac | 5 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Mebeverine | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Propranolol | 5 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Mebeverine | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Tramadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Zuclopenthixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Mebeverine | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Nicotinamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Mebeverine | Sertindole | 5 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Methyldopa | Nifedipine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Salmeterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Bedaquiline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Methyldopa | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Propafenone | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Atropine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C8 mediated DDI |
Methyldopa | Bisacodyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Procaine | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | |
Methyldopa | Propranolol | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Umifenovir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Chlorpromazine | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Methyldopa | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Miglustat | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Nifedipine | Bedaquiline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Nifedipine | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Nifedipine | Indacaterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Nifedipine | Tetrabenazine | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nifedipine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nifedipine | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Tropicamide | 5 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Zuclopenthixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nifedipine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nifedipine | Loratadine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Nifedipine | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nifedipine | Benzyl benzoate | 5 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Propofol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Nitisinone | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Nitisinone | Salbutamol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Nitisinone | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Nitisinone | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nitisinone | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Paliperidone | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Paliperidone | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Paliperidone | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Quetiapine | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2D6 mediated DDI |
Quetiapine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI |
Salmeterol | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salmeterol | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salmeterol | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Ivacaftor | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salmeterol | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salmeterol | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Salmeterol | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salmeterol | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Salmeterol | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Propranolol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salmeterol | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salmeterol | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salmeterol | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salmeterol | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Salmeterol | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Siponimod | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Siponimod | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Sulpiride | Fluphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Sulpiride | Oxybuprocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Sulpiride | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Sulpiride | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Sulpiride | Methotrimeprazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Sulpiride | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Sulpiride | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Sulpiride | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Sulpiride | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Sulpiride | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Sulpiride | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Sulpiride | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Trametinib | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Aminosalicylic acid | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Aminosalicylic acid | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Aminosalicylic acid | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Aminosalicylic acid | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Apalutamide | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Apalutamide | Sotalol | 5 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Apalutamide | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Atenolol | Bedaquiline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Paroxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Tetrabenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Fingolimod | 5 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Mefloquine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Cinacalcet | 5 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Bedaquiline | Dobutamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Bedaquiline | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Bedaquiline | Oxybuprocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Bedaquiline | Propafenone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bedaquiline | Salbutamol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Bedaquiline | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Bedaquiline | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Bedaquiline | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Bedaquiline | Propranolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bedaquiline | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Bedaquiline | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Dapsone | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | |
Dobutamine | Epinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Ethambutol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Hydroxyzine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Dobutamine | Indacaterol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Metoclopramide | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Paroxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Salbutamol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Tetrabenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Atropine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Chloropyramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dobutamine | Enzalutamide | 5 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dobutamine | Fluorescein | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Lacosamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | |
Dobutamine | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Dobutamine | Methylergometrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Dobutamine | Perampanel | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dobutamine | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Tramadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Zuclopenthixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Loratadine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Dobutamine | Nicotinamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dobutamine | Praziquantel | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Dobutamine | Ethanol | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dobutamine | Pirfenidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Propofol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dobutamine | Sertraline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Epinephrine | Ivacaftor | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Mebendazole | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Epinephrine | Metoclopramide | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Oseltamivir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Epinephrine | Periciazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Perphenazine | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Sotalol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Vismodegib | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Epinephrine | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Bisacodyl | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Epinephrine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Epinephrine | Mefloquine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Methylergometrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Propranolol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Umifenovir | 5 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Epinephrine | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Pirfenidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Ethambutol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Ethambutol | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Favipiravir | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Favipiravir | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Favipiravir | Propranolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Fluphenazine | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Fluphenazine | Propafenone | 5 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fluphenazine | Salbutamol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Fluphenazine | Tetrabenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Fluphenazine | Vismodegib | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Fluphenazine | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Fluphenazine | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Fluphenazine | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Perampanel | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Fluphenazine | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Fluphenazine | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Fluphenazine | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Fluphenazine | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Fluphenazine | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Fluphenazine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Fosfomycin | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Fosfomycin | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Fosfomycin | Trihexyphenidyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Fosfomycin | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Hydroxychloroquine | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hydroxychloroquine | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Hydroxyzine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Hydroxyzine | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Hydroxyzine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Indacaterol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Indacaterol | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Indacaterol | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Indacaterol | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI |
Ivacaftor | Norepinephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Ivacaftor | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Ivacaftor | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Ivacaftor | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Mebendazole | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mesalazine | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Mesalazine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Metoclopramide | Norepinephrine | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Metoclopramide | Sotalol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Metoclopramide | Vismodegib | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Metoclopramide | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Metoclopramide | Phenylephrine | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoclopramide | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Metoclopramide | Procaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Metoclopramide | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Metoclopramide | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Metoclopramide | Imipramine | 5 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Metoclopramide | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Metoclopramide | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Metoclopramide | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Metoclopramide | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | |
Metoclopramide | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Metoprolol | Oseltamivir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Metoprolol | Tetrabenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Fingolimod | 5 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Phenylephrine | 5 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Biperiden | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Clomifene | 5 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Trihexyphenidyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Midostaurin | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Norepinephrine | Oseltamivir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Norepinephrine | Propafenone | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Norepinephrine | Sotalol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Norepinephrine | Ketorolac | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Norepinephrine | Mefloquine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Norepinephrine | Methotrimeprazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Norepinephrine | Methylergometrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Norepinephrine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Propranolol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Norepinephrine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Norepinephrine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Norepinephrine | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Norepinephrine | Pirfenidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Olaparib | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Oseltamivir | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Oseltamivir | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Oxybuprocaine | Perphenazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Oxybuprocaine | Propafenone | 5 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Oxybuprocaine | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Oxybuprocaine | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Mefloquine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Oxybuprocaine | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Tramadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Oxybuprocaine | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Oxybuprocaine | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Oxybuprocaine | Nicotinamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Sertindole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Oxybuprocaine | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI |
Oxybuprocaine | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Paroxetine | Sotalol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Paroxetine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Pentoxifylline | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI |
Periciazine | Propafenone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Periciazine | Salbutamol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Periciazine | Cycloserine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Periciazine | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Periciazine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Periciazine | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Periciazine | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Periciazine | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Periciazine | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Periciazine | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Periciazine | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Periciazine | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Perphenazine | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Perphenazine | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Perphenazine | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Perphenazine | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Propafenone | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Atropine | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Fingolimod | 5 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Methotrimeprazine | 5 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Propafenone | Phenylephrine | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Tramadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Nicotinamide | 5 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Propafenone | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salbutamol | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salbutamol | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Salbutamol | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Salbutamol | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salbutamol | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI |
Salbutamol | Propranolol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Salbutamol | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salbutamol | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salbutamol | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Salbutamol | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salbutamol | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salbutamol | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Salbutamol | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Salbutamol | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Salbutamol | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Sotalol | Acetylsalicylic acid | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Amiodarone | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Axitinib | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Droperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Fenofibrate | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Mefloquine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Methylergometrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Sotalol | Phenylephrine | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Sotalol | Zuclopenthixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Sotalol | Biperiden | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Solifenacin | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Sotalol | Trihexyphenidyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Sertraline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Tetrabenazine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Tetrabenazine | Propranolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tetrabenazine | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Tetrabenazine | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Vismodegib | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Vismodegib | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI |
Vismodegib | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI |
Vismodegib | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Vismodegib | Sunitinib | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Vismodegib | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Vismodegib | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP3A4 mediated DDI |
Vismodegib | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Vismodegib | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vismodegib | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP3A4 mediated DDI |
Vismodegib | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP3A4 mediated DDI |
Vismodegib | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2D6 mediated DDI |
Vismodegib | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Vismodegib | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Acetylsalicylic acid | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Aminocaproic acid | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Amiodarone | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Amiodarone | Haloperidol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Amiodarone | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Amiodarone | Propranolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Amiodarone | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Amiodarone | Acetaminophen | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Amiodarone | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Amiodarone | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Amiodarone | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Amiodarone | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Amiodarone | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Amiodarone | Tamoxifen | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Amiodarone | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atropine | Fingolimod | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Atropine | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Atropine | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Atropine | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | |
Atropine | Tramadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atropine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atropine | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Atropine | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atropine | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atropine | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Atropine | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Atropine | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | |
Atropine | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atropine | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Bisacodyl | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Bisacodyl | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Bisacodyl | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Caffeine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI |
Captopril | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | |
Captopril | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Captopril | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | |
Chloropyramine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Chloropyramine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Clonidine | Dopamine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Cycloserine | Procaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Cycloserine | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Diclofenac | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Dopamine | Flupentixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Dopamine | Flutamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Dopamine | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dopamine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Sunitinib | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Zuclopenthixol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI |
Dopamine | Acetaminophen | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Dopamine | Levetiracetam | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Sertindole | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Dopamine | Tamoxifen | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Dopamine | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Droperidol | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Droperidol | Procaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Droperidol | Propranolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Droperidol | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Droperidol | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fingolimod | Methotrimeprazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fingolimod | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Procaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Propranolol | 5 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fingolimod | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Tramadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Umifenovir | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fingolimod | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fingolimod | Levetiracetam | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Fingolimod | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Rivastigmine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Flupentixol | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Flupentixol | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Flutamide | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Flutamide | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Flutamide | Procarbazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Flutamide | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Flutamide | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Flutamide | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Flutamide | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Flutamide | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Flutamide | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Flutamide | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Flutamide | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Flutamide | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Glycine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Haloperidol | Loperamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Haloperidol | Sorafenib | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Haloperidol | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Haloperidol | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Piracetam | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Haloperidol | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Sertindole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Haloperidol | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ketorolac | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Lacosamide | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI |
Lacosamide | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Lacosamide | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Lacosamide | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Lacosamide | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Loperamide | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI |
Mefloquine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mefloquine | Procaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | |
Mefloquine | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Mefloquine | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Mefloquine | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Mefloquine | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Procainamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Methotrimeprazine | Propranolol | 5 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Methotrimeprazine | Chlorpromazine | 5 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methylergometrine | Phenylephrine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Perampanel | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Phenylephrine | Propranolol | 5 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Umifenovir | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Phenylephrine | Levamisole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Phenylephrine | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Tamoxifen | 5 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Phenylephrine | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Pirfenidone | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Procainamide | Sunitinib | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Procainamide | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Procainamide | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Procainamide | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Procainamide | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Procainamide | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Sertindole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Tamoxifen | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Procaine | Teriflunomide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Procaine | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Procaine | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Procaine | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Procaine | Clomifene | 5 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Procaine | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Procaine | Nicotinamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI |
Procaine | Tamoxifen | 5 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Procaine | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procarbazine | Propranolol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Procarbazine | Salicylic acid | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing hypotension | |
Procarbazine | Trifluoperazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Procarbazine | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Procarbazine | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Procarbazine | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Procarbazine | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procarbazine | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Procarbazine | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Procarbazine | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Propranolol | Agomelatine | 5 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Trihexyphenidyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | |
Salicylic acid | Chlorpromazine | 5 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salicylic acid | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salicylic acid | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Sunitinib | Tropicamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Sunitinib | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Sunitinib | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Sunitinib | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Sunitinib | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Teriflunomide | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Teriflunomide | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Tramadol | Agomelatine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tramadol | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Tramadol | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Tramadol | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Acetaminophen | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Trifluoperazine | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Trifluoperazine | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Trifluoperazine | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Trifluoperazine | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Trifluoperazine | Praziquantel | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Trifluoperazine | Vinpocetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Trifluoperazine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Clotrimazole | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Tropicamide | Chlorpromazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Umifenovir | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Umifenovir | Clomifene | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Umifenovir | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Umifenovir | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Umifenovir | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Zuclopenthixol | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Acetaminophen | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Agomelatine | Bupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Agomelatine | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Agomelatine | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Agomelatine | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Agomelatine | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Agomelatine | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bupivacaine | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Bupivacaine | Rivastigmine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Chlorpromazine | Clomipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Chlorpromazine | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Chlorpromazine | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Chlorpromazine | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Chlorpromazine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Chlorpromazine | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Chlorpromazine | Clotrimazole | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Clomifene | Fentanyl | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Clomifene | Fluoxetine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomifene | Lidocaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Clomifene | Nicotinamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Clomifene | Piracetam | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Clomifene | Sertindole | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Clomifene | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Clomifene | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomipramine | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomipramine | Levobupivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Clomipramine | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Clomipramine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Clomipramine | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fentanyl | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Fentanyl | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | |
Fluoxetine | Imipramine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Fluoxetine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Fluoxetine | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Nicotinamide | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Amitriptyline | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Imipramine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Levobupivacaine | Rivastigmine | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Lidocaine | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Lidocaine | Thioridazine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Lidocaine | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Lidocaine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nicotinamide | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Piracetam | Ropivacaine | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing arrhythmia | |
Piracetam | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Rivastigmine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Rivastigmine | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Ropivacaine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Ropivacaine | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Sertindole | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Solifenacin | Tapentadol | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Solifenacin | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | |
Tamoxifen | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Tapentadol | Benzyl benzoate | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Thioridazine | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Vinpocetine | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Amitriptyline | Mitotane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Benzyl benzoate | Cinacalcet | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Benzyl benzoate | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Carbamazepine | Sevoflurane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing arrhythmia | |
Cinacalcet | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Pirfenidone | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Propofol | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Protionamide | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Sevelamer | Halothane | 5 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Daptomycin | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Micafungin | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Ganirelix | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Ganirelix | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Ganirelix | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Ganirelix | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Ganirelix | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Ganirelix | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ganirelix | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Ganirelix | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ganirelix | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Sennosides | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI |
Cetrorelix | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Cetrorelix | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Degarelix | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Degarelix | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Degarelix | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Degarelix | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Degarelix | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Degarelix | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Goserelin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Polymyxin B | Iopromide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Polymyxin B | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Polymyxin B | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Polymyxin B | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Terlipressin | Iohexol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Terlipressin | Iomeprol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Terlipressin | Iopromide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Terlipressin | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Terlipressin | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Terlipressin | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Terlipressin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Terlipressin | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Terlipressin | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Triptorelin | Fenoterol | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Triptorelin | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI |
Triptorelin | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Triptorelin | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Triptorelin | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI |
Triptorelin | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Triptorelin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Leuprolide | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI |
Leuprolide | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Leuprolide | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Leuprolide | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C19 mediated DDI |
Leuprolide | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Leuprolide | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Leuprolide | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Leuprolide | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C19 mediated DDI |
Leuprolide | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI |
Leuprolide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Leuprolide | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Desmopressin | Iomeprol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Desmopressin | Iopromide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Desmopressin | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Desmopressin | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Desmopressin | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Desmopressin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Desmopressin | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Desmopressin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Atosiban | Iopromide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Atosiban | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Atosiban | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Atosiban | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Atosiban | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Azithromycin | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Azithromycin | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Azithromycin | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Azithromycin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Azithromycin | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Azithromycin | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Azithromycin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Azithromycin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Azithromycin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Azithromycin | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Azithromycin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Alectinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Clarithromycin | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Clarithromycin | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Clarithromycin | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Clarithromycin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Clarithromycin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Clarithromycin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Clarithromycin | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Clarithromycin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Clarithromycin | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Clarithromycin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Carbetocin | Iopromide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Carbetocin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Carbetocin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Lanreotide | Iohexol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Lanreotide | Ioversol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Lanreotide | Hexoprenaline | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Lanreotide | Iomeprol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Lanreotide | Iopromide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI |
Lanreotide | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Lanreotide | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Lanreotide | Formoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Lanreotide | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Lanreotide | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Lanreotide | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Lanreotide | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI |
Lanreotide | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Lanreotide | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Lanreotide | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lanreotide | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Lanreotide | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lanreotide | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI |
Lanreotide | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Lanreotide | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lanreotide | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lanreotide | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lanreotide | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lanreotide | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lanreotide | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Lanreotide | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Octreotide | Iohexol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Octreotide | Ioversol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Octreotide | Hexoprenaline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Octreotide | Iomeprol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Octreotide | Iopromide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Octreotide | Nintedanib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Octreotide | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Octreotide | Formoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Octreotide | Mebeverine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Octreotide | Paliperidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Octreotide | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Octreotide | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Octreotide | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Octreotide | Risperidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Octreotide | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Octreotide | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Octreotide | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Octreotide | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Octreotide | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Octreotide | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Octreotide | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Octreotide | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Octreotide | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Octreotide | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Octreotide | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Octreotide | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Octreotide | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Octreotide | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Cromoglicic acid | Gefitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Carbidopa | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | |
Cromoglicic acid | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Cromoglicic acid | Glyburide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Sulpiride | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Metoclopramide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Cromoglicic acid | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Cromoglicic acid | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Piracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Cromoglicic acid | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Lactulose | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Ademetionine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Chlorhexidine | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Chlorhexidine | Procarbazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Chlorhexidine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Chlorhexidine | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Chlorhexidine | Mitotane | 4 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Glecaprevir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Grazoprevir | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI |
Grazoprevir | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Pasireotide | Iohexol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI |
Pasireotide | Ioversol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Pasireotide | Iomeprol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Pasireotide | Iopromide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Pasireotide | Nintedanib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI |
Pasireotide | Carvedilol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Pasireotide | Chloramphenicol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Pasireotide | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Pasireotide | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Pasireotide | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Pasireotide | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Pasireotide | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Pasireotide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Pasireotide | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI |
Pibrentasvir | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Pibrentasvir | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Pibrentasvir | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Pibrentasvir | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Pibrentasvir | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Pibrentasvir | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Venetoclax | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Doxazosin | Avibactam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Fluphenazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Doxazosin | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Trifluoperazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Doxazosin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Doxazosin | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Doxazosin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iohexol | Oxybuprocaine | 4 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Iohexol | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iohexol | Procaine | 4 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iohexol | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Ioversol | Hexoprenaline | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Ioversol | Fenoterol | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Ioversol | Nifedipine | 4 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Ioversol | Epinephrine | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ioversol | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Ioversol | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Ioversol | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Ioversol | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Ioversol | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Ioversol | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ioversol | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Ioversol | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Macitentan | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Nelarabine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Posaconazole | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Posaconazole | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Remdesivir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Alendronic acid | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Alfuzosin | Fluphenazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Haloperidol | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Trifluoperazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Bupivacaine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Chlorpromazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Alfuzosin | Clomifene | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Imipramine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Alfuzosin | Levobupivacaine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Ropivacaine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Alfuzosin | Mitotane | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Bosutinib | Terizidone | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Bosutinib | Verapamil | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Bosutinib | Carvedilol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Bosutinib | Formoterol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Mebeverine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Oxybuprocaine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bosutinib | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C8 mediated DDI |
Bosutinib | Dopamine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bosutinib | Procainamide | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Bosutinib | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Bosutinib | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Carfilzomib | Verapamil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Carfilzomib | Carvedilol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carfilzomib | Drotaverine | 4 | CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carfilzomib | Nifedipine | 4 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Carfilzomib | Salmeterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carfilzomib | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Carfilzomib | Oxybuprocaine | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Carfilzomib | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI |
Carfilzomib | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Carfilzomib | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Carfilzomib | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carfilzomib | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Carfilzomib | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carfilzomib | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carfilzomib | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Carfilzomib | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Carfilzomib | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Carfilzomib | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Carfilzomib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Carfilzomib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Ceritinib | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ceritinib | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Ceritinib | Formoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Ceritinib | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Ceritinib | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Delamanid | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Delamanid | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI |
Ertapenem | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Fosamprenavir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Hexoprenaline | Iomeprol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Hexoprenaline | Iopromide | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Gefitinib | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Saquinavir | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Lumacaftor | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Hexoprenaline | Nilotinib | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2C9 mediated DDI |
Hexoprenaline | Urapidil | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Hexoprenaline | Bicalutamide | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Cabozantinib | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Hexoprenaline | Dasabuvir | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing arrhythmia | CYP2C9 mediated DDI |
Hexoprenaline | Enalapril | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Hexoprenaline | Formoterol | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Ipragliflozin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Losartan | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI |
Hexoprenaline | Methyldopa | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Nelfinavir | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI |
Hexoprenaline | Siponimod | 4 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Apalutamide | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Diatrizoate | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Hexoprenaline | Favipiravir | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Hexoprenaline | Hydroxychloroquine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Hexoprenaline | Nitrazepam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Norepinephrine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Tetrabenazine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Cariprazine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Chlorambucil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Hexoprenaline | Fluorescein | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Hexoprenaline | Isoniazid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Hexoprenaline | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Leflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C9 mediated DDI |
Hexoprenaline | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C9 mediated DDI |
Hexoprenaline | Tamoxifen | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Carbamazepine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Hexoprenaline | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C9 mediated DDI |
Hexoprenaline | Sertraline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C9 mediated DDI |
Inosine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iomeprol | Carvedilol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iomeprol | Chloramphenicol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Glyburide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Iomeprol | Nifedipine | 4 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Iomeprol | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iomeprol | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Iomeprol | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Iomeprol | Phenylephrine | 4 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing arrhythmia | |
Iomeprol | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Iomeprol | Procaine | 4 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Iomeprol | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Iomeprol | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iomeprol | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Iomeprol | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Iomeprol | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Iomeprol | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Iomeprol | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Iomeprol | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Iopromide | Saquinavir | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iopromide | Alectinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iopromide | Bicalutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Iopromide | Chloramphenicol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Iopromide | Fenoterol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Mebeverine | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iopromide | Nifedipine | 4 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Iopromide | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Epinephrine | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iopromide | Norepinephrine | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iopromide | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Iopromide | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Iopromide | Phenylephrine | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Procaine | 4 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Iopromide | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iopromide | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Iopromide | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iopromide | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Iopromide | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iopromide | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Iopromide | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Iopromide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Isosorbide dinitrate | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Palbociclib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Palbociclib | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C8 mediated DDI |
Palbociclib | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C8 mediated DDI |
Palbociclib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Palbociclib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Riociguat | Sotalol | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Tenofovir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Abemaciclib | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Abemaciclib | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Abemaciclib | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Abemaciclib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Abemaciclib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Abemaciclib | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Abemaciclib | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Abemaciclib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Abemaciclib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Afatinib | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Afatinib | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Afatinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Afatinib | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Afatinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Apremilast | Oxybuprocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Apremilast | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Apremilast | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI |
Apremilast | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Apremilast | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Apremilast | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Apremilast | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Apremilast | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Apremilast | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Apremilast | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Atazanavir | Mebeverine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Atazanavir | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Atazanavir | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Atazanavir | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atazanavir | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Atazanavir | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atazanavir | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atazanavir | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Atazanavir | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atazanavir | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Atazanavir | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Atazanavir | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atazanavir | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Atazanavir | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Atazanavir | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Atazanavir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Atazanavir | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Benserazide | Verapamil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Benserazide | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Benserazide | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Benserazide | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Benserazide | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Benserazide | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Cladribine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Cobicistat | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP3A4 mediated DDI |
Cobicistat | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Cobicistat | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Cobicistat | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Cobicistat | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Cobicistat | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Darunavir | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Empagliflozin | Dobutamine | 4 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Empagliflozin | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Erlotinib | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Erlotinib | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Erlotinib | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Erlotinib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Erlotinib | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Erlotinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Erlotinib | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Erlotinib | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Erlotinib | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Erlotinib | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Erlotinib | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Erlotinib | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Erlotinib | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Erlotinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Erlotinib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Ertugliflozin | Fenoterol | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ertugliflozin | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Ertugliflozin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Carvedilol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Gefitinib | Salmeterol | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | |
Gefitinib | Atenolol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Hydroxychloroquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Gefitinib | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Metoclopramide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Gefitinib | Oxybuprocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gefitinib | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gefitinib | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Gefitinib | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Gefitinib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Phenylephrine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Gefitinib | Propranolol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Gefitinib | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gefitinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gefitinib | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Gefitinib | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Gefitinib | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gefitinib | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Gefitinib | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gefitinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gefitinib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Imatinib | Alectinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C8 mediated DDI |
Imatinib | Formoterol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Imatinib | Mebeverine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Imatinib | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Imatinib | Salmeterol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Imatinib | Atenolol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Imatinib | Dobutamine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Imatinib | Epinephrine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Imatinib | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Imatinib | Metoprolol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Imatinib | Norepinephrine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Imatinib | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Imatinib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Imatinib | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Imatinib | Phenylephrine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Imatinib | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Imatinib | Propranolol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Imatinib | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Imatinib | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Imatinib | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Imatinib | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Imatinib | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Imatinib | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Imatinib | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Imatinib | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Imatinib | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Imatinib | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Imatinib | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Imatinib | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Imatinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Imatinib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Lapatinib | Verapamil | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Mebeverine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Atenolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Lapatinib | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Ivacaftor | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Lapatinib | Oxybuprocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C9 mediated DDI |
Lapatinib | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Propafenone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Lapatinib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Lapatinib | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Lapatinib | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Lapatinib | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C9 mediated DDI |
Lapatinib | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Lapatinib | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Lapatinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Lapatinib | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Lapatinib | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C8 mediated DDI |
Lapatinib | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Lapatinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lapatinib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Levofloxacin | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Alectinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Levofloxacin | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Levofloxacin | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Leflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lisinopril | Carbidopa | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Lisinopril | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Lisinopril | Verapamil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Lisinopril | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Lisinopril | Mebeverine | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Lisinopril | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Lisinopril | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Lisinopril | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Lisinopril | Atropine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Lisinopril | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Lisinopril | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Lisinopril | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Lisinopril | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Lisinopril | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Lisinopril | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C8 mediated DDI |
Lisinopril | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lisinopril | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mitomycin | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Moxifloxacin | Alectinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Bicalutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Moxifloxacin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Moxifloxacin | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Alectinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ofloxacin | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ofloxacin | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Leflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ombitasvir | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ombitasvir | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ombitasvir | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Ombitasvir | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Ombitasvir | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Ombitasvir | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Ombitasvir | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ombitasvir | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Ombitasvir | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Ombitasvir | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Ombitasvir | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Osimertinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Osimertinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Raltegravir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ribociclib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Saquinavir | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2B6 mediated DDI |
Saquinavir | Epinephrine | 4 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Saquinavir | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Saquinavir | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Saquinavir | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Saquinavir | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Saquinavir | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Saquinavir | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Saquinavir | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Saquinavir | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Saquinavir | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Saquinavir | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Saquinavir | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Saquinavir | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Saquinavir | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Saquinavir | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Saquinavir | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Saquinavir | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Selexipag | Norepinephrine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Selexipag | Oxybuprocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Selexipag | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Selexipag | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Selexipag | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Selexipag | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Selexipag | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Selexipag | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Tenofovir alafenamide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Timolol | Dobutamine | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Timolol | Dopamine | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Timolol | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Timolol | Fingolimod | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | |
Timolol | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Trimethoprim | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Acalabrutinib | Formoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Acalabrutinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Baricitinib | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Bictegravir | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Bictegravir | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Bictegravir | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Bromocriptine | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Bromocriptine | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Bromocriptine | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Bromocriptine | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Bromocriptine | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Bromocriptine | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Capecitabine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Carbidopa | Nintedanib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI |
Carbidopa | Piribedil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Carbidopa | Tamsulosin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Carbidopa | Vilanterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Carvedilol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | |
Carbidopa | Enalapril | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Carbidopa | Formoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Salmeterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Indacaterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Carbidopa | Metoprolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | |
Carbidopa | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Carbidopa | Propafenone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | |
Carbidopa | Atropine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Carbidopa | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Carbidopa | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Isoniazid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2C8 mediated DDI |
Carbidopa | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | |
Carbidopa | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI |
Carbidopa | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Carbidopa | Propranolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | |
Carbidopa | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Carbidopa | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Carbidopa | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Carbidopa | Betahistine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Carbidopa | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2C8 mediated DDI |
Carbidopa | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Carbidopa | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Carbidopa | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Carbidopa | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2C8 mediated DDI |
Carbidopa | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Carbidopa | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Carbidopa | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Carbidopa | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Cilastatin | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Cilastatin | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Cilastatin | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Cilastatin | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Ciprofloxacin | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Alectinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Fluconazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Ciprofloxacin | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ciprofloxacin | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ciprofloxacin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Leflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ciprofloxacin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Dapagliflozin | Fenoterol | 4 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dapagliflozin | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C9 mediated DDI |
Dapagliflozin | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Deferasirox | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Deferasirox | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Deferasirox | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Deferasirox | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Deferasirox | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Deferasirox | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Deferasirox | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Elvitegravir | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Elvitegravir | Sotalol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | |
Elvitegravir | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Elvitegravir | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Elvitegravir | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Elvitegravir | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Elvitegravir | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Elvitegravir | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Elvitegravir | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Elvitegravir | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Elvitegravir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Etravirine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Gosogliptin | Periciazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Haloperidol | 4 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Trifluoperazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Clomifene | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Imipenem | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Irinotecan | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ivabradine | Verapamil | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Ivabradine | Carvedilol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Fenoterol | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Favipiravir | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Ivabradine | Fluphenazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Ivabradine | Propafenone | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Ivabradine | Haloperidol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Methotrimeprazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Ivabradine | Phenylephrine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Procainamide | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Ivabradine | Propranolol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Trifluoperazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Ivabradine | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Ivabradine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Ivabradine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Lomefloxacin | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lomefloxacin | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lomefloxacin | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lomefloxacin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lomefloxacin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lomefloxacin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lomefloxacin | Leflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lomefloxacin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lumacaftor | Fenoterol | 4 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Lumacaftor | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Mannitol | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Meropenem | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Moxonidine | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Nilotinib | Fluconazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Nilotinib | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nilotinib | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nilotinib | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Nilotinib | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Nilotinib | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Nilotinib | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nilotinib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Nilotinib | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Nilotinib | Phenylephrine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Nilotinib | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Nilotinib | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nilotinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nilotinib | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Nilotinib | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Nilotinib | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Nilotinib | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nilotinib | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Nilotinib | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Nilotinib | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Nilotinib | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Nilotinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Nilotinib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Nimodipine | Olodaterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Alectinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Nimodipine | Avibactam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Nimodipine | Cetirizine | 4 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nimodipine | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Nimodipine | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nimodipine | Favipiravir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Indacaterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Tetrabenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Nimodipine | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Atropine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Fluorescein | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Nimodipine | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Nimodipine | Propranolol | 4 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nimodipine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nimodipine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nimodipine | Lomustine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Nimodipine | Loratadine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nimodipine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nimodipine | Sertindole | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Nimodipine | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nintedanib | Alectinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nintedanib | Chloramphenicol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Nintedanib | Methyldopa | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Nintedanib | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Nintedanib | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Nintedanib | Flutamide | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Nintedanib | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Nintedanib | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Nintedanib | Procainamide | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Nintedanib | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nintedanib | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nintedanib | Clomifene | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nintedanib | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Nintedanib | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nintedanib | Amitriptyline | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nintedanib | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Olodaterol | Verapamil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Olodaterol | Carvedilol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Olodaterol | Fenoterol | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI |
Olodaterol | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Olodaterol | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Olodaterol | Propranolol | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Olodaterol | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI |
Olodaterol | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Olodaterol | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Olodaterol | Lidocaine | 4 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Olodaterol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Piribedil | Avibactam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Piribedil | Bisoprolol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Piribedil | Atenolol | 4 | Major DDI | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Piribedil | Propafenone | 4 | Major DDI | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Piribedil | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI |
Piribedil | Trifluoperazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Piribedil | Bupivacaine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Piribedil | Levobupivacaine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Piribedil | Ropivacaine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Rilpivirine | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Rilpivirine | Trifluoperazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP3A4 mediated DDI |
Rilpivirine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ritonavir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Tamsulosin | Terizidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Tamsulosin | Verapamil | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Tamsulosin | Methyldopa | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI |
Tamsulosin | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Tamsulosin | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Tamsulosin | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Tamsulosin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Tamsulosin | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Tamsulosin | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Tamsulosin | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Terizidone | Urapidil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Chloramphenicol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Terizidone | Enalapril | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2C8 mediated DDI |
Terizidone | Formoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Terizidone | Losartan | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Siponimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Atenolol | 4 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Fosfomycin | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Indacaterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Metoprolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Terizidone | Acetylsalicylic acid | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Aminophylline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Terizidone | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Dexketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Fluorescein | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Terizidone | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Ketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Tranexamic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Terizidone | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Pyrantel | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Terizidone | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP3A4 mediated DDI |
Terizidone | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Terizidone | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Verapamil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP3A4 mediated DDI |
Urapidil | Carvedilol | 4 | CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Salmeterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP1A2 mediated DDI |
Urapidil | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Urapidil | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vandetanib | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Vandetanib | Metoclopramide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Vandetanib | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI |
Vandetanib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vandetanib | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Vandetanib | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Vandetanib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Vandetanib | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Vandetanib | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Vandetanib | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vandetanib | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Vandetanib | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Vandetanib | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Vandetanib | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Vandetanib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Vandetanib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Verapamil | Avibactam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP3A4 mediated DDI |
Verapamil | Bicalutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Verapamil | Cabozantinib | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Verapamil | Chloramphenicol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Verapamil | Drotaverine | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Enalapril | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Verapamil | Glyburide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Verapamil | Siponimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Verapamil | Sulpiride | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Verapamil | Ethambutol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Verapamil | Indapamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2D6 mediated DDI |
Verapamil | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Midostaurin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Verapamil | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Verapamil | Tetrabenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Verapamil | Cariprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Verapamil | Chlorambucil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Verapamil | Dexketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI |
Verapamil | Ketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI |
Verapamil | Ketorolac | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Verapamil | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Sunitinib | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Verapamil | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Verapamil | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Verapamil | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Verapamil | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Loratadine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP3A4 mediated DDI |
Verapamil | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Vilanterol | Fenoterol | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Vilanterol | Norepinephrine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Vilanterol | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Vilanterol | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI |
Vilanterol | Sotalol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Vilanterol | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI |
Vilanterol | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Vilanterol | Propranolol | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Vilanterol | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Vilanterol | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | |
Vilanterol | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Vilanterol | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | |
Vilanterol | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI |
Vilanterol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vilanterol | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C9 mediated DDI |
Alectinib | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Alectinib | Oxybuprocaine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C8 mediated DDI |
Alectinib | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Alectinib | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Alectinib | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Alectinib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Alectinib | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Alectinib | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Alectinib | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Alectinib | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Alectinib | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Alectinib | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Alectinib | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Alectinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Alectinib | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Alogliptin | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Alogliptin | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Alogliptin | Sotalol | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Alogliptin | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Amlodipine | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Amlodipine | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Amlodipine | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Amlodipine | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Amlodipine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Amlodipine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Amlodipine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Amlodipine | Mitotane | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Apixaban | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Apixaban | Sotalol | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Apixaban | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Avibactam | Carvedilol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Chloramphenicol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia | |
Avibactam | Enalapril | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Avibactam | Formoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Avibactam | Nifedipine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Avibactam | Salmeterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Avibactam | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Dexketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Avibactam | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Ketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Avibactam | Ketorolac | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Avibactam | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI |
Avibactam | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Betahistine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Avibactam | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Avibactam | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Avibactam | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Avibactam | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Avibactam | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Avibactam | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Avibactam | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Bicalutamide | Chloramphenicol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Bicalutamide | Mebeverine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Bicalutamide | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Bicalutamide | Hydroxychloroquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Bicalutamide | Oxybuprocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Bicalutamide | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Bicalutamide | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C8 mediated DDI |
Bicalutamide | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Bicalutamide | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Bicalutamide | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Bicalutamide | Phenylephrine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Bicalutamide | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Bicalutamide | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Bicalutamide | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bicalutamide | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bicalutamide | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Bisoprolol | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Bisoprolol | Sotalol | 4 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bisoprolol | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bisoprolol | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bisoprolol | Tropicamide | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bisoprolol | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Bisoprolol | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Bisoprolol | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Bisoprolol | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Bisoprolol | Mitotane | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cabozantinib | Epinephrine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Cabozantinib | Sotalol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cabozantinib | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cabozantinib | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cabozantinib | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Cabozantinib | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cabozantinib | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Cabozantinib | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Carvedilol | Drotaverine | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Formoterol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Quetiapine | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Sulpiride | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Tizanidine | 4 | Major DDI | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Carvedilol | Ethambutol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Carvedilol | Favipiravir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Carvedilol | Mebendazole | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Metoclopramide | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Pentoxifylline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP1A2 mediated DDI |
Carvedilol | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Salbutamol | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Carvedilol | Caffeine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP1A2 mediated DDI |
Carvedilol | Procainamide | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Tropicamide | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Agomelatine | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Biperiden | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Clomipramine | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Piracetam | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Tapentadol | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Cinacalcet | 4 | Major DDI | DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Cetirizine | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cetirizine | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cetirizine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Chloramphenicol | Glyburide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Methyldopa | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Chloramphenicol | Salmeterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Chloramphenicol | Atenolol | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Favipiravir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Fosfomycin | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Hydroxyzine | 4 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Ivacaftor | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Chloramphenicol | Metoclopramide | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Metoprolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Chloramphenicol | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Chloramphenicol | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Chloramphenicol | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Chloramphenicol | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Chloramphenicol | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Chloramphenicol | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Chloramphenicol | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Chloramphenicol | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Chloramphenicol | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Chloramphenicol | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Chloramphenicol | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Chloramphenicol | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Chloramphenicol | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Chloramphenicol | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Dasabuvir | Atenolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Dasabuvir | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Dasabuvir | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Dasabuvir | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Dasabuvir | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Dasabuvir | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Dasabuvir | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Dasabuvir | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Dasabuvir | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Dasabuvir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Dasabuvir | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C9 mediated DDI |
Doravirine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Drotaverine | Methyldopa | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI |
Drotaverine | Epinephrine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Propafenone | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Sotalol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Drotaverine | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Flutamide | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Phenylephrine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Propranolol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Zuclopenthixol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Amitriptyline | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Elsulfavirine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Emtricitabine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Enalapril | Fenoterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Enalapril | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Enalapril | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Enalapril | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Enalapril | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Enalapril | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Enalapril | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Enalapril | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Enalapril | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Enalapril | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Enalapril | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Enalapril | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Enalapril | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Enalapril | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Enalapril | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2D6 mediated DDI |
Enalapril | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Enalapril | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2D6 mediated DDI |
Fenoterol | Levodopa | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Fenoterol | Losartan | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI |
Fenoterol | Miglustat | 4 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Nelfinavir | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2B6 mediated DDI |
Fenoterol | Rivaroxaban | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Fenoterol | Clonazepam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Ethambutol | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Favipiravir | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Fenoterol | Fosfomycin | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Fenoterol | Nitrazepam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Fenoterol | Acetylsalicylic acid | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Fenoterol | Axitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Fenoterol | Cariprazine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Chlorambucil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Fenoterol | Enzalutamide | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Fenoterol | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Sunitinib | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Fenoterol | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fenoterol | Praziquantel | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Fenoterol | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Fenoterol | Carbamazepine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Fenoterol | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Cariprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Formoterol | Levodopa | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Formoterol | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Siponimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Epinephrine | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Formoterol | Hydroxyzine | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Ivacaftor | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Formoterol | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Chloropyramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Ketorolac | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Methylergometrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Formoterol | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Formoterol | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Formoterol | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Formoterol | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Rivastigmine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Formoterol | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Formoterol | Carbamazepine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Formoterol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Formoterol | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Formoterol | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Glyburide | Methyldopa | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Salmeterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C9 mediated DDI |
Glyburide | Metoclopramide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Glyburide | Oxybuprocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Salbutamol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Glyburide | Atropine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C9 mediated DDI |
Glyburide | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI |
Glyburide | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Glyburide | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Glyburide | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C9 mediated DDI |
Glyburide | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Ibrutinib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Ipragliflozin | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Lamivudine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Levodopa | Nifedipine | 4 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Levodopa | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Levodopa | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Levodopa | Atropine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Levodopa | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Levodopa | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C9 mediated DDI |
Levodopa | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Levodopa | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI |
Levodopa | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C8 mediated DDI |
Levodopa | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Levodopa | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Levodopa | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Levodopa | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Levodopa | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Levodopa | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Levodopa | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Levodopa | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Levodopa | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Levodopa | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Linezolid | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Linezolid | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Linezolid | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Linezolid | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Linezolid | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2B6 mediated DDI |
Lopinavir | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Lopinavir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Lopinavir | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Losartan | Mebeverine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI |
Losartan | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Oxybuprocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Losartan | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Losartan | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Losartan | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Losartan | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Lurasidone | Sotalol | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Mebeverine | Miglustat | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Mebeverine | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Tizanidine | 4 | Major DDI | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | |
Mebeverine | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Epinephrine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mebeverine | Favipiravir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Mebeverine | Indacaterol | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Mebeverine | Ivacaftor | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Mebeverine | Paroxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Mebeverine | Axitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Mebeverine | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Mebeverine | Fenofibrate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Mebeverine | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Sunitinib | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Mebeverine | Umifenovir | 4 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Mebeverine | Rivastigmine | 4 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Mebeverine | Solifenacin | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Mebeverine | Vinpocetine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Mebeverine | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Mebeverine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Mebeverine | Sertraline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Methyldopa | Siponimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C8 mediated DDI |
Methyldopa | Atenolol | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing bradycardia | |
Methyldopa | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Methyldopa | Indapamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Methyldopa | Norepinephrine | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Oxybuprocaine | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Paroxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Methyldopa | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Methyldopa | Perphenazine | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Methyldopa | Acetylsalicylic acid | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Chloropyramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Fluorescein | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Methyldopa | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Methyldopa | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Methotrimeprazine | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI |
Methyldopa | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Methyldopa | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Methyldopa | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Methyldopa | Ketamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Methyldopa | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Methyldopa | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Methyldopa | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Methyldopa | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Methyldopa | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Methyldopa | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Methyldopa | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Miglustat | Nifedipine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Miglustat | Atenolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Miglustat | Dobutamine | 4 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Miglustat | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Miglustat | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Miglustat | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Nelfinavir | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Nelfinavir | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Nelfinavir | Sotalol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Nelfinavir | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2B6 mediated DDI |
Nelfinavir | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Nelfinavir | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Nelfinavir | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Nelfinavir | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Nelfinavir | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Nelfinavir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Nelfinavir | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Nitisinone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Favipiravir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Perphenazine | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing arrhythmia | |
Nifedipine | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Nifedipine | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Lacosamide | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Nifedipine | Methylergometrine | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Propranolol | 4 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nifedipine | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Salmeterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Nitisinone | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Nitisinone | Fosfomycin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Nitisinone | Hydroxychloroquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nitisinone | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Nitisinone | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Nitisinone | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Nitisinone | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Nitisinone | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nitisinone | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Nitisinone | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Nitisinone | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Nitisinone | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Nitisinone | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Oxycodone | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Paliperidone | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Paliperidone | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Paliperidone | Trifluoperazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Perindopril | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Perindopril | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Pomalidomide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Quetiapine | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Quetiapine | Phenylephrine | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Quetiapine | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Quetiapine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Quetiapine | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Repaglinide | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C8 mediated DDI |
Repaglinide | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Repaglinide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Repaglinide | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Rivaroxaban | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Rivaroxaban | Epinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Rivaroxaban | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Rivaroxaban | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Rivaroxaban | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Salmeterol | Bedaquiline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Salmeterol | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Salmeterol | Metoclopramide | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Salmeterol | Pentoxifylline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Salmeterol | Salbutamol | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Salmeterol | Tetrabenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Salmeterol | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salmeterol | Chloropyramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Salmeterol | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI |
Salmeterol | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Methotrimeprazine | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Methylergometrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Salmeterol | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Zuclopenthixol | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Salmeterol | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Salmeterol | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Salmeterol | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Salmeterol | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Salmeterol | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Siponimod | Indacaterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Siponimod | Norepinephrine | 4 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Siponimod | Oxybuprocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Siponimod | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C8 mediated DDI |
Siponimod | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI |
Siponimod | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI |
Siponimod | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Siponimod | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Siponimod | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C8 mediated DDI |
Siponimod | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Siponimod | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Siponimod | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI |
Siponimod | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI |
Siponimod | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Siponimod | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Sulpiride | Hydroxychloroquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sulpiride | Metoclopramide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Sulpiride | Sotalol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sulpiride | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sulpiride | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sulpiride | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Sulpiride | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sulpiride | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sulpiride | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sulpiride | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Sulpiride | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Sulpiride | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Sulpiride | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sulpiride | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Sulpiride | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Talazoparib | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Tizanidine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Tofacitinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Trametinib | Fosfomycin | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Trametinib | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Trametinib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Trametinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Voriconazole | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Voriconazole | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Voriconazole | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Voriconazole | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Voriconazole | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Voriconazole | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Voriconazole | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Aminosalicylic acid | Sotalol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing bradycardia | |
Aminosalicylic acid | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Aminosalicylic acid | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Aminosalicylic acid | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Aminosalicylic acid | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Apalutamide | Phenylephrine | 4 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Atenolol | Cobimetinib | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Indacaterol | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Atenolol | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Dexketoprofen | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Ketoprofen | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Ketorolac | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Loperamide | 4 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Methylergometrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Atenolol | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Atenolol | Biperiden | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Levamisole | 4 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Atenolol | Lidocaine | 4 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Sertindole | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI |
Atenolol | Sertraline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Bedaquiline | Fluphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Bedaquiline | Indacaterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Bedaquiline | Metoprolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bedaquiline | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C9 mediated DDI |
Bedaquiline | Atropine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Bedaquiline | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Bedaquiline | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Bedaquiline | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Bedaquiline | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Bedaquiline | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Bedaquiline | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Bedaquiline | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Bedaquiline | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Bedaquiline | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI |
Bedaquiline | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Bedaquiline | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Bedaquiline | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Clonazepam | Dobutamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Clonazepam | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Clonazepam | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Clonazepam | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Cobimetinib | Metoprolol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cobimetinib | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Cobimetinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Dapsone | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Diatrizoate | Norepinephrine | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Dobutamine | Indapamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Dobutamine | Nitrazepam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Dobutamine | Axitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dobutamine | Chlorambucil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Dobutamine | Fenofibrate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Dobutamine | Isoniazid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Dobutamine | Betahistine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Dobutamine | Leflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Dobutamine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Dobutamine | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Dobutamine | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Dobutamine | Carbamazepine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Dobutamine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Epinephrine | Fosfomycin | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Epinephrine | Olaparib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Paroxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Chloropyramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Epinephrine | Dexketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Epinephrine | Enzalutamide | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Epinephrine | Fluorescein | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Flutamide | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Epinephrine | Ketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Epinephrine | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Pyrazinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Epinephrine | Sunitinib | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Teriflunomide | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Epinephrine | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Leflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Epinephrine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Praziquantel | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Tamoxifen | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Carbamazepine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Epinephrine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Sertraline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Ethambutol | Norepinephrine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Ethambutol | Sotalol | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | |
Ethambutol | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Ethambutol | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Ethambutol | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Ethambutol | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Favipiravir | Metoprolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Favipiravir | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Favipiravir | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Favipiravir | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Favipiravir | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Favipiravir | Ketorolac | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Favipiravir | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Favipiravir | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Favipiravir | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Favipiravir | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Fluphenazine | Fosfomycin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Fluphenazine | Hydroxychloroquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Indacaterol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Fluphenazine | Ivacaftor | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Fluphenazine | Lenvatinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Fluphenazine | Metoclopramide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Fluphenazine | Olaparib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Fluphenazine | Oseltamivir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Fluphenazine | Paroxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Fluphenazine | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Fluphenazine | Risperidone | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Fluphenazine | Bisacodyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Fluphenazine | Cariprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Fluphenazine | Dexketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Fluphenazine | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Fluphenazine | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Ketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Fluphenazine | Ketorolac | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Fluphenazine | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Fluphenazine | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Fluphenazine | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Fluphenazine | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2D6 mediated DDI |
Fluphenazine | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Fluphenazine | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Acetaminophen | 4 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Fluphenazine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Fluphenazine | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Fluphenazine | Loratadine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Praziquantel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Fluphenazine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Fluphenazine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Fluphenazine | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Fluphenazine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fluphenazine | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Fosfomycin | Norepinephrine | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Fosfomycin | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Fosfomycin | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Fosfomycin | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Fosfomycin | Phenylephrine | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Fosfomycin | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Fosfomycin | Warfarin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Fosfomycin | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Fosfomycin | Biperiden | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Fosfomycin | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP3A4 mediated DDI |
Fosfomycin | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP3A4 mediated DDI |
Fosfomycin | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI |
Fosfomycin | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Fosfomycin | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Gliclazide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Hydroxychloroquine | Mebendazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Hydroxychloroquine | Oxybuprocaine | 4 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Hydroxychloroquine | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Hydroxychloroquine | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Hydroxychloroquine | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Hydroxychloroquine | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Hydroxychloroquine | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Hydroxychloroquine | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hydroxychloroquine | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Hydroxychloroquine | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Hydroxychloroquine | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Hydroxychloroquine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Hydroxychloroquine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Hydroxychloroquine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Hydroxychloroquine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Hydroxyzine | Phenylephrine | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI |
Hydroxyzine | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hydroxyzine | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Hydroxyzine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Hydroxyzine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Hydroxyzine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Indacaterol | Norepinephrine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Indacaterol | Sotalol | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Indacaterol | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Indacaterol | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Indacaterol | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Indacaterol | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Indacaterol | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Indacaterol | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Indacaterol | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Indacaterol | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Indacaterol | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Indacaterol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Indacaterol | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Indapamide | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2D6 mediated DDI |
Indapamide | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Indapamide | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Indapamide | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Ivacaftor | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ivacaftor | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ivacaftor | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Ivacaftor | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Ivacaftor | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ivacaftor | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ivacaftor | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ivacaftor | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ivacaftor | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ivacaftor | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ivacaftor | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ivacaftor | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ivacaftor | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ivacaftor | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ivacaftor | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP1A2 mediated DDI |
Ivacaftor | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP3A4 mediated DDI |
Ixazomib | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Ixazomib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Lenalidomide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Lenvatinib | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI |
Lenvatinib | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Lenvatinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lenvatinib | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C8 mediated DDI |
Lenvatinib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lenvatinib | Mitotane | 4 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Norepinephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Mebendazole | Oxybuprocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Mebendazole | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Mebendazole | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Propranolol | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Piracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Mebendazole | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Mebendazole | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Mesalazine | Sotalol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Mesalazine | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Mesalazine | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Mesalazine | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C9 mediated DDI |
Mesalazine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C9 mediated DDI |
Metoclopramide | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Metoclopramide | Propafenone | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoclopramide | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Metoclopramide | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Metoclopramide | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Metoclopramide | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Metoclopramide | Propranolol | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoclopramide | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Metoclopramide | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Metoclopramide | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Metoclopramide | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Metoclopramide | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoclopramide | Tapentadol | 4 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Metoprolol | Paroxetine | 4 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Haloperidol | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Ketorolac | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Tramadol | 4 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Diphenhydramine | 4 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Sertindole | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Amitriptyline | 4 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nevirapine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Nitrazepam | Sotalol | 4 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Nitrazepam | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Norepinephrine | Paroxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Norepinephrine | Tetrabenazine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Cariprazine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Chlorambucil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Norepinephrine | Chloropyramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Norepinephrine | Enzalutamide | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Norepinephrine | Fluorescein | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Norepinephrine | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Norepinephrine | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Norepinephrine | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Norepinephrine | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Norepinephrine | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Norepinephrine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Norepinephrine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Norepinephrine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Norepinephrine | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Norepinephrine | Carbamazepine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Norepinephrine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Norepinephrine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Norepinephrine | Sertraline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Olaparib | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Olaparib | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Olaparib | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Olaparib | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Oseltamivir | Salbutamol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Oseltamivir | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Oseltamivir | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Oseltamivir | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI |
Oseltamivir | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Oseltamivir | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Oseltamivir | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Oseltamivir | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Oseltamivir | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Oseltamivir | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI |
Oseltamivir | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Oseltamivir | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Oxybuprocaine | Paroxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Oxybuprocaine | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Bisacodyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Oxybuprocaine | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Oxybuprocaine | Lacosamide | 4 | CLASS 1 (from 5); Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Oxybuprocaine | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C8 mediated DDI |
Oxybuprocaine | Betahistine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Oxybuprocaine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Oxybuprocaine | Piracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Paroxetine | Periciazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Paroxetine | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Paroxetine | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Paroxetine | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Paroxetine | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Paroxetine | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Paroxetine | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Paroxetine | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Paroxetine | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Paroxetine | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Paroxetine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Paroxetine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Paroxetine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Paroxetine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Pentoxifylline | Sotalol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Periciazine | Perphenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Periciazine | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Periciazine | Amiodarone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Periciazine | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Periciazine | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Periciazine | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Periciazine | Ketorolac | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Periciazine | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Periciazine | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Periciazine | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Periciazine | Propranolol | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Periciazine | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Periciazine | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Periciazine | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Periciazine | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Periciazine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Periciazine | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Periciazine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Periciazine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Periciazine | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Tetrabenazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Perphenazine | Vismodegib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Perphenazine | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Perphenazine | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Perphenazine | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Perphenazine | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Perphenazine | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Perphenazine | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Perphenazine | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Perphenazine | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Perphenazine | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Perphenazine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Perphenazine | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Perphenazine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Perphenazine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Perphenazine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Perphenazine | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Tapentadol | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension; DDI causing tachycardia | CYP2D6 mediated DDI |
Perphenazine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2D6 mediated DDI |
Propafenone | Sotalol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Tetrabenazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Procainamide | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Fluoxetine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Benzyl benzoate | 4 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Pyridoxine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Risperidone | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Risperidone | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Risperidone | Trifluoperazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Risperidone | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Risperidone | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Risperidone | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Risperidone | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C19 mediated DDI |
Salbutamol | Sotalol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing tachycardia | |
Salbutamol | Loperamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2B6 mediated DDI |
Salbutamol | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salbutamol | Methylergometrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salbutamol | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Salbutamol | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salbutamol | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salbutamol | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salbutamol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Salbutamol | Pirfenidone | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension; DDI causing tachycardia | |
Salbutamol | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Sotalol | Tetrabenazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Sotalol | Cariprazine | 4 | CLASS 1 (from 5); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Sotalol | Chlorambucil | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Sotalol | Enzalutamide | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Sotalol | Fluorescein | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Isoniazid | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Sotalol | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Sunitinib | 4 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Sotalol | Acetaminophen | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | |
Sotalol | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Sotalol | Ketamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Sotalol | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Sotalol | Lipoic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia | |
Sulfamethoxazole | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Tetrabenazine | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Tetrabenazine | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Tetrabenazine | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Tetrabenazine | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Tetrabenazine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Tetrabenazine | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Vemurafenib | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Vemurafenib | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP3A4 mediated DDI |
Vemurafenib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Vismodegib | Atropine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Vismodegib | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Vismodegib | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Vismodegib | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Vismodegib | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vismodegib | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C9 mediated DDI |
Vismodegib | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Vismodegib | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Vismodegib | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Vismodegib | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vismodegib | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vismodegib | Piracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Vismodegib | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Vismodegib | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Vismodegib | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Vismodegib | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Acetylsalicylic acid | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Acetylsalicylic acid | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Acetylsalicylic acid | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Acetylsalicylic acid | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Acetylsalicylic acid | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Acetylsalicylic acid | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Acetylsalicylic acid | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Acetylsalicylic acid | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ambroxol | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Aminocaproic acid | Cycloserine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Aminophylline | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Amiodarone | Bisacodyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Amiodarone | Captopril | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Amiodarone | Clonidine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Amiodarone | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Amiodarone | Ketorolac | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Amiodarone | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Amiodarone | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Amiodarone | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Amiodarone | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Amiodarone | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Amiodarone | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Amiodarone | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Amiodarone | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Amiodarone | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Amiodarone | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Amiodarone | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Amiodarone | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Amiodarone | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Amiodarone | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Amiodarone | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Atropine | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Atropine | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Atropine | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Atropine | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Atropine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Atropine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI |
Atropine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Atropine | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Atropine | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Atropine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Atropine | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI |
Atropine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Baclofen | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Bisacodyl | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C8 mediated DDI |
Bisacodyl | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Bisacodyl | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Bisacodyl | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Captopril | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Captopril | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Captopril | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Captopril | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Captopril | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Captopril | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Captopril | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | |
Captopril | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Cariprazine | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Cariprazine | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI |
Cariprazine | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Cariprazine | Phenylephrine | 4 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cariprazine | Procainamide | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Cariprazine | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Cariprazine | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI |
Cariprazine | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Cariprazine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI |
Cariprazine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI |
Cariprazine | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Cariprazine | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Chlorambucil | Dopamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI |
Chloropyramine | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Chloropyramine | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Clonidine | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Clonidine | Clomifene | 4 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension; DDI causing tachycardia | |
Clonidine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Cycloserine | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Cycloserine | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Cycloserine | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Cycloserine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Cycloserine | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI |
Cycloserine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Cycloserine | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Dexketoprofen | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dexketoprofen | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Dexketoprofen | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Dexketoprofen | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C8 mediated DDI |
Dexketoprofen | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Dexketoprofen | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Dopamine | Droperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Dopamine | Enzalutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C8 mediated DDI |
Dopamine | Fluorescein | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Dopamine | Isoniazid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Dopamine | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Dopamine | Methylergometrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Dopamine | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Dopamine | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Dopamine | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Dopamine | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Dopamine | Tranexamic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Dopamine | Betahistine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Dopamine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Dopamine | Ketamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C9 mediated DDI |
Dopamine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Dopamine | Pyrantel | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Dopamine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Dopamine | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Dopamine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Dopamine | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Dopamine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Dopamine | Sertraline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Droperidol | Fingolimod | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Droperidol | Flupentixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Droperidol | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Droperidol | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Droperidol | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Droperidol | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Droperidol | Acetaminophen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Droperidol | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Droperidol | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Droperidol | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Droperidol | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Droperidol | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Droperidol | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Droperidol | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Droperidol | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Droperidol | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Droperidol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Enzalutamide | Phenylephrine | 4 | Major DDI | DDI causing hypertension; DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Fenofibrate | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C8 mediated DDI |
Fingolimod | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Ketoprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Fingolimod | Ketorolac | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fingolimod | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Fingolimod | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Fingolimod | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fingolimod | Betahistine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Fingolimod | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fingolimod | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fingolimod | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Fingolimod | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Fingolimod | Piracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Fingolimod | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fingolimod | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Fingolimod | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Fingolimod | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Fingolimod | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Fingolimod | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fingolimod | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI |
Fingolimod | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Fingolimod | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Fluorescein | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Fluorescein | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Flupentixol | Flutamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Haloperidol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Flupentixol | Ketorolac | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Flupentixol | Methotrimeprazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Flupentixol | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Flupentixol | Propranolol | 4 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Flupentixol | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Flupentixol | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Flupentixol | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Flupentixol | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Flupentixol | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Flupentixol | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Flupentixol | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Flupentixol | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Flupentixol | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Flupentixol | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Flupentixol | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Flutamide | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Flutamide | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Flutamide | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Flutamide | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Flutamide | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Flutamide | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Flutamide | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flutamide | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Flutamide | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Flutamide | Lomustine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Flutamide | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flutamide | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Flutamide | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Lacosamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Haloperidol | Perampanel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Propranolol | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Haloperidol | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI |
Haloperidol | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI |
Haloperidol | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Haloperidol | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Haloperidol | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Haloperidol | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Haloperidol | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Isoniazid | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Isoniazid | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Isoniazid | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Ketoprofen | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Ketoprofen | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Ketoprofen | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C8 mediated DDI |
Ketoprofen | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Ketoprofen | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI |
Ketorolac | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Ketorolac | Propranolol | 4 | Major DDI | DDI causing hypertension; DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ketorolac | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Ketorolac | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Ketorolac | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Ketorolac | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Ketorolac | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Ketorolac | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Ketorolac | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Lacosamide | Phenylephrine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Lacosamide | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Lacosamide | Propranolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Lacosamide | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Lacosamide | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Mefloquine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Loperamide | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Loperamide | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Loperamide | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Loperamide | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Loperamide | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Loperamide | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Loperamide | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI |
Loperamide | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2D6 mediated DDI |
Loperamide | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Loperamide | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI |
Loperamide | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Loperamide | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Loperamide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Lorazepam | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Mefloquine | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Mefloquine | Propranolol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Mefloquine | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Mefloquine | Acetaminophen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Mefloquine | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mefloquine | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Mefloquine | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Mefloquine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Mefloquine | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Mefloquine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mefloquine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mefloquine | Piracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Mefloquine | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Mefloquine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mefloquine | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Mefloquine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Meldonium | Desflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Methotrimeprazine | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Clomipramine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Imipramine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Amitriptyline | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Methotrimeprazine | Benzyl benzoate | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methylergometrine | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Methylergometrine | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Methylergometrine | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Methylergometrine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Methylergometrine | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Methylergometrine | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Methylergometrine | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Methylergometrine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Oxazepam | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Penicillamine | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Perampanel | Procainamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Perampanel | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Perampanel | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Perampanel | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Perampanel | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perampanel | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Perampanel | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perampanel | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perampanel | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perampanel | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Perampanel | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Perampanel | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Perampanel | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Perampanel | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perampanel | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Perampanel | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Perampanel | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Perampanel | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Phenobarbital | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Phenylephrine | Pyrazinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Phenylephrine | Salicylic acid | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Phenylephrine | Sunitinib | 4 | Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Phenylephrine | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Ketamine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Phenylephrine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Phenylephrine | Ondansetron | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Phenylephrine | Praziquantel | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Phenylephrine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Phenylephrine | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Phenylephrine | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Carbamazepine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Phenylephrine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Phenylephrine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Phenylephrine | Sertraline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Procainamide | Procaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Procarbazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Procainamide | Propranolol | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Procainamide | Teriflunomide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Procainamide | Tramadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Procainamide | Tropicamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procainamide | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Procainamide | Betahistine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI |
Procainamide | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Procainamide | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Procainamide | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Procainamide | Piracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Procainamide | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Procainamide | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Procainamide | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Procainamide | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Procaine | Lidocaine | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Procaine | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Procaine | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI |
Procarbazine | Sunitinib | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Procarbazine | Betahistine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI |
Procarbazine | Clomipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Procarbazine | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Procarbazine | Ibuprofen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Procarbazine | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Procarbazine | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Procarbazine | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Procarbazine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Procarbazine | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Procarbazine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Procarbazine | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Procarbazine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Procarbazine | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Procarbazine | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Procarbazine | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Procarbazine | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Procarbazine | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Propranolol | Tramadol | 4 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Levamisole | 4 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Propranolol | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Propranolol | Piracetam | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Propranolol | Sertindole | 4 | Major DDI | DDI causing hypotension; DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Propranolol | Amitriptyline | 4 | Major DDI | DDI causing hypotension; DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Propranolol | Sertraline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Regorafenib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Salicylic acid | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Salicylic acid | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Salicylic acid | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salicylic acid | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Salicylic acid | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Salicylic acid | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salicylic acid | Mitotane | 4 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Sorafenib | Bupivacaine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Sorafenib | Levobupivacaine | 4 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Sorafenib | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Sorafenib | Mitotane | 4 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Sunitinib | Trifluoperazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Sunitinib | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Sunitinib | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Sunitinib | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Sunitinib | Mitotane | 4 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Teriflunomide | Agomelatine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Teriflunomide | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Teriflunomide | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Teriflunomide | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Teriflunomide | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Teriflunomide | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2C19 mediated DDI |
Teriflunomide | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Teriflunomide | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Teriflunomide | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Teriflunomide | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Teriflunomide | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Teriflunomide | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Tramadol | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Tramadol | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tramadol | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Tramadol | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Tramadol | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tramadol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Trifluoperazine | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Trifluoperazine | Zuclopenthixol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Trifluoperazine | Loratadine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Trifluoperazine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Trifluoperazine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Trifluoperazine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Trifluoperazine | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Tropicamide | Umifenovir | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Tropicamide | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tropicamide | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Tropicamide | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Tropicamide | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Tropicamide | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tropicamide | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Tropicamide | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Tropicamide | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Tropicamide | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tropicamide | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Tropicamide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Umifenovir | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Zuclopenthixol | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Zuclopenthixol | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Zuclopenthixol | Clomifene | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Zuclopenthixol | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Zuclopenthixol | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Zuclopenthixol | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Zuclopenthixol | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Zuclopenthixol | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Zuclopenthixol | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Acetaminophen | Bupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Acetaminophen | Clomifene | 4 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Acetaminophen | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Acetaminophen | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Acetaminophen | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Acetaminophen | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Acetaminophen | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Agomelatine | Chlorpromazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Agomelatine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Agomelatine | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Agomelatine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Agomelatine | Rivastigmine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Agomelatine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Agomelatine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Agomelatine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Agomelatine | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Agomelatine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Agomelatine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Betahistine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Betahistine | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Biperiden | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Bupivacaine | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Bupivacaine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Bupivacaine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bupivacaine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Bupivacaine | Loratadine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Bupivacaine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Bupivacaine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Bupivacaine | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Bupivacaine | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Bupivacaine | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Bupivacaine | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Bupivacaine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Bupivacaine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Bupivacaine | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Chlorpromazine | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Chlorpromazine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Chlorpromazine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Chlorpromazine | Piracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Chlorpromazine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Chlorpromazine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Chlorpromazine | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Chlorpromazine | Tapentadol | 4 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Chlorpromazine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Chlorpromazine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Clomifene | Diphenhydramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Clomifene | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Clomifene | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Clomifene | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Clomipramine | Fentanyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Clomipramine | Fluoxetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomipramine | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Clomipramine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Clomipramine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomipramine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomipramine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomipramine | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomipramine | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Clomipramine | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Diazepam | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Diphenhydramine | Imipramine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Diphenhydramine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Diphenhydramine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2D6 mediated DDI |
Diphenhydramine | Nicotinamide | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Diphenhydramine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Diphenhydramine | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Diphenhydramine | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Diphenhydramine | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Diphenhydramine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Diphenhydramine | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Efavirenz | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Fentanyl | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fentanyl | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fentanyl | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Fentanyl | Piracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fentanyl | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fentanyl | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fentanyl | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fentanyl | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Fentanyl | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Fentanyl | Pirfenidone | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fentanyl | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI |
Fluorouracil | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Fluoxetine | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Fluoxetine | Levobupivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Fluoxetine | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Fluoxetine | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Levamisole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Imipramine | Levetiracetam | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Imipramine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Imipramine | Praziquantel | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Imipramine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Imipramine | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Imipramine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Imipramine | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Imipramine | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ketamine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Leflunomide | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Leflunomide | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Levamisole | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Levamisole | Benzyl benzoate | 4 | CLASS 1 (from 3); Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Levetiracetam | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Levetiracetam | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Levobupivacaine | Lidocaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Levobupivacaine | Loratadine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Levobupivacaine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Levobupivacaine | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Levobupivacaine | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Levobupivacaine | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP2C19 mediated DDI |
Levobupivacaine | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Levobupivacaine | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Levobupivacaine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Levobupivacaine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Levobupivacaine | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lidocaine | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP2D6 mediated DDI |
Lidocaine | Trihexyphenidyl | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | CYP1A2 mediated DDI |
Lomustine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Lomustine | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Loratadine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Loratadine | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Midazolam | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Nicotinamide | Tapentadol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Nicotinamide | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nicotinamide | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Oxcarbazepine | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Oxcarbazepine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Praziquantel | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Pyrantel | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Rivastigmine | Ropivacaine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Rivastigmine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Rivastigmine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Rivastigmine | Propofol | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Ropivacaine | Sertindole | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ropivacaine | Tamoxifen | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Ropivacaine | Thioridazine | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ropivacaine | Vinpocetine | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Ropivacaine | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Ropivacaine | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Sertindole | Solifenacin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Sertindole | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Sertindole | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Solifenacin | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Tamoxifen | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Tamoxifen | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tamoxifen | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Tapentadol | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Tapentadol | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Tapentadol | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Thiopental | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Thioridazine | Amitriptyline | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Thioridazine | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | |
Thioridazine | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Trihexyphenidyl | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Trihexyphenidyl | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Trihexyphenidyl | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI |
Valproic acid | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vinpocetine | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Amitriptyline | Benzyl benzoate | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Amitriptyline | Cinacalcet | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Amitriptyline | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Carbamazepine | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Cinacalcet | Clotrimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Cinacalcet | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Pirfenidone | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Propofol | Mitotane | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C9 mediated DDI |
Sertraline | Halothane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Sevelamer | Sevoflurane | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Sevoflurane | Methimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension; DDI causing arrhythmia | |
Halothane | Methimazole | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Halothane | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Mitotane | Oxaliplatin | 4 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Lixisenatide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lixisenatide | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Lixisenatide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lixisenatide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lixisenatide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lixisenatide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lixisenatide | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lixisenatide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lixisenatide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Semaglutide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Semaglutide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Semaglutide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Semaglutide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Semaglutide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Semaglutide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Telavancin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Telavancin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Telavancin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Daptomycin | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Daptomycin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Daptomycin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Daptomycin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daptomycin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Vancomycin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vancomycin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vancomycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vancomycin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Etelcalcetide | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Etelcalcetide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Etelcalcetide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Etelcalcetide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Etelcalcetide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Micafungin | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Pibrentasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Micafungin | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Iopromide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Verapamil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Micafungin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Micafungin | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Micafungin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Micafungin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Micafungin | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Micafungin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Micafungin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Micafungin | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Micafungin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ganirelix | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Ticagrelor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ganirelix | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Ganirelix | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ganirelix | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Ganirelix | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Ganirelix | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ganirelix | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ganirelix | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ganirelix | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Ganirelix | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ganirelix | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ganirelix | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Ganirelix | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ganirelix | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ganirelix | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Ganirelix | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Sennosides | Dobutamine | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia | |
Sennosides | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sennosides | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Sennosides | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sennosides | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Sennosides | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Sennosides | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Streptomycin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Streptomycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Caspofungin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Caspofungin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Caspofungin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Caspofungin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Caspofungin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Caspofungin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Cetrorelix | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cetrorelix | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Cetrorelix | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Cetrorelix | Sotalol | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Cetrorelix | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cetrorelix | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cetrorelix | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Cetrorelix | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cetrorelix | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cetrorelix | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cetrorelix | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cetrorelix | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetrorelix | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cetrorelix | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Cetrorelix | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cetrorelix | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cetrorelix | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Cetrorelix | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Cyanocobalamin | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyanocobalamin | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyanocobalamin | Fosfomycin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyanocobalamin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyanocobalamin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyanocobalamin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cyanocobalamin | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyanocobalamin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cyanocobalamin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Degarelix | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Degarelix | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Degarelix | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Degarelix | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Degarelix | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Degarelix | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Degarelix | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Degarelix | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Degarelix | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Degarelix | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Degarelix | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Degarelix | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Degarelix | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Degarelix | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Degarelix | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Degarelix | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Degarelix | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Degarelix | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Degarelix | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Degarelix | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Degarelix | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Goserelin | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Ticagrelor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Fenoterol | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Goserelin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Goserelin | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Goserelin | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Goserelin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Goserelin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Goserelin | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Goserelin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Goserelin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Clomifene | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | |
Goserelin | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Goserelin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Goserelin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Goserelin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Goserelin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Goserelin | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Goserelin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Goserelin | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Polymyxin B | Pibrentasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Ioversol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Sotalol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Polymyxin B | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Polymyxin B | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Polymyxin B | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Polymyxin B | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Polymyxin B | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Polymyxin B | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Amikacin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amikacin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amikacin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amikacin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amphotericin B | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Amphotericin B | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nystatin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nystatin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Pibrentasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Terlipressin | Ioversol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Terlipressin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Terlipressin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Terlipressin | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Phenylephrine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Terlipressin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Terlipressin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Terlipressin | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Terlipressin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Terlipressin | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Terlipressin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Terlipressin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terlipressin | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Triptorelin | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Pibrentasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Triptorelin | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Iopromide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Triptorelin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Triptorelin | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Norepinephrine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing bradycardia | |
Triptorelin | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Triptorelin | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Triptorelin | Sotalol | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Triptorelin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Triptorelin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Triptorelin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Triptorelin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Triptorelin | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Triptorelin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Triptorelin | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Triptorelin | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Triptorelin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Triptorelin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Triptorelin | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Triptorelin | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Triptorelin | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Triptorelin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Triptorelin | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Triptorelin | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Triptorelin | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Glycyrrhizic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Glycyrrhizic acid | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Leuprolide | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Pibrentasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Leuprolide | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Iopromide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Leuprolide | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Leuprolide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Leuprolide | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Norepinephrine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing bradycardia | |
Leuprolide | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Leuprolide | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Leuprolide | Sotalol | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Leuprolide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Leuprolide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Leuprolide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Leuprolide | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Leuprolide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Leuprolide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Leuprolide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Leuprolide | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Leuprolide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Leuprolide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Leuprolide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leuprolide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Leuprolide | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Leuprolide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Desmopressin | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Ioversol | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Desmopressin | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Desmopressin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Desmopressin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Desmopressin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Desmopressin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Desmopressin | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Desmopressin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Desmopressin | Levamisole | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | |
Desmopressin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Desmopressin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Kanamycin | Hexoprenaline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Kanamycin | Epinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Kanamycin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Kanamycin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Kanamycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Kanamycin | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Iohexol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Ioversol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Iopromide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Ribociclib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Sparfloxacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Acalabrutinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Bictegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Deferasirox | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Capreomycin | Nilotinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Trametinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Apalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Metoprolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Capreomycin | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Propranolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Capreomycin | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Capreomycin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Rifampicin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Rifampicin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Tobramycin | Iopromide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tobramycin | Bictegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tobramycin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tobramycin | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tobramycin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tobramycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tobramycin | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Iohexol | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Atosiban | Ioversol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Atosiban | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Atosiban | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Atosiban | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Atosiban | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Atosiban | Acetaminophen | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Atosiban | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Atosiban | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Atosiban | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Atosiban | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atosiban | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Atosiban | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atosiban | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Azithromycin | Ioversol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Azithromycin | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Azithromycin | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Azithromycin | Atorvastatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Azithromycin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Azithromycin | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Azithromycin | Paliperidone | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Azithromycin | Mebendazole | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Azithromycin | Paroxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Azithromycin | Risperidone | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Azithromycin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Azithromycin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Procarbazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Azithromycin | Sunitinib | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Azithromycin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Azithromycin | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Azithromycin | Imipramine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Azithromycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Azithromycin | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Azithromycin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Azithromycin | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Azithromycin | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Azithromycin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ceftaroline fosamil | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Clarithromycin | Ivabradine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Clarithromycin | Atorvastatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Clarithromycin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clarithromycin | Drotaverine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Paliperidone | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Clarithromycin | Mebendazole | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Paroxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Risperidone | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Clarithromycin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Clarithromycin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clarithromycin | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Clarithromycin | Sunitinib | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Clarithromycin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Clarithromycin | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clarithromycin | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Clarithromycin | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Clarithromycin | Imipramine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Clarithromycin | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clarithromycin | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Clarithromycin | Sertindole | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Clarithromycin | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Clarithromycin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Digoxin | Iohexol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Digoxin | Ioversol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Digoxin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Digoxin | Teriflunomide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Digoxin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Everolimus | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Everolimus | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Everolimus | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Josamycin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Josamycin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Josamycin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Josamycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Josamycin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Josamycin | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Natamycin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Natamycin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Natamycin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Natamycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rifabutin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Rifabutin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Carbetocin | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Ioversol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Carbetocin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carbetocin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carbetocin | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Carbetocin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Carbetocin | Acetaminophen | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Carbetocin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Carbetocin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Carbetocin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carbetocin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbetocin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Cyclosporine | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Cyclosporine | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Cyclosporine | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Cyclosporine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyclosporine | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyclosporine | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyclosporine | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyclosporine | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Cyclosporine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cyclosporine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Cyclosporine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Cyclosporine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Doxorubicin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Doxorubicin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doxorubicin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Doxorubicin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doxorubicin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doxorubicin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doxorubicin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doxorubicin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Epirubicin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Epirubicin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Epirubicin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Epirubicin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Epirubicin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Epirubicin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Epirubicin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Epirubicin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Eribulin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Eribulin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Eribulin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Etoposide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Folic acid | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Folic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gentamicin | Octreotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gentamicin | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gentamicin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gentamicin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Grazoprevir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lanreotide | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Pibrentasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lanreotide | Posaconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Tenofovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lanreotide | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Ombitasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Ribociclib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Acalabrutinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Bictegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Nintedanib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Lanreotide | Verapamil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Lanreotide | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lanreotide | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Carvedilol | 3 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing bradycardia | |
Lanreotide | Chloramphenicol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Lanreotide | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Lanreotide | Mebeverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Lanreotide | Salmeterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Lanreotide | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Trametinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lanreotide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Ethambutol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Lanreotide | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lanreotide | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lanreotide | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Lanreotide | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Lanreotide | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Lanreotide | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Lanreotide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Lanreotide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lanreotide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lanreotide | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Lanreotide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lanreotide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Lanreotide | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Lanreotide | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lanreotide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Lanreotide | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Lanreotide | Ethanol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Lanreotide | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Lanreotide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Lanreotide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lanreotide | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methotrexate | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Methotrexate | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Grazoprevir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Pibrentasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Posaconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Ertugliflozin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Ombitasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Ribociclib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Acalabrutinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Bictegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Mannitol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Octreotide | Verapamil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Apixaban | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Octreotide | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Carvedilol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Chloramphenicol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Salmeterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Octreotide | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Trametinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Octreotide | Apalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Ethambutol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Octreotide | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Octreotide | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Flutamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI |
Octreotide | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Octreotide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Octreotide | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Octreotide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Octreotide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Octreotide | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Octreotide | Ethanol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Octreotide | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Octreotide | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Octreotide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Octreotide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Octreotide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Octreotide | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cromoglicic acid | Macitentan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Cromoglicic acid | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Cromoglicic acid | Iomeprol | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Isosorbide dinitrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Cromoglicic acid | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Cromoglicic acid | Selexipag | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Cromoglicic acid | Methyldopa | 3 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing bradycardia | |
Cromoglicic acid | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Cromoglicic acid | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Cromoglicic acid | Siponimod | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Cromoglicic acid | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cromoglicic acid | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Cromoglicic acid | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Cromoglicic acid | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Cromoglicic acid | Lacosamide | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | |
Cromoglicic acid | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Cromoglicic acid | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Cromoglicic acid | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cromoglicic acid | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Cromoglicic acid | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Cromoglicic acid | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Cromoglicic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Cromoglicic acid | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Cromoglicic acid | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Daunorubicin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Daunorubicin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daunorubicin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Daunorubicin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daunorubicin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daunorubicin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daunorubicin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daunorubicin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lactulose | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Leucovorin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Rifamycin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Tacrolimus | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tacrolimus | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tacrolimus | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ademetionine | Procarbazine | 3 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia | |
Ademetionine | Bupivacaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia | |
Ademetionine | Levobupivacaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia | |
Ademetionine | Mitotane | 3 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI |
Ceftazidime | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Chlorhexidine | Iopromide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Chlorhexidine | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Chlorhexidine | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Chlorhexidine | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Chlorhexidine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Chlorhexidine | Fingolimod | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Chlorhexidine | Flutamide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Chlorhexidine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Chlorhexidine | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Chlorhexidine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Chlorhexidine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Chlorhexidine | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Chlorhexidine | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Chlorhexidine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Chlorhexidine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Citicoline | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Glecaprevir | Verapamil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Glecaprevir | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Glecaprevir | Metoprolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Glecaprevir | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Glecaprevir | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Glecaprevir | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Glecaprevir | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Glecaprevir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Glecaprevir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Glecaprevir | Propranolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Glecaprevir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Glecaprevir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Glecaprevir | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Glecaprevir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Glecaprevir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Glecaprevir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Glecaprevir | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Glecaprevir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Glecaprevir | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Glecaprevir | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Glecaprevir | Methimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Glecaprevir | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Grazoprevir | Hexoprenaline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Grazoprevir | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Grazoprevir | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Grazoprevir | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Grazoprevir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Grazoprevir | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Grazoprevir | Epinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Grazoprevir | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Grazoprevir | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Grazoprevir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Grazoprevir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Grazoprevir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Grazoprevir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Grazoprevir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Grazoprevir | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Grazoprevir | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Grazoprevir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Grazoprevir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Grazoprevir | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Grazoprevir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Grazoprevir | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Grazoprevir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Grazoprevir | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Grazoprevir | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Grazoprevir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Grazoprevir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Grazoprevir | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Grazoprevir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Grazoprevir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Grazoprevir | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Grazoprevir | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Grazoprevir | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Grazoprevir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Grazoprevir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Grazoprevir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Grazoprevir | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Grazoprevir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Grazoprevir | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Idarubicin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Idarubicin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Idarubicin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Idarubicin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Idarubicin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Idarubicin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Idarubicin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mitoxantrone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mitoxantrone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Mitoxantrone | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Paritaprevir | Pasireotide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Posaconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Paritaprevir | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Fenoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Paritaprevir | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Paritaprevir | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Paritaprevir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paritaprevir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paritaprevir | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paritaprevir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Paritaprevir | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Pasireotide | Pibrentasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Ertapenem | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Ombitasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Acalabrutinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Bictegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Irinotecan | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Mannitol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Pasireotide | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pasireotide | Verapamil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pasireotide | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Enalapril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Pasireotide | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Pasireotide | Formoterol | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Pasireotide | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Talazoparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Trametinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pasireotide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pasireotide | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pasireotide | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Norepinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Pasireotide | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pasireotide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pasireotide | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pasireotide | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pasireotide | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Pasireotide | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pasireotide | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Pasireotide | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pasireotide | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pasireotide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Pasireotide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Carfilzomib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Dolutegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Irinotecan | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Verapamil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pibrentasvir | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Chloramphenicol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Pibrentasvir | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Mebeverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Pibrentasvir | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Pibrentasvir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pibrentasvir | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pibrentasvir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Pibrentasvir | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pibrentasvir | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Pibrentasvir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Pibrentasvir | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pimecrolimus | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pimecrolimus | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pimecrolimus | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Venetoclax | Hexoprenaline | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C9 mediated DDI |
Venetoclax | Amlodipine | 3 | Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Venetoclax | Carvedilol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI |
Venetoclax | Nifedipine | 3 | Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Venetoclax | Epinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Venetoclax | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Venetoclax | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Venetoclax | Phenylephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Venetoclax | Propranolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI |
Venetoclax | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Venetoclax | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bosentan | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bosentan | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Doxazosin | Ioversol | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C19 mediated DDI |
Doxazosin | Iomeprol | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Iopromide | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Isosorbide dinitrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Doxazosin | Gefitinib | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C19 mediated DDI |
Doxazosin | Ivabradine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Doxazosin | Cabozantinib | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Drotaverine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Doxazosin | Sulpiride | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Doxazosin | Mebendazole | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C19 mediated DDI |
Doxazosin | Metoclopramide | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Periciazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Doxazosin | Tetrabenazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Doxazosin | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Doxazosin | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Doxazosin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doxazosin | Fingolimod | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Haloperidol | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Doxazosin | Procainamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Chlorpromazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Doxazosin | Clomifene | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doxazosin | Ropivacaine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Doxazosin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Doxycycline | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doxycycline | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Alendronic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Hexoprenaline | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Imipenem | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Iohexol | Carvedilol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iohexol | Fenoterol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Iohexol | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Nifedipine | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Iohexol | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Dobutamine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Epinephrine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Fosfomycin | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Norepinephrine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iohexol | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Sotalol | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iohexol | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Fingolimod | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Iohexol | Haloperidol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Iohexol | Loperamide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iohexol | Procainamide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Propranolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Iohexol | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iohexol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iohexol | Clomifene | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Iohexol | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iohexol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iohexol | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Lidocaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iohexol | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Iohexol | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iohexol | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iohexol | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Ioversol | Posaconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ioversol | Alendronic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Ertapenem | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Atazanavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Darunavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Gefitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ioversol | Imatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Ombitasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ioversol | Saquinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Ciprofloxacin | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | |
Ioversol | Imipenem | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Irinotecan | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Meropenem | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ioversol | Carvedilol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ioversol | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Ioversol | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ioversol | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ioversol | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ioversol | Dapsone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Dobutamine | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Ioversol | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ioversol | Norepinephrine | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Ioversol | Oxybuprocaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Ioversol | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ioversol | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Sotalol | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ioversol | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ioversol | Captopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Clonidine | 3 | Major DDI | DDI causing hypotension; DDI causing tachycardia | |
Ioversol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ioversol | Fingolimod | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Ioversol | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ioversol | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ioversol | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Phenylephrine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Ioversol | Procainamide | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | |
Ioversol | Procaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Ioversol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ioversol | Clomifene | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Ioversol | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ioversol | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ioversol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ioversol | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Lidocaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Ioversol | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Ioversol | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ioversol | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ioversol | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Ioversol | Mitotane | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Macitentan | Gefitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Macitentan | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Macitentan | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Macitentan | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Macitentan | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Macitentan | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Macitentan | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Macitentan | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Macitentan | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pemetrexed | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pemetrexed | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pemetrexed | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pemetrexed | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pemetrexed | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pemetrexed | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pemetrexed | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Posaconazole | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Posaconazole | Iopromide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Posaconazole | Bictegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Bromocriptine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Posaconazole | Irinotecan | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Atorvastatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Posaconazole | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Posaconazole | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Sotalol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Posaconazole | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Posaconazole | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Posaconazole | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Posaconazole | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Posaconazole | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Posaconazole | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Posaconazole | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Posaconazole | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Posaconazole | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Posaconazole | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Posaconazole | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Posaconazole | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Posaconazole | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP3A4 mediated DDI | |
Posaconazole | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Posaconazole | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Raltitrexed | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Raltitrexed | Fenoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Raltitrexed | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Raltitrexed | Epinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Raltitrexed | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Raltitrexed | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Raltitrexed | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Raltitrexed | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Raltitrexed | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltitrexed | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Raltitrexed | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Raltitrexed | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Remdesivir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Remdesivir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Riboflavin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Tetracycline | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetracycline | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Deferasirox | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ticagrelor | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ticagrelor | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ticagrelor | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ticagrelor | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ticagrelor | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ticagrelor | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ticagrelor | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ticagrelor | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Valganciclovir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vinblastine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Vinblastine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alendronic acid | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alendronic acid | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alendronic acid | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alfuzosin | Bosutinib | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Alfuzosin | Piribedil | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Cetirizine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Drotaverine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Alfuzosin | Hydroxyzine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Alfuzosin | Oxybuprocaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Perphenazine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alfuzosin | Cariprazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Alfuzosin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Alfuzosin | Fingolimod | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Alfuzosin | Flutamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Alfuzosin | Procainamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Alfuzosin | Teriflunomide | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | |
Alfuzosin | Tropicamide | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Alfuzosin | Agomelatine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2C19 mediated DDI |
Alfuzosin | Clomipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Alfuzosin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alfuzosin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alfuzosin | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Azacitidine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bosutinib | Ceritinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bosutinib | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bosutinib | Nintedanib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Bosutinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bosutinib | Chloramphenicol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Bosutinib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bosutinib | Paliperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Bosutinib | Aminosalicylic acid | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Bosutinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bosutinib | Mebendazole | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Bosutinib | Mesalazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Bosutinib | Perphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Bosutinib | Propafenone | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Bosutinib | Risperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Bosutinib | Sotalol | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Bosutinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bosutinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bosutinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bosutinib | Flupentixol | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bosutinib | Methotrimeprazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Procaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Bosutinib | Salicylic acid | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bosutinib | Agomelatine | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Chlorpromazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Clomipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bosutinib | Imipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bosutinib | Lidocaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Bosutinib | Cinacalcet | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bosutinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Ertapenem | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Lisinopril | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | |
Carfilzomib | Piribedil | 3 | Major DDI | DDI causing hypotension; DDI causing tachycardia | |
Carfilzomib | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carfilzomib | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Carfilzomib | Chloramphenicol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Carfilzomib | Enalapril | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | |
Carfilzomib | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2B6 mediated DDI |
Carfilzomib | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Carfilzomib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carfilzomib | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carfilzomib | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Aminocaproic acid | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carfilzomib | Atropine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Carfilzomib | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2B6 mediated DDI |
Carfilzomib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carfilzomib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Carfilzomib | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Carfilzomib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Carfilzomib | Salicylic acid | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Carfilzomib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carfilzomib | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Carfilzomib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carfilzomib | Acetaminophen | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Carfilzomib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carfilzomib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Carfilzomib | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Carfilzomib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carfilzomib | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carfilzomib | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carfilzomib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Carfilzomib | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Carfilzomib | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Carfilzomib | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Delamanid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Hexoprenaline | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C9 mediated DDI |
Ceritinib | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Iopromide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Riociguat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Ceritinib | Apremilast | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Gefitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Linagliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ceritinib | Raltegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Saquinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Selexipag | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Acalabrutinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Bromocriptine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Irinotecan | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Ivabradine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Nilotinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Tamsulosin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ceritinib | Verapamil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ceritinib | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ceritinib | Atorvastatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Ceritinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Bisoprolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Cabozantinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Carvedilol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Ceritinib | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Dorzolamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Mebeverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Ceritinib | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Paliperidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Phenoxymethylpenicillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Trametinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Atenolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Ethambutol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Lenvatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Metoclopramide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Metoprolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Nevirapine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Oxybuprocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ceritinib | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Propafenone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Ceritinib | Risperidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Ceritinib | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Ceritinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ceritinib | Bisacodyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Ceritinib | Caffeine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ceritinib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ceritinib | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Ceritinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Fluorescein | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ceritinib | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Ceritinib | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ceritinib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ceritinib | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Ceritinib | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Procaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Propranolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Betahistine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Ceritinib | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Brivaracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ceritinib | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ceritinib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ceritinib | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ceritinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Loratadine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Ceritinib | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ceritinib | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ceritinib | Protionamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Ceritinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ceritinib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Dabigatran etexilate | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Dabigatran etexilate | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Dasatinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasatinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasatinib | Procarbazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Dasatinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Dasatinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasatinib | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Delamanid | Hexoprenaline | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Delamanid | Verapamil | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Delamanid | Fenoterol | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Delamanid | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Delamanid | Norepinephrine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Delamanid | Sotalol | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Delamanid | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Delamanid | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Delamanid | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Delamanid | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Delamanid | Procainamide | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | |
Delamanid | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Delamanid | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Delamanid | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI |
Delamanid | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Delamanid | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Delamanid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Delamanid | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Delamanid | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ertapenem | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Verapamil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP3A4 mediated DDI |
Ertapenem | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ertapenem | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ertapenem | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Ertapenem | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ertapenem | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ertapenem | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Ertapenem | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertapenem | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Ertapenem | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Fludarabine | Halothane | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Fosamprenavir | Iomeprol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fosamprenavir | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Fosamprenavir | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Fosamprenavir | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Phenylephrine | 3 | CLASS 1 (from 3); Major DDI | DDI causing tachycardia | |
Fosamprenavir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Fosamprenavir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Fosamprenavir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fosamprenavir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Fosamprenavir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Fosamprenavir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fosamprenavir | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Hexoprenaline | Palbociclib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Hexoprenaline | Abemaciclib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2C9 mediated DDI |
Hexoprenaline | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Hexoprenaline | Lisinopril | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Hexoprenaline | Ombitasvir | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Hexoprenaline | Osimertinib | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Hexoprenaline | Timolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Hexoprenaline | Bortezomib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Bromocriptine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Hexoprenaline | Vandetanib | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Ibrutinib | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Hexoprenaline | Trametinib | 3 | Major DDI | DDI causing hypertension; DDI causing arrhythmia | |
Hexoprenaline | Indapamide | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Hexoprenaline | Lenvatinib | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Hexoprenaline | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Hexoprenaline | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Hexoprenaline | Sulfamethoxazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Hexoprenaline | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Hexoprenaline | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Hexoprenaline | Dexketoprofen | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Ketoprofen | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Tramadol | 3 | CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Hexoprenaline | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Hexoprenaline | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C9 mediated DDI |
Hexoprenaline | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Iomeprol | Afatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Atazanavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Cobicistat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Darunavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Gefitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Imatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Lisinopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Moxifloxacin | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | |
Iomeprol | Ombitasvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Raltegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Saquinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Bictegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iomeprol | Ciprofloxacin | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | |
Iomeprol | Dolutegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iomeprol | Imipenem | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Irinotecan | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Ivabradine | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iomeprol | Meropenem | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Nilotinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Vandetanib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Iomeprol | Formoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Iomeprol | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Iomeprol | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Epinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Iomeprol | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Iomeprol | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iomeprol | Metoclopramide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iomeprol | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Bisacodyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iomeprol | Captopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iomeprol | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Lacosamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iomeprol | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Iomeprol | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iomeprol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Lidocaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | |
Iomeprol | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Iomeprol | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iomeprol | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Benzyl benzoate | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Iomeprol | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iomeprol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iomeprol | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Iopromide | Atazanavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iopromide | Gefitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Iopromide | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Carbidopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iopromide | Imipenem | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Nimodipine | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Iopromide | Nintedanib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Iopromide | Olodaterol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Iopromide | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Iopromide | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Iopromide | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Iopromide | Formoterol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Iopromide | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iopromide | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Salmeterol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Sulpiride | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Iopromide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Iopromide | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Iopromide | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iopromide | Indacaterol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iopromide | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Iopromide | Metoclopramide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Iopromide | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iopromide | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Iopromide | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iopromide | Caffeine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Iopromide | Captopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iopromide | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Iopromide | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iopromide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iopromide | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Iopromide | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iopromide | Tramadol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Iopromide | Umifenovir | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Iopromide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Iopromide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iopromide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Iopromide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Iopromide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iopromide | Benzyl benzoate | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Iopromide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Iopromide | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Iopromide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Isosorbide dinitrate | Lisinopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Drotaverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Enalapril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Fenoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Isosorbide dinitrate | Atenolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Ethambutol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Metoprolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Propafenone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Captopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Propranolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide dinitrate | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Isosorbide dinitrate | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Palbociclib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Palbociclib | Carvedilol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Palbociclib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Palbociclib | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Palbociclib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Palbociclib | Procarbazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Palbociclib | Propranolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Palbociclib | Trifluoperazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Palbociclib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Palbociclib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Palbociclib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Riociguat | Fenoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Riociguat | Telbivudine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Riociguat | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Riociguat | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Riociguat | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Riociguat | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Riociguat | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Riociguat | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Riociguat | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Riociguat | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Riociguat | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Riociguat | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Riociguat | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Riociguat | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Riociguat | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Riociguat | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Riociguat | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Riociguat | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Riociguat | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Sulfasalazine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Sulfasalazine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sulfasalazine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sulfasalazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Sulfasalazine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Sulfasalazine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Tenofovir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tenofovir | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tenofovir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Tenofovir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Tenofovir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tenofovir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Tenofovir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tenofovir | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Tenofovir | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Velpatasvir | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Velpatasvir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Velpatasvir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Velpatasvir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Velpatasvir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Velpatasvir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Velpatasvir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Velpatasvir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Velpatasvir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Velpatasvir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Velpatasvir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Velpatasvir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Velpatasvir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Velpatasvir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Velpatasvir | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Vinorelbine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Zoledronic acid | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Abemaciclib | Bisoprolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Abemaciclib | Carvedilol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Abemaciclib | Fenoterol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Abemaciclib | Atenolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Abemaciclib | Epinephrine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Abemaciclib | Metoprolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Abemaciclib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Abemaciclib | Phenylephrine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Abemaciclib | Propranolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Abemaciclib | Teriflunomide | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Abemaciclib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Abemaciclib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Abemaciclib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Abemaciclib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acyclovir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Afatinib | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Afatinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Afatinib | Metoclopramide | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Afatinib | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Afatinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Afatinib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Afatinib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Afatinib | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Afatinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Afatinib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Afatinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Afatinib | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Tamoxifen | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Afatinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Afatinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Afatinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Afatinib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apremilast | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apremilast | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apremilast | Mebeverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Apremilast | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apremilast | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Fosfomycin | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Apremilast | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Metoclopramide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apremilast | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Apremilast | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apremilast | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Apremilast | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Apremilast | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apremilast | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apremilast | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apremilast | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Apremilast | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apremilast | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Apremilast | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apremilast | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Irinotecan | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Atazanavir | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Atazanavir | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Atazanavir | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP3A4 mediated DDI | |
Atazanavir | Atorvastatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Atazanavir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Atazanavir | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Atazanavir | Formoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Atazanavir | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Atazanavir | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atazanavir | Salmeterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atazanavir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Atazanavir | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atazanavir | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Atazanavir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Atropine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP3A4 mediated DDI | |
Atazanavir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Atazanavir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atazanavir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Atazanavir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Atazanavir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Methotrimeprazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Atazanavir | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atazanavir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atazanavir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atazanavir | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atazanavir | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Atazanavir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Atazanavir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Atazanavir | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Atazanavir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atazanavir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Atazanavir | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atazanavir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Atazanavir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Atazanavir | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Benserazide | Nimodipine | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Benserazide | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Benserazide | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Benserazide | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Benserazide | Atropine | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing tachycardia | |
Benserazide | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Benserazide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Benserazide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Benserazide | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Benserazide | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Benserazide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Benserazide | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Benserazide | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Benserazide | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Benserazide | Clomipramine | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Benserazide | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Benserazide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Benserazide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Benserazide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Benserazide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Benserazide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Benserazide | Amitriptyline | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Benserazide | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Benserazide | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Cladribine | Oxybuprocaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI |
Cladribine | Dopamine | 3 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2C9 mediated DDI |
Cladribine | Propranolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia | |
Cobicistat | Irinotecan | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Cobicistat | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Cobicistat | Atorvastatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Fenoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Cobicistat | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Cobicistat | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cobicistat | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cobicistat | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobicistat | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cobicistat | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cobicistat | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Cobicistat | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cobicistat | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Cobicistat | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Cobicistat | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cobicistat | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Cobicistat | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cobicistat | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cobicistat | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cobicistat | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Cobicistat | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Cobicistat | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cobicistat | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobicistat | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Cobicistat | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Cobicistat | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cobicistat | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cobicistat | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Cobicistat | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Cytarabine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Darunavir | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Darunavir | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Darunavir | Atorvastatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Darunavir | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Darunavir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Darunavir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Darunavir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Darunavir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Darunavir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Darunavir | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Darunavir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Darunavir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Darunavir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Darunavir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Darunavir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Elbasvir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Elbasvir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elbasvir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Elbasvir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Elbasvir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Elbasvir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Elbasvir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elbasvir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Elbasvir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elbasvir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Elbasvir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elbasvir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Elbasvir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Elbasvir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Elbasvir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Elbasvir | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Empagliflozin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Empagliflozin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI |
Empagliflozin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Empagliflozin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Empagliflozin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Empagliflozin | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Empagliflozin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Empagliflozin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Erlotinib | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Erlotinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Erlotinib | Metoclopramide | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Erlotinib | Oxybuprocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Erlotinib | Periciazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Erlotinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Erlotinib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Erlotinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Erlotinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Erlotinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Erlotinib | Methotrimeprazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Erlotinib | Procaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Erlotinib | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Erlotinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Erlotinib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Erlotinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Erlotinib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Erlotinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Erlotinib | Ropivacaine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Erlotinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Erlotinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ertugliflozin | Methyldopa | 3 | CLASS 1 (from 3) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI |
Ertugliflozin | Ethambutol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Ertugliflozin | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ertugliflozin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Ertugliflozin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Ertugliflozin | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ertugliflozin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ertugliflozin | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Ertugliflozin | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Ertugliflozin | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ertugliflozin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Ertugliflozin | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ertugliflozin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ertugliflozin | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Ertugliflozin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Lapatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Gefitinib | Vandetanib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Gefitinib | Alectinib | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C8 mediated DDI |
Gefitinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gefitinib | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gefitinib | Drotaverine | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Gefitinib | Fenoterol | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Gefitinib | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Gefitinib | Formoterol | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI |
Gefitinib | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Gefitinib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gefitinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gefitinib | Sulpiride | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gefitinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Gefitinib | Epinephrine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI |
Gefitinib | Norepinephrine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Gefitinib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Gefitinib | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gefitinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gefitinib | Cariprazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Gefitinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gefitinib | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Gefitinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gefitinib | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gefitinib | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gefitinib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gefitinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Gefitinib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gefitinib | Sunitinib | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gefitinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gefitinib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Gefitinib | Zuclopenthixol | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Gefitinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gefitinib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Gefitinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gefitinib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gefitinib | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gefitinib | Benzyl benzoate | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Gefitinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Gefitinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imatinib | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Imatinib | Verapamil | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP3A4 mediated DDI |
Imatinib | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Imatinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imatinib | Bisoprolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Imatinib | Carvedilol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Imatinib | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Imatinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Imatinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Imatinib | Oxybuprocaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Imatinib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Imatinib | Propafenone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Imatinib | Risperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Imatinib | Salbutamol | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Imatinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imatinib | Cariprazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Imatinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Imatinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Imatinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imatinib | Procaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C9 mediated DDI |
Imatinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imatinib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Imatinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imatinib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Imatinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imatinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Imatinib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imatinib | Lidocaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Imatinib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Imatinib | Benzyl benzoate | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Imatinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Imatinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Deferasirox | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Irinotecan | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Ivabradine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Nilotinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Tamsulosin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lapatinib | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Lapatinib | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Lapatinib | Vandetanib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Lapatinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Cabozantinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Carvedilol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lapatinib | Crizotinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Drotaverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lapatinib | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Lapatinib | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Salmeterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Lapatinib | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Trametinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Epinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Lapatinib | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Lenvatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Metoclopramide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Lapatinib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lapatinib | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lapatinib | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Lapatinib | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Lapatinib | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Aminocaproic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Lapatinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Lapatinib | Chlorambucil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Lapatinib | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP3A4 mediated DDI | |
Lapatinib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Lapatinib | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lapatinib | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP3A4 mediated DDI | |
Lapatinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Lapatinib | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Salicylic acid | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Lapatinib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Lapatinib | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Lapatinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lapatinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Lapatinib | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Lapatinib | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lapatinib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lapatinib | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C9 mediated DDI |
Lapatinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lapatinib | Pirfenidone | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Lapatinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Levofloxacin | Raltegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Levofloxacin | Urapidil | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Levofloxacin | Atenolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Levofloxacin | Mebendazole | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Levofloxacin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Levofloxacin | Fluoxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Ropivacaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Levofloxacin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Linagliptin | Ribociclib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Linagliptin | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Linagliptin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Linagliptin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Linagliptin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Lisinopril | Isosorbide mononitrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Lisinopril | Chloramphenicol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Lisinopril | Formoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Lisinopril | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Lisinopril | Methyldopa | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | |
Lisinopril | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Lisinopril | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lisinopril | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Lisinopril | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Lisinopril | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Lisinopril | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Lisinopril | Caffeine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Lisinopril | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Lisinopril | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lisinopril | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lisinopril | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Lisinopril | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Lisinopril | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Lisinopril | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Lisinopril | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Lisinopril | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Lisinopril | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Lisinopril | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Lisinopril | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lisinopril | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lisinopril | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Lisinopril | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Lisinopril | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lisinopril | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Lisinopril | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Lisinopril | Nicotinamide | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Lisinopril | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Lisinopril | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Lisinopril | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Lisinopril | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Lisinopril | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Lisinopril | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Lisinopril | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Mitomycin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mitomycin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Mitomycin | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Moxifloxacin | Raltegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Moxifloxacin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxifloxacin | Fluconazole | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Moxifloxacin | Glyburide | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Moxifloxacin | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxifloxacin | Paroxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Moxifloxacin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxifloxacin | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxifloxacin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxifloxacin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxifloxacin | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Moxifloxacin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxifloxacin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxifloxacin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ofloxacin | Raltegravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ofloxacin | Urapidil | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ofloxacin | Atenolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Ofloxacin | Mebendazole | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ofloxacin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ofloxacin | Fluoxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Ropivacaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ofloxacin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ombitasvir | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ombitasvir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ombitasvir | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ombitasvir | Fenoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Ombitasvir | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Ombitasvir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ombitasvir | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ombitasvir | Epinephrine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Ombitasvir | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ombitasvir | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ombitasvir | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Ombitasvir | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Ombitasvir | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ombitasvir | Sotalol | 3 | Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ombitasvir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ombitasvir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Ombitasvir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ombitasvir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ombitasvir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Ombitasvir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ombitasvir | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ombitasvir | Perampanel | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Ombitasvir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ombitasvir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ombitasvir | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ombitasvir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ombitasvir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ombitasvir | Chlorpromazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Ombitasvir | Clomipramine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Ombitasvir | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Ombitasvir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ombitasvir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ombitasvir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Ombitasvir | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Ombitasvir | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Ombitasvir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Ombitasvir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ombitasvir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ombitasvir | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Ombitasvir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Osimertinib | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Osimertinib | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Fenoterol | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Osimertinib | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Osimertinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Osimertinib | Dobutamine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Osimertinib | Epinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Osimertinib | Ethambutol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Fluphenazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Osimertinib | Norepinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Osimertinib | Salbutamol | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Osimertinib | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Osimertinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Osimertinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Osimertinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Osimertinib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Phenylephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Osimertinib | Procainamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Osimertinib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Osimertinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Osimertinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Osimertinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Osimertinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Osimertinib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Pazopanib | Atenolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Pazopanib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pazopanib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Pazopanib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pazopanib | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Raltegravir | Ribociclib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltegravir | Ciprofloxacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Raltegravir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Raltegravir | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Raltegravir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Raltegravir | Epinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Raltegravir | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Raltegravir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Raltegravir | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Raltegravir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Raltegravir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Raltegravir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ribociclib | Carbidopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Ribociclib | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ribociclib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ribociclib | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Ribociclib | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ribociclib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ribociclib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ribociclib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ribociclib | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ribociclib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Ribociclib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Ribociclib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ribociclib | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Ribociclib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ribociclib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Sapropterin | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Saquinavir | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Saquinavir | Verapamil | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Saquinavir | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Atorvastatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Saquinavir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Saquinavir | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Saquinavir | Carvedilol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP3A4 mediated DDI |
Saquinavir | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Saquinavir | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Saquinavir | Salmeterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Saquinavir | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Saquinavir | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Saquinavir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Saquinavir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Saquinavir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Saquinavir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Saquinavir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Saquinavir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Saquinavir | Propranolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2B6 mediated DDI |
Saquinavir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Saquinavir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Zuclopenthixol | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Saquinavir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Saquinavir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Saquinavir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Saquinavir | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Saquinavir | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Saquinavir | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Saquinavir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Saquinavir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Saquinavir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Saquinavir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Selexipag | Formoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Selexipag | Salmeterol | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Selexipag | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Selexipag | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Selexipag | Epinephrine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Selexipag | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Selexipag | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Selexipag | Flutamide | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Selexipag | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI |
Selexipag | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Selexipag | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Selexipag | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Selexipag | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Selexipag | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Selexipag | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Selexipag | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Selexipag | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Selexipag | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Selexipag | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Selexipag | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Selexipag | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Selexipag | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Selexipag | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Sparfloxacin | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sparfloxacin | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Sparfloxacin | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sparfloxacin | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sparfloxacin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sparfloxacin | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sparfloxacin | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sparfloxacin | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sparfloxacin | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sparfloxacin | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sparfloxacin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sparfloxacin | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Tazobactam | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tedizolid | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tedizolid | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tedizolid | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Tedizolid | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tedizolid | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Tedizolid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tedizolid | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tedizolid | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tenofovir alafenamide | Sotalol | 3 | CLASS 1 (from 3); Major DDI | DDI causing tachycardia | |
Tenofovir alafenamide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tenofovir alafenamide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir alafenamide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir alafenamide | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir alafenamide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tenofovir alafenamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Tenofovir alafenamide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Timolol | Carbidopa | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | |
Timolol | Vilanterol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Timolol | Fenoterol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Timolol | Methyldopa | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | |
Timolol | Epinephrine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Timolol | Phenylephrine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Timolol | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Trimethoprim | Fluphenazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Trimethoprim | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Trimethoprim | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Trimethoprim | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Trimethoprim | Trifluoperazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Trimethoprim | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Trimethoprim | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Trimethoprim | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Trimethoprim | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Trimethoprim | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Carbidopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Acalabrutinib | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Acalabrutinib | Verapamil | 3 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Acalabrutinib | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Acalabrutinib | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Carvedilol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Acalabrutinib | Chloramphenicol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Acalabrutinib | Mebeverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Methyldopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Acalabrutinib | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Acalabrutinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Acalabrutinib | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Acalabrutinib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Acalabrutinib | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Acalabrutinib | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Acalabrutinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Acalabrutinib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Acalabrutinib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Acalabrutinib | Propranolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI |
Acalabrutinib | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Acalabrutinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Acalabrutinib | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Acalabrutinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Acalabrutinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Lidocaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | |
Acalabrutinib | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Acalabrutinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Acalabrutinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acalabrutinib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Acalabrutinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Acalabrutinib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Ambrisentan | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Ambrisentan | Mebeverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ambrisentan | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Ambrisentan | Oseltamivir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ambrisentan | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ambrisentan | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Ambrisentan | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Ambrisentan | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Ambrisentan | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ambrisentan | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ambrisentan | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Ambrisentan | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Ambrisentan | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ambrisentan | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Azathioprine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Azathioprine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Baricitinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Baricitinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Baricitinib | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Baricitinib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bictegravir | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Bictegravir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bictegravir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bictegravir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bictegravir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bictegravir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Bictegravir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bictegravir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bictegravir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Bictegravir | Chlorpromazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Bictegravir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bictegravir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bictegravir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Bictegravir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Bictegravir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bictegravir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Bortezomib | Fenoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Bortezomib | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Bortezomib | Epinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Bortezomib | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Bortezomib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bortezomib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bortezomib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Bortezomib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bortezomib | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Bortezomib | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bortezomib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bortezomib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bortezomib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bortezomib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bortezomib | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Bortezomib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Bromocriptine | Levodopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Bromocriptine | Linezolid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bromocriptine | Rivaroxaban | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bromocriptine | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bromocriptine | Atenolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Bromocriptine | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bromocriptine | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Bromocriptine | Metoprolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Bromocriptine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bromocriptine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bromocriptine | Efavirenz | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Bromocriptine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bromocriptine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bromocriptine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Bromocriptine | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bromocriptine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bromocriptine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Bromocriptine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Bromocriptine | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Capecitabine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Capecitabine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Carbidopa | Ivabradine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Carbidopa | Lumacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Carbidopa | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Verapamil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Carbidopa | Cetirizine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Drotaverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C8 mediated DDI |
Carbidopa | Levodopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Carbidopa | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Carbidopa | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Carbidopa | Rivaroxaban | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbidopa | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Carbidopa | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Carbidopa | Atenolol | 3 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing bradycardia | CYP2C8 mediated DDI |
Carbidopa | Ethambutol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Carbidopa | Hydroxyzine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Carbidopa | Metoclopramide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Carbidopa | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Carbidopa | Salbutamol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Carbidopa | Acetylsalicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Carbidopa | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Carbidopa | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Clonidine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Carbidopa | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Carbidopa | Diclofenac | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Carbidopa | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Carbidopa | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Carbidopa | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Carbidopa | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Carbidopa | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Carbidopa | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Carbidopa | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Carbidopa | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Carbidopa | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Carbidopa | Tranexamic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbidopa | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Carbidopa | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carbidopa | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Carbidopa | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carbidopa | Efavirenz | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Carbidopa | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Carbidopa | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Carbidopa | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Carbidopa | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Carbidopa | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Carbidopa | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Carbidopa | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Carbidopa | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Carbidopa | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cilastatin | Formoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cilastatin | Salmeterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cilastatin | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cilastatin | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cilastatin | Atropine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Cilastatin | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cilastatin | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Cilastatin | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cilastatin | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Cilastatin | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cilastatin | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cilastatin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Cilastatin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Cilastatin | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Ciprofloxacin | Urapidil | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Alogliptin | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ciprofloxacin | Bicalutamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ciprofloxacin | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ciprofloxacin | Mebendazole | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Ciprofloxacin | Paroxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Ciprofloxacin | Dopamine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Procainamide | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Procarbazine | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | |
Ciprofloxacin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ciprofloxacin | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Ropivacaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Ciprofloxacin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Dabrafenib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dabrafenib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Daclatasvir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Daclatasvir | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Daclatasvir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Daclatasvir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Daclatasvir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Daclatasvir | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Daclatasvir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Daclatasvir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Daclatasvir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Daclatasvir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Daclatasvir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Daclatasvir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Daclatasvir | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Dapagliflozin | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Dapagliflozin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Dapagliflozin | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Dapagliflozin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dapagliflozin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Dapagliflozin | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Dapagliflozin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Deferasirox | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Deferasirox | Fenoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Deferasirox | Formoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Deferasirox | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Deferasirox | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Deferasirox | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Deferasirox | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Deferasirox | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Deferasirox | Sulfamethoxazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Deferasirox | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Deferasirox | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Deferasirox | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Deferasirox | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Deferasirox | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Deferasirox | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Deferasirox | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Deferasirox | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Deferasirox | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Deferasirox | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Deferasirox | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Deferasirox | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Deferasirox | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Deferasirox | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Deferasirox | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Deferasirox | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Dolutegravir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Dolutegravir | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dolutegravir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dolutegravir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Dolutegravir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dolutegravir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dolutegravir | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dolutegravir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Dolutegravir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Dolutegravir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dolutegravir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dolutegravir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Elvitegravir | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Elvitegravir | Verapamil | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Elvitegravir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Elvitegravir | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Elvitegravir | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elvitegravir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Elvitegravir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Elvitegravir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Elvitegravir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elvitegravir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Elvitegravir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elvitegravir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Elvitegravir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elvitegravir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Elvitegravir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elvitegravir | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Elvitegravir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Elvitegravir | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Elvitegravir | Mitotane | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Etravirine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Etravirine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Etravirine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Etravirine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gemcitabine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Gosogliptin | Nintedanib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Quetiapine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Atenolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | |
Gosogliptin | Fluphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Metoclopramide | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Gosogliptin | Oxybuprocaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Perphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gosogliptin | Procainamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Gosogliptin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gosogliptin | Chlorpromazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Clomipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Imipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Gosogliptin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Gosogliptin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gosogliptin | Mitotane | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP3A4 mediated DDI |
Imipenem | Rivaroxaban | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imipenem | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imipenem | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Imipenem | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Irinotecan | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Irinotecan | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Irinotecan | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Irinotecan | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Irinotecan | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Irinotecan | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Irinotecan | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Irinotecan | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Isosorbide mononitrate | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide mononitrate | Drotaverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide mononitrate | Enalapril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide mononitrate | Fenoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Isosorbide mononitrate | Atenolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide mononitrate | Metoprolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide mononitrate | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide mononitrate | Propranolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Isosorbide mononitrate | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Ivabradine | Nintedanib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Alogliptin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Cabozantinib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Chloramphenicol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Ivabradine | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ivabradine | Atenolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Oseltamivir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Ivabradine | Oxybuprocaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia | |
Ivabradine | Periciazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Ivabradine | Perphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Ivabradine | Sotalol | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Flutamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Ivabradine | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ivabradine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ivabradine | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Chlorpromazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Ivabradine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Ivabradine | Lidocaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Ivabradine | Tamoxifen | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivabradine | Benzyl benzoate | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Ivabradine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Ivabradine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ixabepilone | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Levosimendan | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Levosimendan | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Levosimendan | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Levosimendan | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Levosimendan | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Levosimendan | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Levosimendan | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Levosimendan | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Levosimendan | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Levosimendan | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Lomefloxacin | Atenolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Lomefloxacin | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lomefloxacin | Dopamine | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Lomefloxacin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lomefloxacin | Loperamide | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lomefloxacin | Propranolol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP1A2 mediated DDI |
Lomefloxacin | Teriflunomide | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | |
Lomefloxacin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lomefloxacin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lomefloxacin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lomefloxacin | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lomefloxacin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Lomefloxacin | Mitotane | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Lumacaftor | Nimodipine | 3 | Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP2C9 mediated DDI |
Lumacaftor | Amlodipine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Lumacaftor | Carvedilol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Lumacaftor | Formoterol | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Lumacaftor | Methyldopa | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Lumacaftor | Epinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Lumacaftor | Fluphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Lumacaftor | Norepinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Lumacaftor | Perphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Lumacaftor | Propafenone | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Lumacaftor | Clonidine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Lumacaftor | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lumacaftor | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lumacaftor | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Lumacaftor | Phenylephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Lumacaftor | Propranolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Lumacaftor | Trifluoperazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Lumacaftor | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Lumacaftor | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Mannitol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Mannitol | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Mannitol | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Mannitol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Mannitol | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Meropenem | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Meropenem | Rivaroxaban | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Meropenem | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Meropenem | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Meropenem | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Meropenem | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Meropenem | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Meropenem | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Meropenem | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Meropenem | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Moxonidine | Tizanidine | 3 | Major DDI | DDI causing hypotension; DDI causing tachycardia | |
Moxonidine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxonidine | Clomifene | 3 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing tachycardia | |
Moxonidine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Moxonidine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Moxonidine | Mitotane | 3 | Major DDI | DDI causing hypotension; DDI causing tachycardia | |
Mycophenolate mofetil | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mycophenolate mofetil | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nilotinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Nilotinib | Fenoterol | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Nilotinib | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nilotinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nilotinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nilotinib | Epinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Nilotinib | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Nilotinib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Nilotinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nilotinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nilotinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nilotinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nilotinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nilotinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Nilotinib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Nilotinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nilotinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Nilotinib | Nicotinamide | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Nilotinib | Tapentadol | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Nilotinib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C8 mediated DDI |
Nilotinib | Amitriptyline | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Nilotinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Nilotinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nimodipine | Bicalutamide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nimodipine | Chloramphenicol | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | |
Nimodipine | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nimodipine | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Nimodipine | Siponimod | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Nimodipine | Risperidone | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Nimodipine | Vemurafenib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Nimodipine | Axitinib | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Chlorambucil | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nimodipine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Nimodipine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Nimodipine | Fulvestrant | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Nimodipine | Lacosamide | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Regorafenib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nimodipine | Umifenovir | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nimodipine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nimodipine | Betahistine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Nimodipine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nimodipine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Nimodipine | Pyrantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Nimodipine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Nintedanib | Rilpivirine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Nintedanib | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Nintedanib | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C9 mediated DDI |
Nintedanib | Paliperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Nintedanib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nintedanib | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Nintedanib | Indacaterol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI |
Nintedanib | Ivacaftor | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nintedanib | Mebendazole | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nintedanib | Metoclopramide | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Nintedanib | Oseltamivir | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | |
Nintedanib | Perphenazine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Nintedanib | Risperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Nintedanib | Vismodegib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP3A4 mediated DDI |
Nintedanib | Caffeine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Nintedanib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nintedanib | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Nintedanib | Sunitinib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Nintedanib | Teriflunomide | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nintedanib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Nintedanib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Nintedanib | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Nintedanib | Clomipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Nintedanib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Nintedanib | Levamisole | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | |
Nintedanib | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Nintedanib | Piracetam | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Nintedanib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Nintedanib | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nintedanib | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Nintedanib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olodaterol | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olodaterol | Chloramphenicol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Olodaterol | Mebeverine | 3 | CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Methyldopa | 3 | CLASS 1 (from 3) | DDI causing tachycardia; DDI causing bradycardia | |
Olodaterol | Salmeterol | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Olodaterol | Siponimod | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C8 mediated DDI |
Olodaterol | Oseltamivir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Olodaterol | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Olodaterol | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Olodaterol | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Olodaterol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olodaterol | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Olodaterol | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Olodaterol | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Olodaterol | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Olodaterol | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olodaterol | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Olodaterol | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Olodaterol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Olodaterol | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Olodaterol | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Olodaterol | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Olodaterol | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Olodaterol | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Olodaterol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olodaterol | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Olodaterol | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Olodaterol | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Olodaterol | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Olodaterol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Olodaterol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Olodaterol | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Olodaterol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Piribedil | Verapamil | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Piribedil | Carvedilol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Piribedil | Sulpiride | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Piribedil | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Piribedil | Fluphenazine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Piribedil | Periciazine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Piribedil | Sotalol | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Piribedil | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Piribedil | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Piribedil | Flupentixol | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Piribedil | Haloperidol | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Piribedil | Perampanel | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP3A4 mediated DDI |
Piribedil | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Piribedil | Acetaminophen | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Piribedil | Agomelatine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Piribedil | Clomifene | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Piribedil | Clomipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Piribedil | Fluoxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Piribedil | Imipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Piribedil | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Piribedil | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Piribedil | Amitriptyline | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Piribedil | Cinacalcet | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Rilpivirine | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rilpivirine | Fluphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP3A4 mediated DDI |
Rilpivirine | Oxybuprocaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Rilpivirine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rilpivirine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Rilpivirine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Rilpivirine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Rilpivirine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Rilpivirine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Rilpivirine | Benzyl benzoate | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Rilpivirine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Rilpivirine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Risdiplam | Fosfomycin | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Risdiplam | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Risdiplam | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Ritonavir | Terizidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Urapidil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Ritonavir | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ritonavir | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ritonavir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Ritonavir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ritonavir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Ritonavir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ritonavir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Procainamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP3A4 mediated DDI |
Ritonavir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ritonavir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Ritonavir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Ritonavir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ritonavir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ritonavir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Ritonavir | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Sofosbuvir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sofosbuvir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sofosbuvir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sofosbuvir | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Tamsulosin | Chloramphenicol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Tamsulosin | Levodopa | 3 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Tamsulosin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tamsulosin | Oseltamivir | 3 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tamsulosin | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Tamsulosin | Atropine | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Tamsulosin | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Tamsulosin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tamsulosin | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Tamsulosin | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Tamsulosin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Tamsulosin | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Tamsulosin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tamsulosin | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Tamsulosin | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Tamsulosin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Tamsulosin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Tamsulosin | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Tamsulosin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Tamsulosin | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Tamsulosin | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Tamsulosin | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Terizidone | Vandetanib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Terizidone | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Terizidone | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI | |
Terizidone | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Terizidone | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Linezolid | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Terizidone | Lopinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Terizidone | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Lenvatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Metoclopramide | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Terizidone | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Terizidone | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Terizidone | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Tafluprost | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C8 mediated DDI |
Terizidone | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Terizidone | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Terizidone | Caffeine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Captopril | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | |
Terizidone | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Terizidone | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Terizidone | Betahistine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Terizidone | Dimethyl fumarate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Terizidone | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Terizidone | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Terizidone | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Terizidone | Desflurane | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Ethanol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Terizidone | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Terizidone | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Terizidone | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Urapidil | Alectinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Bisoprolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Urapidil | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Enalapril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Urapidil | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Urapidil | Formoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Urapidil | Mebeverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Methyldopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Urapidil | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Urapidil | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Urapidil | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Urapidil | Atenolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Epinephrine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Urapidil | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Lenvatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Urapidil | Metoprolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Urapidil | Oxybuprocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Urapidil | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Urapidil | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Urapidil | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Urapidil | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Urapidil | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Urapidil | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Urapidil | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Urapidil | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Urapidil | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Urapidil | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Phenylephrine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Urapidil | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Propranolol | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Urapidil | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Urapidil | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Urapidil | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Urapidil | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Urapidil | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Urapidil | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Urapidil | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Urapidil | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Urapidil | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Urapidil | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Urapidil | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Urapidil | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Urapidil | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Urapidil | Oxaliplatin | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Vandetanib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Vandetanib | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Fenoterol | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Vandetanib | Mebeverine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Vandetanib | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Vandetanib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vandetanib | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Vandetanib | Norepinephrine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Vandetanib | Oxybuprocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Vandetanib | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Vandetanib | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vandetanib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vandetanib | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vandetanib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Vandetanib | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vandetanib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vandetanib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Vandetanib | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Vandetanib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Vandetanib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Vandetanib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vandetanib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Vandetanib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Vandetanib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Verapamil | Apixaban | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | CYP3A4 mediated DDI |
Verapamil | Atorvastatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP3A4 mediated DDI |
Verapamil | Lopinavir | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Verapamil | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C9 mediated DDI |
Verapamil | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP3A4 mediated DDI |
Verapamil | Nelfinavir | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Verapamil | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Verapamil | Hydroxychloroquine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2D6 mediated DDI |
Verapamil | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Verapamil | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Verapamil | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Verapamil | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI |
Verapamil | Fenofibrate | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Verapamil | Fluorescein | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Verapamil | Fulvestrant | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Verapamil | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Verapamil | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Verapamil | Regorafenib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Verapamil | Sorafenib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Verapamil | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Verapamil | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Verapamil | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C9 mediated DDI |
Verapamil | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Verapamil | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Verapamil | Lipoic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Verapamil | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Verapamil | Piracetam | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Verapamil | Pyrantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Verapamil | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Verapamil | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP3A4 mediated DDI |
Verapamil | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Verapamil | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vilanterol | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Vilanterol | Carvedilol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Vilanterol | Chloramphenicol | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing bradycardia | |
Vilanterol | Methyldopa | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Vilanterol | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Vilanterol | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Vilanterol | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Vilanterol | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vilanterol | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Vilanterol | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Vilanterol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Vilanterol | Diphenhydramine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vilanterol | Fluoxetine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Vilanterol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vilanterol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Vilanterol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Vilanterol | Amitriptyline | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Zidovudine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Zidovudine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Zopiclone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Zopiclone | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Zopiclone | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Alectinib | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alectinib | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Carvedilol | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI |
Alectinib | Chloramphenicol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Doravirine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Alectinib | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Alectinib | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Alectinib | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Alectinib | Talazoparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Alectinib | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Alectinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Alectinib | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alectinib | Lenalidomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alectinib | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Alectinib | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alectinib | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP3A4 mediated DDI | |
Alectinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Alectinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Alectinib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Alectinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Alectinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Alectinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Alectinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Alectinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Alectinib | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Alectinib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C8 mediated DDI |
Alectinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alectinib | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Alectinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Alectinib | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alogliptin | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alogliptin | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Alogliptin | Salmeterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Alogliptin | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alogliptin | Apalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Alogliptin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Alogliptin | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Alogliptin | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Alogliptin | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Alogliptin | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Alogliptin | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Alogliptin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alogliptin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Alogliptin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alogliptin | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alogliptin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alogliptin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alogliptin | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alogliptin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alogliptin | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Alogliptin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alogliptin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Alogliptin | Efavirenz | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Alogliptin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Alogliptin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Alogliptin | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Alogliptin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Alogliptin | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Alprostadil | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Alprostadil | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amlodipine | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Amlodipine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Amlodipine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Amlodipine | Isoniazid | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Amlodipine | Teriflunomide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Amlodipine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amlodipine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Amlodipine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Amlodipine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Amlodipine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Amlodipine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Amlodipine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Apixaban | Avibactam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Apixaban | Fluphenazine | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Apixaban | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apixaban | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apixaban | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apixaban | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apixaban | Phenylephrine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Apixaban | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apixaban | Trifluoperazine | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Apixaban | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Apixaban | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apixaban | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apixaban | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apixaban | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apixaban | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Apixaban | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apixaban | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apixaban | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apixaban | Cinacalcet | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Apixaban | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Apixaban | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Ascorbic acid | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ascorbic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atorvastatin | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Atorvastatin | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Atorvastatin | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atorvastatin | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Atorvastatin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Atorvastatin | Fosfomycin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Atorvastatin | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Atorvastatin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Atorvastatin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Atorvastatin | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Atorvastatin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Atorvastatin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atorvastatin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atorvastatin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atorvastatin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Avibactam | Bicalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Cabozantinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Drotaverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Elsulfavirine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Avibactam | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Ibrutinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Linezolid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Avibactam | Methyldopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Avibactam | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Perindopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Avibactam | Pomalidomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Rivaroxaban | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Telbivudine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Trametinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Avibactam | Apalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Atenolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Lenalidomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Lenvatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Metoclopramide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Metoprolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Avibactam | Propafenone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Risperidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Avibactam | Salbutamol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Avibactam | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Acetylsalicylic acid | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Avibactam | Atropine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Avibactam | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Bisacodyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Avibactam | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Enzalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Avibactam | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Phenobarbital | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Avibactam | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Avibactam | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Clopidogrel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Avibactam | Dimethyl fumarate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Avibactam | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Avibactam | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Avibactam | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Avibactam | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Avibactam | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Avibactam | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Avibactam | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Avibactam | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Avibactam | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Avibactam | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Avibactam | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Beclomethasone dipropionate | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Betamethasone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Dasabuvir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Bicalutamide | Fenoterol | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Bicalutamide | Fluconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Bicalutamide | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Talazoparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Telbivudine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Bicalutamide | Trametinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Bicalutamide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Fosfomycin | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Bicalutamide | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Lenalidomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Bicalutamide | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Norepinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Bicalutamide | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Oseltamivir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Bicalutamide | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bicalutamide | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bicalutamide | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Stavudine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Bicalutamide | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bicalutamide | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bicalutamide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bicalutamide | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Bicalutamide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Bicalutamide | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Bicalutamide | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bicalutamide | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Bicalutamide | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bicalutamide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bicalutamide | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bicalutamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bicalutamide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bicalutamide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bicalutamide | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Bicalutamide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bicalutamide | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI | |
Bicalutamide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Bicalutamide | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Bicalutamide | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bisoprolol | Miglustat | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | |
Bisoprolol | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisoprolol | Favipiravir | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Bisoprolol | Teriflunomide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisoprolol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bisoprolol | Fluoxetine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisoprolol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Buprenorphine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Buprenorphine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Buprenorphine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Buprenorphine | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Buprenorphine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Buprenorphine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Buprenorphine | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Cabozantinib | Carvedilol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Fenoterol | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cabozantinib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Cabozantinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cabozantinib | Atenolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cabozantinib | Metoprolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Norepinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cabozantinib | Propafenone | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cabozantinib | Atropine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cabozantinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cabozantinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Cabozantinib | Phenylephrine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cabozantinib | Procaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C9 mediated DDI |
Cabozantinib | Propranolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cabozantinib | Chlorpromazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cabozantinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cabozantinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cabozantinib | Benzyl benzoate | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Cabozantinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Cabozantinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Carvedilol | Chloramphenicol | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | |
Carvedilol | Lurasidone | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | |
Carvedilol | Miglustat | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Paliperidone | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Trametinib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Diatrizoate | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Carvedilol | Ivacaftor | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Lenvatinib | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Olaparib | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Risperidone | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Tetrabenazine | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Aminophylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Carvedilol | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Flupentixol | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Flutamide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Carvedilol | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Carvedilol | Sunitinib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Teriflunomide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Tramadol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carvedilol | Acetaminophen | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Fluoxetine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Carvedilol | Nicotinamide | 3 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Carvedilol | Praziquantel | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | |
Carvedilol | Sertindole | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Vinpocetine | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI |
Carvedilol | Amitriptyline | 3 | Major DDI | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Carvedilol | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cephalexin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cephalexin | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cetirizine | Chloramphenicol | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Cetirizine | Formoterol | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Cetirizine | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Cetirizine | Periciazine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Cetirizine | Flutamide | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Cetirizine | Haloperidol | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Cetirizine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Cetirizine | Chlorpromazine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cetirizine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Cetirizine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cetirizine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cetirizine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Cetirizine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Cetirizine | Mitotane | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Chloramphenicol | Drotaverine | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Chloramphenicol | Enalapril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Chloramphenicol | Levodopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Chloramphenicol | Losartan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Chloramphenicol | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Chloramphenicol | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Chloramphenicol | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Chloramphenicol | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Chloramphenicol | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Chloramphenicol | Indapamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Chloramphenicol | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Chloramphenicol | Propafenone | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Chloramphenicol | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Chloramphenicol | Captopril | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing arrhythmia | CYP2C19 mediated DDI |
Chloramphenicol | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Chloramphenicol | Enzalutamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Chloramphenicol | Flutamide | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Chloramphenicol | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Chloramphenicol | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Chloramphenicol | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Chloramphenicol | Propranolol | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Chloramphenicol | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Chloramphenicol | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Chloramphenicol | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Chloramphenicol | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Chloramphenicol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Chloramphenicol | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Chloramphenicol | Levetiracetam | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Chloramphenicol | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Chloramphenicol | Pyrantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Chloramphenicol | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Chloramphenicol | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Chloramphenicol | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Chloramphenicol | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Chloramphenicol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Clavulanic acid | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clavulanic acid | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Crizotinib | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Crizotinib | Dobutamine | 3 | CLASS 1 (from 3); Major DDI | DDI causing tachycardia | |
Crizotinib | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Crizotinib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Crizotinib | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Crizotinib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Crizotinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Desflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Crizotinib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Dacarbazine | Busulfan | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Dacarbazine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Dacarbazine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Dacarbazine | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Dacarbazine | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Dacarbazine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dacarbazine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Dacarbazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Dacarbazine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Dacarbazine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Dasabuvir | Fenoterol | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Dasabuvir | Formoterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Dasabuvir | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Dasabuvir | Mebeverine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Dasabuvir | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Dasabuvir | Norepinephrine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Dasabuvir | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Dasabuvir | Oxybuprocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Dasabuvir | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Dasabuvir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Dasabuvir | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Dasabuvir | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Dasabuvir | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Phenylephrine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Dasabuvir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Dasabuvir | Propranolol | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | CYP2D6 mediated DDI |
Dasabuvir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Dasabuvir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Dasabuvir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Dasabuvir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Dasabuvir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Dasabuvir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dasabuvir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Dasabuvir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Dasabuvir | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Dexamethasone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dinoprostone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doravirine | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Doravirine | Oxacillin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doravirine | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Doravirine | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Doravirine | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Doravirine | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Doravirine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doravirine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Doravirine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Doravirine | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Doravirine | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doravirine | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Doravirine | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Doravirine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Doravirine | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doravirine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Doravirine | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Doravirine | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Doravirine | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI | |
Doravirine | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Doravirine | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Doravirine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Doravirine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Doravirine | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Doravirine | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Doravirine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Doravirine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Doravirine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Doravirine | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Dorzolamide | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C9 mediated DDI |
Drotaverine | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Drotaverine | Linezolid | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | |
Drotaverine | Paliperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Drotaverine | Quetiapine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Drotaverine | Tizanidine | 3 | Major DDI | DDI causing hypotension; DDI causing tachycardia | |
Drotaverine | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Drotaverine | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Drotaverine | Fosfomycin | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP3A4 mediated DDI |
Drotaverine | Oseltamivir | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Drotaverine | Risperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Drotaverine | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Drotaverine | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Drotaverine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Drotaverine | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Drotaverine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Drotaverine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Drotaverine | Tramadol | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Clomipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Drotaverine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Drotaverine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Drotaverine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Drotaverine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Elsulfavirine | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Elsulfavirine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elsulfavirine | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Elsulfavirine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Elsulfavirine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Elsulfavirine | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Elsulfavirine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elsulfavirine | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Elsulfavirine | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elsulfavirine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elsulfavirine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Elsulfavirine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Elsulfavirine | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Elsulfavirine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Elsulfavirine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Emtricitabine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Emtricitabine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Emtricitabine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Enalapril | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Enalapril | Mebeverine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | |
Enalapril | Methyldopa | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | |
Enalapril | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Enalapril | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Enalapril | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Enalapril | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Enalapril | Sulfamethoxazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Enalapril | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Enalapril | Aminophylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Enalapril | Caffeine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Enalapril | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Enalapril | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Enalapril | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Enalapril | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Enalapril | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Enalapril | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Enalapril | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Enalapril | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Enalapril | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Enalapril | Clomipramine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | CYP2D6 mediated DDI |
Enalapril | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Enalapril | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Enalapril | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Enalapril | Nicotinamide | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | CYP2C19 mediated DDI |
Enalapril | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Enalapril | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Enalapril | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Enalapril | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Enalapril | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Esomeprazole | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Esomeprazole | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Fenoterol | Ibrutinib | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Fenoterol | Ipragliflozin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Fenoterol | Linezolid | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Fenoterol | Trametinib | 3 | Major DDI | DDI causing hypertension; DDI causing arrhythmia | |
Fenoterol | Diatrizoate | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Fenoterol | Hydroxychloroquine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Fenoterol | Indapamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Fenoterol | Lenvatinib | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Fenoterol | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Fenoterol | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Fenoterol | Sulfamethoxazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Fenoterol | Baclofen | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Fenoterol | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Fenoterol | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fenoterol | Oxazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Fenoterol | Pyrazinamide | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Fenoterol | Regorafenib | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Fenoterol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fenoterol | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C9 mediated DDI |
Fenoterol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Fenoterol | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Fenoterol | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Fenoterol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fenoterol | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Fenoterol | Oxcarbazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI |
Fluconazole | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Talazoparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Fluconazole | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Ivacaftor | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Fluconazole | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Sotalol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Fluconazole | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Fluconazole | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fluconazole | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Fluconazole | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Fluconazole | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Fluconazole | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Fludrocortisone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Formoterol | Glyburide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Formoterol | Miglustat | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Formoterol | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Formoterol | Fosfomycin | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Formoterol | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Formoterol | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Formoterol | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Formoterol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Formoterol | Fluorescein | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Formoterol | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Formoterol | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Formoterol | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Formoterol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Formoterol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Formoterol | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Formoterol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Formoterol | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Formoterol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Vinpocetine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Formoterol | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Furosemide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Glyburide | Levodopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Nelfinavir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Glyburide | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Glyburide | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Glyburide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Glyburide | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Glyburide | Fosfomycin | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Glyburide | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Glyburide | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI | |
Glyburide | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Glyburide | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Glyburide | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Glyburide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Glyburide | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Glyburide | Bisacodyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Glyburide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Glyburide | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Glyburide | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Glyburide | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Glyburide | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Glyburide | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Glyburide | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Glyburide | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Glyburide | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Glyburide | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Glyburide | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Glyburide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Glyburide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Glyburide | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Piracetam | 3 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Glyburide | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI | |
Glyburide | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Glyburide | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Glyburide | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Glyburide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Glyburide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Glyburide | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Glyburide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI | |
Glyburide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Glyburide | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydrochlorothiazide | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Hydrochlorothiazide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Hydrocortisone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ibrutinib | Atenolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Ibrutinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ibrutinib | Dobutamine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Ibrutinib | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ibrutinib | Metoprolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Ibrutinib | Norepinephrine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Ibrutinib | Sotalol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Ibrutinib | Dopamine | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Ibrutinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ibrutinib | Phenylephrine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Ibrutinib | Propranolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Ibrutinib | Clomifene | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Ibrutinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ipragliflozin | Salmeterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Ipragliflozin | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Ipragliflozin | Epinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Ipragliflozin | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Ipragliflozin | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Ipragliflozin | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Ipragliflozin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ipragliflozin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ipragliflozin | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Lamivudine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Levodopa | Linezolid | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | |
Levodopa | Methyldopa | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing hypotension | |
Levodopa | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Levodopa | Salmeterol | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Levodopa | Epinephrine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Levodopa | Norepinephrine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Levodopa | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Levodopa | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Levodopa | Flupentixol | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Levodopa | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Levodopa | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Levodopa | Procainamide | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia | |
Levodopa | Salicylic acid | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Levodopa | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Levodopa | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Levodopa | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Levodopa | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Levodopa | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Levodopa | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Levodopa | Lidocaine | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing tachycardia | CYP2D6 mediated DDI |
Levodopa | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Levodopa | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Linezolid | Mebeverine | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | |
Linezolid | Methyldopa | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | |
Linezolid | Repaglinide | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | CYP2C8 mediated DDI |
Linezolid | Salmeterol | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Linezolid | Atenolol | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | |
Linezolid | Dobutamine | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | |
Linezolid | Epinephrine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Linezolid | Norepinephrine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Linezolid | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Linezolid | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Linezolid | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Linezolid | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Linezolid | Phenylephrine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Linezolid | Propranolol | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI |
Linezolid | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Linezolid | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Linezolid | Agomelatine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Linezolid | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Linezolid | Clomifene | 3 | Major DDI | DDI causing hypertension; DDI causing hypotension | |
Linezolid | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Linezolid | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Linezolid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Linezolid | Levamisole | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Linezolid | Tapentadol | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Lopinavir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Lopinavir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lopinavir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Lopinavir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lopinavir | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lopinavir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lopinavir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Lopinavir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lopinavir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lopinavir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lopinavir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lopinavir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Lopinavir | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Lopinavir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lopinavir | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Losartan | Methyldopa | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Losartan | Nifedipine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Atenolol | 3 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing arrhythmia | |
Losartan | Epinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C9 mediated DDI |
Losartan | Ethambutol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C9 mediated DDI |
Losartan | Fosfomycin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Losartan | Salbutamol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C9 mediated DDI |
Losartan | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Losartan | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Losartan | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Losartan | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Losartan | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C9 mediated DDI |
Losartan | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Losartan | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Losartan | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Losartan | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Losartan | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Lurasidone | Fosfomycin | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Lurasidone | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Lurasidone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lurasidone | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Lurasidone | Propranolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Lurasidone | Trifluoperazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP1A2 mediated DDI |
Lurasidone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lurasidone | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Mebeverine | Paliperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Mebeverine | Hydroxychloroquine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mebeverine | Risperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Mebeverine | Cariprazine | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Chlorambucil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Mebeverine | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Mebeverine | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Mebeverine | Fluorescein | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Mebeverine | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Mebeverine | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Mebeverine | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Mebeverine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mebeverine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Mebeverine | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Mebeverine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Mebeverine | Clotrimazole | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Mebeverine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Methyldopa | Nitisinone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methyldopa | Indacaterol | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Methyldopa | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methyldopa | Metoprolol | 3 | CLASS 1 (from 3) | DDI causing hypotension; DDI causing bradycardia | |
Methyldopa | Salbutamol | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Methyldopa | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Clonidine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Methyldopa | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methyldopa | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Methyldopa | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methyldopa | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methyldopa | Zuclopenthixol | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI |
Methyldopa | Acetaminophen | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Methyldopa | Betahistine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Methyldopa | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Methyldopa | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Methyldopa | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Methyldopa | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Methyldopa | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methyldopa | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methyldopa | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Methyldopa | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Methyldopa | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Methyldopa | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Miglustat | Salmeterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Miglustat | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Miglustat | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Miglustat | Apalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Miglustat | Fosfomycin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Miglustat | Metoprolol | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Miglustat | Oxybuprocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Miglustat | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Miglustat | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Miglustat | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Miglustat | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Miglustat | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Miglustat | Procaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Miglustat | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Miglustat | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Miglustat | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Miglustat | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Miglustat | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Miglustat | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Miglustat | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Mycophenolic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Mycophenolic acid | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Naltrexone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Naltrexone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nelfinavir | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Nelfinavir | Dobutamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI |
Nelfinavir | Epinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Nelfinavir | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nelfinavir | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nelfinavir | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Nelfinavir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nelfinavir | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI |
Nelfinavir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI | |
Nelfinavir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Nelfinavir | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nelfinavir | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Nelfinavir | Propranolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2B6 mediated DDI |
Nelfinavir | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nelfinavir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nelfinavir | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Nelfinavir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Nelfinavir | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Nelfinavir | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nelfinavir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Nelfinavir | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Nelfinavir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Nelfinavir | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Nelfinavir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Nelfinavir | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Nelfinavir | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Nelfinavir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nelfinavir | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nelfinavir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Nifedipine | Siponimod | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Ixazomib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Nifedipine | Vemurafenib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Nifedipine | Chlorambucil | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Enzalutamide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Nifedipine | Fulvestrant | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Nifedipine | Isoniazid | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nifedipine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nifedipine | Dimethyl fumarate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Nifedipine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Nifedipine | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Nifedipine | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP3A4 mediated DDI |
Nifedipine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Nifedipine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Sulpiride | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Nitisinone | Trametinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Nitisinone | Apalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nitisinone | Atenolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Nitisinone | Hydroxyzine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Nitisinone | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Lenvatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Nitisinone | Metoclopramide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Nitisinone | Metoprolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Nitisinone | Propafenone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Nitisinone | Risperidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Nitisinone | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nitisinone | Captopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Nitisinone | Clonidine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Nitisinone | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Nitisinone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Nitisinone | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nitisinone | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Nitisinone | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nitisinone | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Nitisinone | Procaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Nitisinone | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nitisinone | Propranolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Nitisinone | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nitisinone | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Nitisinone | Acetaminophen | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Nitisinone | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nitisinone | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Nitisinone | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Nitisinone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Nitisinone | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nitisinone | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nitisinone | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nitisinone | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nitisinone | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Nitisinone | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitisinone | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Nitisinone | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Nitisinone | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Nitisinone | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Omeprazole | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Omeprazole | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Oxacillin | Siponimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxacillin | Apalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Oxacillin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxacillin | Lenvatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Oxacillin | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxacillin | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxacillin | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Oxacillin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Oxacillin | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxacillin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxacillin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxacillin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Oxacillin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Oxacillin | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxacillin | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Oxacillin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Oxycodone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Oxycodone | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxycodone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxycodone | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paliperidone | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paliperidone | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paliperidone | Fluphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Paliperidone | Fosfomycin | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Paliperidone | Oseltamivir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Paliperidone | Oxybuprocaine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Paliperidone | Perphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Paliperidone | Sotalol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Paliperidone | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paliperidone | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paliperidone | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paliperidone | Methotrimeprazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Paliperidone | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paliperidone | Chlorpromazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Paliperidone | Clomipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Paliperidone | Imipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Paliperidone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paliperidone | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paliperidone | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paliperidone | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Perindopril | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Perindopril | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Perindopril | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Perindopril | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Perindopril | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Perindopril | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Perindopril | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Phenoxymethylpenicillin | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Phenoxymethylpenicillin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Phenoxymethylpenicillin | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Phenoxymethylpenicillin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Pomalidomide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pomalidomide | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pomalidomide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pomalidomide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pomalidomide | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pomalidomide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pomalidomide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pomalidomide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Pomalidomide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pomalidomide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pomalidomide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Quetiapine | Paroxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Quetiapine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Quetiapine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Quetiapine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Quetiapine | Procarbazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Quetiapine | Clomifene | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Quetiapine | Fluoxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Quetiapine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Quetiapine | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Quetiapine | Nicotinamide | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Quetiapine | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Quetiapine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Repaglinide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Repaglinide | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI |
Repaglinide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Repaglinide | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Repaglinide | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Repaglinide | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Repaglinide | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Repaglinide | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Repaglinide | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Repaglinide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C8 mediated DDI |
Repaglinide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Repaglinide | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Repaglinide | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Repaglinide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Repaglinide | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Rivaroxaban | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rivaroxaban | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rivaroxaban | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rivaroxaban | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rivaroxaban | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rivaroxaban | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rivaroxaban | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Rivaroxaban | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Rivaroxaban | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Salmeterol | Siponimod | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Salmeterol | Apalutamide | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Salmeterol | Hydroxychloroquine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Indacaterol | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Salmeterol | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Salmeterol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Salmeterol | Fluorescein | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Salmeterol | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Salmeterol | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Salmeterol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Salmeterol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Salmeterol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Salmeterol | Sertindole | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Salmeterol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Salmeterol | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Siponimod | Atenolol | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Siponimod | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Siponimod | Epinephrine | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Siponimod | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Siponimod | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Siponimod | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Siponimod | Propafenone | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Siponimod | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Siponimod | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Siponimod | Caffeine | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP1A2 mediated DDI |
Siponimod | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Siponimod | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Siponimod | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Siponimod | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Siponimod | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Siponimod | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Siponimod | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Siponimod | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Siponimod | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Siponimod | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Siponimod | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Siponimod | Phenylephrine | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Siponimod | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Siponimod | Propranolol | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Siponimod | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Siponimod | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Siponimod | Betahistine | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Siponimod | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Siponimod | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Siponimod | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Siponimod | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Siponimod | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Siponimod | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Siponimod | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Siponimod | Rivastigmine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Siponimod | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Siponimod | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Siponimod | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Siponimod | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Siponimod | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Siponimod | Benzyl benzoate | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Siponimod | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Siponimod | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Sulbactam | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Sulpiride | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sulpiride | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sulpiride | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sulpiride | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Sulpiride | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sulpiride | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sulpiride | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sulpiride | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sulpiride | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sulpiride | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sulpiride | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Sulpiride | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Sulpiride | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sulpiride | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sulpiride | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Sulpiride | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sulpiride | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Sulpiride | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sulpiride | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Sulpiride | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Talazoparib | Voriconazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Talazoparib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Talazoparib | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Talazoparib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Talazoparib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Talazoparib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Talazoparib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Talazoparib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Talazoparib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Talazoparib | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Talazoparib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Talazoparib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Talazoparib | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Talazoparib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Talazoparib | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Talazoparib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Talazoparib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Talazoparib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Talazoparib | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Talazoparib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Telbivudine | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Telbivudine | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Telbivudine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Telbivudine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Telbivudine | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Telbivudine | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Telbivudine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Telbivudine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Telbivudine | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Telbivudine | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Telbivudine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Telbivudine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Temozolomide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Temozolomide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Temozolomide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tizanidine | Oxybuprocaine | 3 | Major DDI | DDI causing hypotension; DDI causing tachycardia | |
Tizanidine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tizanidine | Procarbazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Tizanidine | Acetaminophen | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Tizanidine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tizanidine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tizanidine | Mitotane | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2B6 mediated DDI |
Tofacitinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Trametinib | Atenolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Trametinib | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trametinib | Epinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing arrhythmia | |
Trametinib | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trametinib | Norepinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing arrhythmia | |
Trametinib | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trametinib | Propafenone | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Trametinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trametinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trametinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trametinib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trametinib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trametinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trametinib | Procainamide | 3 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Trametinib | Propranolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Trametinib | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trametinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trametinib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Trametinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trametinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trametinib | Clomifene | 3 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | |
Trametinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trametinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Trametinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trametinib | Lidocaine | 3 | CLASS 1 (from 5); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Trametinib | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trametinib | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Trametinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trametinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Trametinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trametinib | Mitotane | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Voriconazole | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Voriconazole | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Voriconazole | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Voriconazole | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Voriconazole | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Aminosalicylic acid | Atenolol | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Aminosalicylic acid | Fluphenazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Aminosalicylic acid | Sulfamethoxazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Aminosalicylic acid | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Aminosalicylic acid | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Aminosalicylic acid | Fingolimod | 3 | CLASS 1 (from 3); Major DDI | DDI causing bradycardia | CYP2C9 mediated DDI |
Aminosalicylic acid | Lacosamide | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Aminosalicylic acid | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Aminosalicylic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Aminosalicylic acid | Levamisole | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | |
Aminosalicylic acid | Thioridazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypertension | |
Aminosalicylic acid | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Aminosalicylic acid | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Aminosalicylic acid | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Anastrozole | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Anastrozole | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Anastrozole | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Anastrozole | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Anastrozole | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Apalutamide | Bedaquiline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Epinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Apalutamide | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Apalutamide | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Norepinephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Apalutamide | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apalutamide | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Apalutamide | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Apalutamide | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Apalutamide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Apalutamide | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Apalutamide | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Apalutamide | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Apalutamide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apalutamide | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Apalutamide | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Apalutamide | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apalutamide | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apalutamide | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Apalutamide | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Apalutamide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apalutamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Apalutamide | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Apalutamide | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Apalutamide | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Apalutamide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apalutamide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Apalutamide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Apalutamide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Apalutamide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Apalutamide | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Atenolol | Favipiravir | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Atenolol | Mesalazine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Atenolol | Fenofibrate | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Flutamide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Regorafenib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Teriflunomide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Atenolol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atenolol | Warfarin | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI |
Atenolol | Diphenhydramine | 3 | CLASS 1 (from 3) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Atenolol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bedaquiline | Clonazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bedaquiline | Cobimetinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Ethambutol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bedaquiline | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Hydroxyzine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Indapamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bedaquiline | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Lenalidomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Lenvatinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Bedaquiline | Mesalazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bedaquiline | Metoclopramide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Nitrazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bedaquiline | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bedaquiline | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bedaquiline | Risperidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bedaquiline | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bedaquiline | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bedaquiline | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Bedaquiline | Acetylsalicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Bisacodyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Bedaquiline | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Bedaquiline | Diclofenac | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Bedaquiline | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Bedaquiline | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Bedaquiline | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bedaquiline | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Bedaquiline | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Bedaquiline | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Bedaquiline | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Lorazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Bedaquiline | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bedaquiline | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Oxazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bedaquiline | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bedaquiline | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Bedaquiline | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Bedaquiline | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bedaquiline | Acetaminophen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bedaquiline | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Bedaquiline | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bedaquiline | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bedaquiline | Diazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bedaquiline | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bedaquiline | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Midazolam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bedaquiline | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bedaquiline | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Bedaquiline | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bedaquiline | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bedaquiline | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Bedaquiline | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Bedaquiline | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Bedaquiline | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Bedaquiline | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bendamustine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bendamustine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Bendamustine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Benzylpenicillin | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Benzylpenicillin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Busulfan | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Busulfan | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Busulfan | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Clonazepam | Epinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Clonazepam | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Clonazepam | Sotalol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Clonazepam | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Clonazepam | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI |
Clonazepam | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Clonazepam | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clonazepam | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clonazepam | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clonazepam | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Cobimetinib | Fluphenazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypotension | CYP2D6 mediated DDI |
Cobimetinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cobimetinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cobimetinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobimetinib | Propranolol | 3 | Major DDI | DDI causing hypotension; DDI causing arrhythmia | CYP2D6 mediated DDI |
Cobimetinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobimetinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobimetinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobimetinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobimetinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobimetinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobimetinib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cobimetinib | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Dapsone | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Dapsone | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Dapsone | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dapsone | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C9 mediated DDI |
Diatrizoate | Fosfomycin | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Diatrizoate | Dopamine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Diatrizoate | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Diatrizoate | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Diatrizoate | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Diatrizoate | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Diatrizoate | Clomifene | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Diatrizoate | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Diatrizoate | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Diatrizoate | Lidocaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Diatrizoate | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Diatrizoate | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Dobutamine | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Dobutamine | Hydroxychloroquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dobutamine | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Dobutamine | Sulfamethoxazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Dobutamine | Tafluprost | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Dobutamine | Baclofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Dobutamine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Dobutamine | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Dobutamine | Fulvestrant | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Dobutamine | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Dobutamine | Lorazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Dobutamine | Oxazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Dobutamine | Phenobarbital | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Dobutamine | Tranexamic acid | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Dobutamine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dobutamine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Dobutamine | Diazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Dobutamine | Dimethyl fumarate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Dobutamine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Dobutamine | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Dobutamine | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Dobutamine | Pyrantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Dobutamine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Epinephrine | Ethambutol | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Favipiravir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Epinephrine | Hydroxychloroquine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Indapamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Epinephrine | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Epinephrine | Nitrazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Epinephrine | Sulfamethoxazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Epinephrine | Tetrabenazine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Epinephrine | Baclofen | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C8 mediated DDI |
Epinephrine | Chlorambucil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Epinephrine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Epinephrine | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Epinephrine | Methotrimeprazine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Epinephrine | Regorafenib | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Epinephrine | Tramadol | 3 | CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Epinephrine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Epinephrine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Epinephrine | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Epinephrine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Epinephrine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Ethambutol | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ethambutol | Atropine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Ethambutol | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ethambutol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ethambutol | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ethambutol | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Ethambutol | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ethambutol | Phenylephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Ethambutol | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ethambutol | Acetaminophen | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Ethambutol | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Ethambutol | Efavirenz | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Ethambutol | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ethambutol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Ethambutol | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Ethambutol | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ethambutol | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Ethambutol | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ethambutol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ethambutol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Ethambutol | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ethambutol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Evogliptin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Evogliptin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Evogliptin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Evogliptin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Favipiravir | Fluphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Favipiravir | Indacaterol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Lenalidomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Olanzapine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Oxybuprocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Favipiravir | Pentoxifylline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Propafenone | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI |
Favipiravir | Risperidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Captopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Favipiravir | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Enzalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Procaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Favipiravir | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Sunitinib | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Teriflunomide | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Favipiravir | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Favipiravir | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Acetaminophen | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | |
Favipiravir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Favipiravir | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Favipiravir | Clopidogrel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Favipiravir | Diazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Favipiravir | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Favipiravir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Lidocaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | |
Favipiravir | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Favipiravir | Phenytoin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Favipiravir | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Favipiravir | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Favipiravir | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Favipiravir | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Favipiravir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Fluphenazine | Hydroxyzine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Mesalazine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP1A2 mediated DDI |
Fluphenazine | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Fluphenazine | Sulfamethoxazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C9 mediated DDI |
Fluphenazine | Tafluprost | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Fluphenazine | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fluphenazine | Acetylsalicylic acid | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluphenazine | Aminocaproic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Fluphenazine | Captopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Fluphenazine | Chlorambucil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Fluphenazine | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Fluphenazine | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Fluphenazine | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Fluphenazine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fluphenazine | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Fluphenazine | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fluphenazine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fluphenazine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Fluphenazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fluphenazine | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Fluphenazine | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Fluphenazine | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fluphenazine | Rivastigmine | 3 | CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Fluphenazine | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Fluphenazine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Fluphenazine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Fluphenazine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Fluphenazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Fluphenazine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Fluphenazine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Fosfomycin | Indacaterol | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Fosfomycin | Mebendazole | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C19 mediated DDI |
Fosfomycin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fosfomycin | Fingolimod | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Fosfomycin | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI |
Fosfomycin | Methotrimeprazine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Fosfomycin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fosfomycin | Acetaminophen | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fosfomycin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Fosfomycin | Imipramine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Fosfomycin | Levamisole | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Fosfomycin | Lipoic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Fosfomycin | Piracetam | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Fosfomycin | Ropivacaine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP3A4 mediated DDI |
Fosfomycin | Sertindole | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fosfomycin | Thioridazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Fosfomycin | Propofol | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Fosfomycin | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Fosfomycin | Oxaliplatin | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI |
Galantamine | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Galantamine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Galantamine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Galantamine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Gliclazide | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C9 mediated DDI |
Gliclazide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Gliclazide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Hydroxychloroquine | Metoclopramide | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Hydroxychloroquine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxychloroquine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxychloroquine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxychloroquine | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxychloroquine | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxychloroquine | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxychloroquine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Hydroxychloroquine | Phenylephrine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Hydroxychloroquine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxychloroquine | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Hydroxychloroquine | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Hydroxychloroquine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Hydroxychloroquine | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Hydroxychloroquine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxychloroquine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Hydroxychloroquine | Imipramine | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Hydroxychloroquine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxychloroquine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Hydroxychloroquine | Nicotinamide | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP2C9 mediated DDI |
Hydroxychloroquine | Tamoxifen | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Hydroxychloroquine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Hydroxychloroquine | Amitriptyline | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Hydroxychloroquine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Hydroxychloroquine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxyzine | Metoclopramide | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Hydroxyzine | Periciazine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI |
Hydroxyzine | Chlorpromazine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hydroxyzine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2B6 mediated DDI |
Hydroxyzine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Hydroxyzine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxyzine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Hydroxyzine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Hydroxyzine | Mitotane | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Indacaterol | Ivacaftor | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indacaterol | Metoprolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Indacaterol | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indacaterol | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indacaterol | Oseltamivir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Indacaterol | Oxybuprocaine | 3 | CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Indacaterol | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Indacaterol | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Propafenone | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | |
Indacaterol | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indacaterol | Atropine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indacaterol | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indacaterol | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Indacaterol | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indacaterol | Phenylephrine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Indacaterol | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indacaterol | Propranolol | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP1A2 mediated DDI |
Indacaterol | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indacaterol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Indacaterol | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Indacaterol | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Indacaterol | Tamoxifen | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | |
Indacaterol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Indacaterol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Indacaterol | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Indacaterol | Clotrimazole | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Indapamide | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Indapamide | Oseltamivir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Indapamide | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Indapamide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Indapamide | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Indapamide | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Indapamide | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Indapamide | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Indapamide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Indapamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Indapamide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Indapamide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Indapamide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Ivacaftor | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Ivacaftor | Midostaurin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Perphenazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ivacaftor | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Atropine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Ivacaftor | Cariprazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Ivacaftor | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ivacaftor | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ivacaftor | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Ivacaftor | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ivacaftor | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ivacaftor | Clomifene | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Ivacaftor | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Ivacaftor | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Ivacaftor | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ivacaftor | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ivacaftor | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ivacaftor | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ivacaftor | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Ivacaftor | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Ivacaftor | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ivacaftor | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ivacaftor | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ixazomib | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ixazomib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Ixazomib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Ixazomib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Ixazomib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Lenalidomide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenalidomide | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lenalidomide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenalidomide | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenalidomide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenalidomide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Lenalidomide | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenvatinib | Mebendazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Lenvatinib | Sotalol | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Lenvatinib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lenvatinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenvatinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenvatinib | Phenylephrine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Lenvatinib | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lenvatinib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Lenvatinib | Propranolol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Lenvatinib | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenvatinib | Agomelatine | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Lenvatinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenvatinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenvatinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lenvatinib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lenvatinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenvatinib | Lidocaine | 3 | CLASS 1 (from 3); Major DDI | DDI causing arrhythmia | |
Lenvatinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lenvatinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lenvatinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Levothyroxine | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Levothyroxine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Levothyroxine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Maraviroc | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Maraviroc | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mebendazole | Metoclopramide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mebendazole | Metoprolol | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Olaparib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mebendazole | Salbutamol | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI |
Mebendazole | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mebendazole | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Mebendazole | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mebendazole | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Mebendazole | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mebendazole | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mebendazole | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mebendazole | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mebendazole | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Mebendazole | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mebendazole | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Mebendazole | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Acetaminophen | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Mebendazole | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Mebendazole | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Mebendazole | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Mebendazole | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Mebendazole | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Mebendazole | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Mebendazole | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Mebendazole | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Mebendazole | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Melphalan | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Melphalan | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Melphalan | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Melphalan | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Melphalan | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Mesalazine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Mesalazine | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Mesalazine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Mesalazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Mesalazine | Levamisole | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | |
Mesalazine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Mesalazine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Mesalazine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Metoclopramide | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Metoclopramide | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Metoclopramide | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Metoclopramide | Haloperidol | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Metoclopramide | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Metoclopramide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Metoclopramide | Acetaminophen | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Metoclopramide | Diphenhydramine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Metoclopramide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Metoclopramide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Metoclopramide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Metoclopramide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Metoclopramide | Amitriptyline | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Metoclopramide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Metoprolol | Sotalol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Metoprolol | Teriflunomide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Metoprolol | Warfarin | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Fluoxetine | 3 | CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Metoprolol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Metoprolol | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2D6 mediated DDI |
Metoprolol | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Metronidazole | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Metronidazole | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Metronidazole | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Midostaurin | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Midostaurin | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Midostaurin | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Midostaurin | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Midostaurin | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Midostaurin | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Midostaurin | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Midostaurin | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Midostaurin | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Midostaurin | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Midostaurin | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Midostaurin | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Midostaurin | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Midostaurin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Midostaurin | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Midostaurin | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Midostaurin | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Midostaurin | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Midostaurin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Midostaurin | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Misoprostol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Misoprostol | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Mometasone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Morphine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Morphine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Morphine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Morphine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Nevirapine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nevirapine | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Nevirapine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Nevirapine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nevirapine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Nevirapine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitrazepam | Norepinephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Nitrazepam | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Nitrazepam | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nitrazepam | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Nitrazepam | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Nitrazepam | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Norepinephrine | Sulfamethoxazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Norepinephrine | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Norepinephrine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Norepinephrine | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Norepinephrine | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Norepinephrine | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Norepinephrine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Norepinephrine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Norepinephrine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Norepinephrine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Norepinephrine | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Norepinephrine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Norepinephrine | Praziquantel | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Norepinephrine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Olanzapine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Olanzapine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Olaparib | Paroxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Olaparib | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olaparib | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olaparib | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Olaparib | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI | |
Olaparib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Olaparib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Olaparib | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Olaparib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Olaparib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olaparib | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olaparib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olaparib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Olaparib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olaparib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Olaparib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Olaparib | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Olaparib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Olaparib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Olaparib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Olaparib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Olaparib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Olaparib | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Olaparib | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Olaparib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Oseltamivir | Periciazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Oseltamivir | Perphenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Oseltamivir | Risperidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Oseltamivir | Amiodarone | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Oseltamivir | Atropine | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | |
Oseltamivir | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Oseltamivir | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Oseltamivir | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Oseltamivir | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Oseltamivir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Oseltamivir | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Oseltamivir | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Oseltamivir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Oseltamivir | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Oseltamivir | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Oseltamivir | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Oseltamivir | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Oseltamivir | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Oseltamivir | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Oseltamivir | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Oseltamivir | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Oseltamivir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Oseltamivir | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Oxybuprocaine | Risperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Oxybuprocaine | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxybuprocaine | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Oxybuprocaine | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Oxybuprocaine | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI |
Oxybuprocaine | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Oxybuprocaine | Sorafenib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Sunitinib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2C9 mediated DDI |
Oxybuprocaine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Oxybuprocaine | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Oxybuprocaine | Acetaminophen | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Oxybuprocaine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Oxybuprocaine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Oxybuprocaine | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Oxybuprocaine | Lomustine | 3 | CLASS 1 (from 5) | DDI causing arrhythmia; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Solifenacin | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Oxybuprocaine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Oxybuprocaine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Oxybuprocaine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Propafenone | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Paroxetine | Salbutamol | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Paroxetine | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paroxetine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Paroxetine | Propranolol | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Paroxetine | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Paroxetine | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Paroxetine | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Paroxetine | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Paroxetine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Paroxetine | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Paroxetine | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Paroxetine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Paroxetine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Paroxetine | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Paroxetine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Paroxetine | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Pentoxifylline | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Pentoxifylline | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pentoxifylline | Phenylephrine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP1A2 mediated DDI |
Pentoxifylline | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pentoxifylline | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pentoxifylline | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Pentoxifylline | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Pentoxifylline | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pentoxifylline | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Pentoxifylline | Methimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Pentoxifylline | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Periciazine | Tetrabenazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Periciazine | Vemurafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Periciazine | Captopril | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Periciazine | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2B6 mediated DDI |
Periciazine | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Periciazine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Periciazine | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Periciazine | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2B6 mediated DDI |
Periciazine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Periciazine | Methotrimeprazine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Periciazine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Periciazine | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Periciazine | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Periciazine | Umifenovir | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI |
Periciazine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Periciazine | Acetaminophen | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Periciazine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Periciazine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Periciazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Periciazine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Periciazine | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Periciazine | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Periciazine | Loratadine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Periciazine | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Periciazine | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Periciazine | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Periciazine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Periciazine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Periciazine | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Periciazine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Periciazine | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Periciazine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Periciazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Periciazine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Perphenazine | Risperidone | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | |
Perphenazine | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Perphenazine | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Perphenazine | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Perphenazine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Perphenazine | Methotrimeprazine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Perphenazine | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Perphenazine | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Perphenazine | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Perphenazine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Perphenazine | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2D6 mediated DDI |
Perphenazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Perphenazine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Perphenazine | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Perphenazine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Perphenazine | Amitriptyline | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Perphenazine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Perphenazine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Perphenazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Perphenazine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Propafenone | Axitinib | 3 | CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Propafenone | Flutamide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Propafenone | Lacosamide | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Propafenone | Teriflunomide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Propafenone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Propafenone | Levamisole | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Sertindole | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Propofol | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Propafenone | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Pyridoxine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Risperidone | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Risperidone | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Risperidone | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Risperidone | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Risperidone | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Risperidone | Chlorpromazine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Risperidone | Clomipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Risperidone | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Risperidone | Imipramine | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2D6 mediated DDI |
Risperidone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Risperidone | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Risperidone | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Risperidone | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Risperidone | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Risperidone | Mitotane | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Salbutamol | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Salbutamol | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Salbutamol | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2B6 mediated DDI |
Salbutamol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Salbutamol | Diphenhydramine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Salbutamol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Salbutamol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Salbutamol | Clotrimazole | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI |
Salbutamol | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Sotalol | Ambroxol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sotalol | Caffeine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Sotalol | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Sotalol | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Sotalol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sotalol | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C9 mediated DDI |
Sotalol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Sotalol | Praziquantel | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | |
Sotalol | Clotrimazole | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | |
Stavudine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Stavudine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Succinic acid | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Sulfamethoxazole | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Sulfamethoxazole | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Sulfamethoxazole | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Sulfamethoxazole | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Sulfamethoxazole | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C9 mediated DDI |
Sulfamethoxazole | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sulfamethoxazole | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Sulfamethoxazole | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Sulfamethoxazole | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C9 mediated DDI |
Sulfamethoxazole | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tafluprost | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tafluprost | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Tafluprost | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Tafluprost | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Tafluprost | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Tafluprost | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tafluprost | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Tafluprost | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Tafluprost | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2B6 mediated DDI |
Tetrabenazine | Vismodegib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Acetylsalicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Tetrabenazine | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Tetrabenazine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Tetrabenazine | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Tetrabenazine | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Phenobarbital | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Tetrabenazine | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Tetrabenazine | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Tetrabenazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Phenytoin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Tetrabenazine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tetrabenazine | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Tetrabenazine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Tetrabenazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tetrabenazine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Vemurafenib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Vemurafenib | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Vemurafenib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vemurafenib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vemurafenib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Vemurafenib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Vemurafenib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vemurafenib | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vemurafenib | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Vemurafenib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vemurafenib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Vemurafenib | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Vemurafenib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vemurafenib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Vemurafenib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Vemurafenib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Vemurafenib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI; CYP3A4 mediated DDI | |
Vemurafenib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Vemurafenib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vemurafenib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Vildagliptin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Vismodegib | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Vismodegib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Vismodegib | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Vismodegib | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Vismodegib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Vismodegib | Acetaminophen | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Vismodegib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Vismodegib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Vismodegib | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Vismodegib | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Vismodegib | Benzyl benzoate | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Vismodegib | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Vismodegib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Vismodegib | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acetylsalicylic acid | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Acetylsalicylic acid | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Acetylsalicylic acid | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Acetylsalicylic acid | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP3A4 mediated DDI |
Acetylsalicylic acid | Lacosamide | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI |
Acetylsalicylic acid | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Acetylsalicylic acid | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Acetylsalicylic acid | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Acetylsalicylic acid | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Acetylsalicylic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Acetylsalicylic acid | Levamisole | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | |
Acetylsalicylic acid | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Acetylsalicylic acid | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Acetylsalicylic acid | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Acetylsalicylic acid | Mitotane | 3 | Major DDI | DDI causing arrhythmia; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ambroxol | Amiodarone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ambroxol | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ambroxol | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ambroxol | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ambroxol | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ambroxol | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ambroxol | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ambroxol | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ambroxol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Ambroxol | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ambroxol | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ambroxol | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ambroxol | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Aminocaproic acid | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Aminocaproic acid | Acetaminophen | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Aminocaproic acid | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Aminocaproic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Aminocaproic acid | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Aminocaproic acid | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Aminocaproic acid | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Aminocaproic acid | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Aminophylline | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Aminophylline | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Aminophylline | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Amiodarone | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Cariprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Chloropyramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Amiodarone | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Pyrazinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Amiodarone | Regorafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Amiodarone | Sorafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Amiodarone | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Amiodarone | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Amiodarone | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Betahistine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Amiodarone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Amiodarone | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Amiodarone | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Amiodarone | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Amiodarone | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Amiodarone | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Amiodarone | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI; CYP2D6 mediated DDI | |
Amiodarone | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atropine | Axitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Atropine | Caffeine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Atropine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Atropine | Fluorescein | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Atropine | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Atropine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Atropine | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Atropine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Atropine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Atropine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Axitinib | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Axitinib | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Axitinib | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Axitinib | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Axitinib | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Axitinib | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Axitinib | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Axitinib | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Axitinib | Procaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Axitinib | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Axitinib | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Axitinib | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Axitinib | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Axitinib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Axitinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Axitinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Axitinib | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Axitinib | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Axitinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Axitinib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Axitinib | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Axitinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Axitinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Axitinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Axitinib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Axitinib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Axitinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Axitinib | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Axitinib | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Axitinib | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Axitinib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Baclofen | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Baclofen | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Baclofen | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bisacodyl | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Bisacodyl | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Bisacodyl | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bisacodyl | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Bisacodyl | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Bisacodyl | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Bisacodyl | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Bisacodyl | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Bisacodyl | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Bisacodyl | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Bisacodyl | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Caffeine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Caffeine | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI |
Caffeine | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Caffeine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Caffeine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Caffeine | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Caffeine | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Caffeine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Caffeine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Caffeine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Caffeine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Caffeine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Caffeine | Methimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Caffeine | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Captopril | Cycloserine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Captopril | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Captopril | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Captopril | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Captopril | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Captopril | Teriflunomide | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | |
Captopril | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Captopril | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Captopril | Cinacalcet | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing hypotension | |
Captopril | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Captopril | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Cariprazine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Cariprazine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cariprazine | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Cariprazine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cariprazine | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cariprazine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cariprazine | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Cariprazine | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Cariprazine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cariprazine | Chlorpromazine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Cariprazine | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Cariprazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cariprazine | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Cariprazine | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI |
Cariprazine | Solifenacin | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | |
Cariprazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Cariprazine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Cariprazine | Oxaliplatin | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Chlorambucil | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Chlorambucil | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Chlorambucil | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Chlorambucil | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Chlorambucil | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Chlorambucil | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Chlorambucil | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Chlorambucil | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Chlorambucil | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Chlorambucil | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Chlorambucil | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Chloropyramine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Chloropyramine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Chloropyramine | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Chloropyramine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Chloropyramine | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Chloropyramine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Chloropyramine | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Chloropyramine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Chloropyramine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Chloropyramine | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Chloropyramine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Chloropyramine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Chloropyramine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Chloropyramine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Chloropyramine | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Clonidine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Clonidine | Tropicamide | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Clonidine | Acetaminophen | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Clonidine | Fluoxetine | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | CYP2D6 mediated DDI |
Clonidine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clonidine | Levamisole | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Clonidine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Clonidine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Clonidine | Amitriptyline | 3 | Major DDI | DDI causing hypertension; DDI causing tachycardia | |
Clonidine | Propofol | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | |
Clonidine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clonidine | Mitotane | 3 | Major DDI | DDI causing hypotension; DDI causing tachycardia | CYP2B6 mediated DDI |
Cycloserine | Dexketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cycloserine | Diclofenac | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Cycloserine | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Cycloserine | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cycloserine | Enzalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Cycloserine | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cycloserine | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Cycloserine | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cycloserine | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Cycloserine | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Cycloserine | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cycloserine | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cycloserine | Penicillamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Cycloserine | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Cycloserine | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Cycloserine | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Cycloserine | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cycloserine | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cycloserine | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Cycloserine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Cycloserine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Cycloserine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Cycloserine | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Cycloserine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Cycloserine | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Cycloserine | Lipoic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Cycloserine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Cycloserine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Cycloserine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Cycloserine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Cycloserine | Sevelamer | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Cycloserine | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Dexketoprofen | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Dexketoprofen | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dexketoprofen | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Dexketoprofen | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Dexketoprofen | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Dexketoprofen | Ketorolac | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C8 mediated DDI |
Dexketoprofen | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Dexketoprofen | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dexketoprofen | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Dexketoprofen | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Dexketoprofen | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Dexketoprofen | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dexketoprofen | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dexketoprofen | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Dexketoprofen | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dexketoprofen | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Dexketoprofen | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dexketoprofen | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Dexketoprofen | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dexketoprofen | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dexketoprofen | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI |
Dexketoprofen | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Dexketoprofen | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dexketoprofen | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dexketoprofen | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dexketoprofen | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dexketoprofen | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dexketoprofen | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dexketoprofen | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Dexketoprofen | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Diclofenac | Dopamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Diclofenac | Droperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Diclofenac | Procarbazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Diclofenac | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Diclofenac | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Diclofenac | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Dopamine | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Dopamine | Fulvestrant | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Dopamine | Glycine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Dopamine | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Dopamine | Penicillamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Dopamine | Regorafenib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI |
Dopamine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dopamine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Dopamine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Dopamine | Dydrogesterone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Dopamine | Efavirenz | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Dopamine | Finasteride | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dopamine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Dopamine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dopamine | Lipoic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Dopamine | Loratadine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dopamine | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Dopamine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Dopamine | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Dopamine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Dopamine | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Enzalutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Fenofibrate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Droperidol | Haloperidol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Droperidol | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Lorazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Droperidol | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Oxazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Droperidol | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Phenobarbital | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Pyrazinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Regorafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Sorafenib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Droperidol | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Tranexamic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Abiraterone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Betahistine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Droperidol | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Droperidol | Diazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Droperidol | Dydrogesterone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Efavirenz | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Droperidol | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Droperidol | Hydroxyurea | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Droperidol | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Droperidol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Droperidol | Loratadine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Midazolam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Droperidol | Nandrolone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Norethisterone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Oxcarbazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Droperidol | Phenytoin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Progesterone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Droperidol | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Testosterone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Droperidol | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Droperidol | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Droperidol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Droperidol | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Droperidol | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Droperidol | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Droperidol | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Enzalutamide | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Enzalutamide | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Enzalutamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Enzalutamide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Enzalutamide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Enzalutamide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Enzalutamide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Fenofibrate | Fingolimod | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Fenofibrate | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fenofibrate | Flutamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Fenofibrate | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Fenofibrate | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Fenofibrate | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Fenofibrate | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Fenofibrate | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Fenofibrate | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI |
Fenofibrate | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C8 mediated DDI |
Fenofibrate | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Fenofibrate | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fenofibrate | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI |
Fenofibrate | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI |
Fenofibrate | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Fenofibrate | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C8 mediated DDI |
Fenofibrate | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fenofibrate | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Fingolimod | Fluorescein | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Fingolimod | Flupentixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fingolimod | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fingolimod | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fingolimod | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fingolimod | Oxazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fingolimod | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fingolimod | Phenobarbital | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Fingolimod | Pyrazinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fingolimod | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fingolimod | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Fingolimod | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fingolimod | Acetaminophen | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Fingolimod | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Fingolimod | Dimethyl fumarate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Fingolimod | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Fingolimod | Efavirenz | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Fingolimod | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI | |
Fingolimod | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fingolimod | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Fingolimod | Loratadine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fingolimod | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Fingolimod | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fingolimod | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fingolimod | Pyrantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fingolimod | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fingolimod | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fingolimod | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fingolimod | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Fingolimod | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI | |
Fingolimod | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Fingolimod | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fingolimod | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Fingolimod | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fluorescein | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Fluorescein | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fluorescein | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Fluorescein | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Fluorescein | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Fluorescein | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Fluorescein | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fluorescein | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Fluorescein | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Fluorescein | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Fluorescein | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Fluorescein | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluorescein | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Flupentixol | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Flupentixol | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Flupentixol | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Flupentixol | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Flupentixol | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Flupentixol | Procaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Flupentixol | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Flupentixol | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Flupentixol | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Flupentixol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Flupentixol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Flupentixol | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Flupentixol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Flupentixol | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Flupentixol | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Flupentixol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Flupentixol | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Flupentixol | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flupentixol | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Flupentixol | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Flupentixol | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Flupentixol | Methimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Flutamide | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Flutamide | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Flutamide | Methotrimeprazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Flutamide | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP3A4 mediated DDI | |
Flutamide | Propranolol | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Flutamide | Tramadol | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Flutamide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Flutamide | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Flutamide | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Flutamide | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Flutamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Flutamide | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Flutamide | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Flutamide | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Flutamide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Flutamide | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Flutamide | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Flutamide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Flutamide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Flutamide | Ethanol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Flutamide | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Flutamide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Fulvestrant | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Fulvestrant | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fulvestrant | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Fulvestrant | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Glycine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Glycine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Haloperidol | Isoniazid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Haloperidol | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Haloperidol | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Haloperidol | Pyrazinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Haloperidol | Sunitinib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP2B6 mediated DDI |
Haloperidol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Haloperidol | Acetaminophen | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Haloperidol | Betahistine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Haloperidol | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Haloperidol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Haloperidol | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Haloperidol | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Haloperidol | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2B6 mediated DDI |
Haloperidol | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Haloperidol | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Haloperidol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI |
Haloperidol | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Haloperidol | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Haloperidol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI |
Haloperidol | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Haloperidol | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Haloperidol | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Isoniazid | Ketoprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Isoniazid | Ketorolac | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Isoniazid | Lacosamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Isoniazid | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Isoniazid | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Isoniazid | Phenylephrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Isoniazid | Propranolol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Isoniazid | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Isoniazid | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Isoniazid | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Isoniazid | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Isoniazid | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Isoniazid | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Isoniazid | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Isoniazid | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Isoniazid | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Isoniazid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Isoniazid | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Isoniazid | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Isoniazid | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Isoniazid | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Isoniazid | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ketoprofen | Ketorolac | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C8 mediated DDI |
Ketoprofen | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Ketoprofen | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ketoprofen | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Ketoprofen | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ketoprofen | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ketoprofen | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ketoprofen | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ketoprofen | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Ketoprofen | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ketoprofen | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Ketoprofen | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ketoprofen | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Ketoprofen | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ketoprofen | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ketoprofen | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C8 mediated DDI |
Ketoprofen | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ketoprofen | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ketoprofen | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ketoprofen | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Ketoprofen | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ketoprofen | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ketoprofen | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ketoprofen | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ketoprofen | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Ketorolac | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ketorolac | Methotrimeprazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2C19 mediated DDI |
Ketorolac | Procarbazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | |
Ketorolac | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ketorolac | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ketorolac | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ketorolac | Fluoxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Ketorolac | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Ketorolac | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Ketorolac | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Ketorolac | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ketorolac | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ketorolac | Cinacalcet | 3 | CLASS 1 (from 5); Major DDI | DDI causing hypertension | CYP2D6 mediated DDI |
Lacosamide | Loperamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Lacosamide | Mefloquine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lacosamide | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Procainamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Lacosamide | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Lacosamide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lacosamide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lacosamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lacosamide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Lacosamide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Lacosamide | Tamoxifen | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Lacosamide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lacosamide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Lacosamide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Lacosamide | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Lacosamide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Lacosamide | Pirfenidone | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Lacosamide | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Lacosamide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Lacosamide | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lacosamide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Loperamide | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Loperamide | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Loperamide | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Loperamide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Loperamide | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Loperamide | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Loperamide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Loperamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Loperamide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Loperamide | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Loperamide | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI; CYP2C8 mediated DDI |
Loperamide | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2B6 mediated DDI |
Loperamide | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Loperamide | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI |
Loperamide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Loperamide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Loperamide | Desflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Lorazepam | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Lorazepam | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Methotrimeprazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Mefloquine | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Perampanel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Sunitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Mefloquine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Mefloquine | Betahistine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI; CYP2D6 mediated DDI | |
Mefloquine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Mefloquine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Mefloquine | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Mefloquine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Mefloquine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Mefloquine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Mefloquine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Mefloquine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Mefloquine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Mefloquine | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Mefloquine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Mefloquine | Methimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2D6 mediated DDI |
Mefloquine | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Meldonium | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Methotrimeprazine | Methylergometrine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Methotrimeprazine | Phenylephrine | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Methotrimeprazine | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Methotrimeprazine | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Umifenovir | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methotrimeprazine | Zuclopenthixol | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Acetaminophen | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2C19 mediated DDI |
Methotrimeprazine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Fluoxetine | 3 | CLASS 1 (from 5); Major DDI | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Methotrimeprazine | Tapentadol | 3 | CLASS 1 (from 5) | DDI causing hypotension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Cinacalcet | 3 | CLASS 1 (from 5) | DDI causing hypertension; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Methotrimeprazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Methotrimeprazine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Methylergometrine | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methylergometrine | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methylergometrine | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methylergometrine | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methylergometrine | Efavirenz | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Methylergometrine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methylergometrine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methylergometrine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methylergometrine | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methylergometrine | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methylergometrine | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methylergometrine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methylergometrine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Methylergometrine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Methylergometrine | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methylergometrine | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Methylergometrine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Methylergometrine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Methylergometrine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Methylergometrine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Methylergometrine | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Oxazepam | Procarbazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Oxazepam | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Oxazepam | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Perampanel | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Perampanel | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Perampanel | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Perampanel | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Perampanel | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Perampanel | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Perampanel | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Perampanel | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Perampanel | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Perampanel | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Perampanel | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Phenobarbital | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI | |
Phenobarbital | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Phenobarbital | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C9 mediated DDI | |
Phenylephrine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Phenylephrine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Phenylephrine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Efavirenz | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Phenylephrine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Phenylephrine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Phenylephrine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Phenylephrine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Pramipexole | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Pramipexole | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Pregabalin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Pregabalin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Procainamide | Salicylic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C8 mediated DDI | |
Procainamide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procainamide | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Procainamide | Acetaminophen | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Procainamide | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Procainamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Procainamide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procainamide | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Procainamide | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procainamide | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Procainamide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Procainamide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Procainamide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procainamide | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procainamide | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procaine | Sorafenib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C9 mediated DDI |
Procaine | Sunitinib | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Procaine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procaine | Betahistine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing tachycardia | |
Procaine | Diphenhydramine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing tachycardia | |
Procaine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Procaine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Procaine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procaine | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C9 mediated DDI |
Procaine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Procaine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Procarbazine | Regorafenib | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Procarbazine | Sorafenib | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Procarbazine | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Procarbazine | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Procarbazine | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Procarbazine | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Procarbazine | Clopidogrel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Procarbazine | Diazepam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Procarbazine | Efavirenz | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Procarbazine | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Procarbazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Procarbazine | Loratadine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Procarbazine | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Pyrantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Procarbazine | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Procarbazine | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Procarbazine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Procarbazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Procarbazine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Procarbazine | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Propranolol | Regorafenib | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Propranolol | Teriflunomide | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Propranolol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Propranolol | Warfarin | 3 | CLASS 1 (from 3) | DDI causing arrhythmia; DDI causing bradycardia | CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Propranolol | Biperiden | 3 | CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Diphenhydramine | 3 | CLASS 1 (from 3) | DDI causing tachycardia; DDI causing bradycardia | CYP2D6 mediated DDI |
Propranolol | Fluoxetine | 3 | Major DDI | DDI causing tachycardia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Propranolol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Propranolol | Tamoxifen | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2D6 mediated DDI |
Pyrazinamide | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Pyrazinamide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Pyrazinamide | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Pyrazinamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Pyrazinamide | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Pyrazinamide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Pyrazinamide | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Regorafenib | Fentanyl | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Regorafenib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Regorafenib | Lidocaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Regorafenib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Regorafenib | Mitotane | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Salicylic acid | Teriflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Salicylic acid | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Salicylic acid | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Salicylic acid | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Salicylic acid | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Salicylic acid | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Salicylic acid | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Salicylic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Salicylic acid | Levamisole | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | |
Salicylic acid | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Salicylic acid | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Salicylic acid | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Salicylic acid | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Salicylic acid | Desflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Salicylic acid | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Salicylic acid | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Sorafenib | Trifluoperazine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Sorafenib | Tropicamide | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI |
Sorafenib | Clomifene | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Sorafenib | Fentanyl | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | CYP2C19 mediated DDI |
Sorafenib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Sorafenib | Lidocaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Sorafenib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Sorafenib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Sorafenib | Benzyl benzoate | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Sunitinib | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Sunitinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Sunitinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sunitinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Sunitinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sunitinib | Benzyl benzoate | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing bradycardia | |
Sunitinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Sunitinib | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Teriflunomide | Tramadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Teriflunomide | Tropicamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Teriflunomide | Umifenovir | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Teriflunomide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Teriflunomide | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Teriflunomide | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Teriflunomide | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Teriflunomide | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Teriflunomide | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Teriflunomide | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Teriflunomide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Teriflunomide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Teriflunomide | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Teriflunomide | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Teriflunomide | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Teriflunomide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Teriflunomide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Teriflunomide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Teriflunomide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Teriflunomide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Teriflunomide | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP3A4 mediated DDI | |
Teriflunomide | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Teriflunomide | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Teriflunomide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Teriflunomide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Teriflunomide | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tramadol | Trifluoperazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tramadol | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tramadol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Tramadol | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tramadol | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tramadol | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Tramadol | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tramadol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tramadol | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tramadol | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tramadol | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Tramadol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tramadol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Tramadol | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Tramadol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Tramadol | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Tranexamic acid | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Tranexamic acid | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tranexamic acid | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Tranexamic acid | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tranexamic acid | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Trifluoperazine | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Trifluoperazine | Betahistine | 3 | CLASS 1 (from 5) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Trifluoperazine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Trifluoperazine | Finasteride | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI |
Trifluoperazine | Fluorouracil | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C9 mediated DDI |
Trifluoperazine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Trifluoperazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trifluoperazine | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Trifluoperazine | Lipoic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Trifluoperazine | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Trifluoperazine | Ondansetron | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI |
Trifluoperazine | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Trifluoperazine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Trifluoperazine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Trifluoperazine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Trifluoperazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Trifluoperazine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Trifluoperazine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Trifluoperazine | Methimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Tropicamide | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tropicamide | Zuclopenthixol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Tropicamide | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Tropicamide | Betahistine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Tropicamide | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Tropicamide | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Tropicamide | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Tropicamide | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tropicamide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Tropicamide | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Tropicamide | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Tropicamide | Loratadine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Tropicamide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Tropicamide | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Tropicamide | Clotrimazole | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Tropicamide | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Tropicamide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Umifenovir | Upadacitinib | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Umifenovir | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Umifenovir | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Umifenovir | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Umifenovir | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Umifenovir | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Umifenovir | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Umifenovir | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Umifenovir | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Umifenovir | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Umifenovir | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Umifenovir | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Upadacitinib | Warfarin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Agomelatine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Chlorpromazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Fentanyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Fluorouracil | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Upadacitinib | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Hydroxyurea | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Upadacitinib | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Imipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Upadacitinib | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Upadacitinib | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Ethionamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Upadacitinib | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Upadacitinib | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Upadacitinib | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Upadacitinib | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Warfarin | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Warfarin | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Warfarin | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Warfarin | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Warfarin | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Warfarin | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Warfarin | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Warfarin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Warfarin | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Zuclopenthixol | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Zuclopenthixol | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Zuclopenthixol | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Zuclopenthixol | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Zuclopenthixol | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Zuclopenthixol | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Zuclopenthixol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Zuclopenthixol | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Zuclopenthixol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Zuclopenthixol | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Zuclopenthixol | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Acetaminophen | Agomelatine | 3 | CLASS 1 (from 5); Major DDI | DDI causing bradycardia | |
Acetaminophen | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Acetaminophen | Chlorpromazine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Acetaminophen | Clomipramine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP2D6 mediated DDI |
Acetaminophen | Imipramine | 3 | Major DDI | DDI causing hypertension; DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Acetaminophen | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Acetaminophen | Levamisole | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | |
Acetaminophen | Lidocaine | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Acetaminophen | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Acetaminophen | Amitriptyline | 3 | Major DDI | DDI causing hypertension; DDI causing arrhythmia | CYP1A2 mediated DDI |
Acetaminophen | Ethanol | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | CYP2D6 mediated DDI |
Acetaminophen | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Acetaminophen | Mitotane | 3 | Major DDI | DDI causing arrhythmia; DDI causing bradycardia | |
Agomelatine | Betahistine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Agomelatine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Agomelatine | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Agomelatine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Agomelatine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C8 mediated DDI |
Agomelatine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Agomelatine | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP2C19 mediated DDI |
Agomelatine | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Agomelatine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Agomelatine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Agomelatine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Agomelatine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Agomelatine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Agomelatine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Agomelatine | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Agomelatine | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Betahistine | Biperiden | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI |
Betahistine | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Betahistine | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Betahistine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Betahistine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Betahistine | Levamisole | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | CYP2C8 mediated DDI |
Betahistine | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Betahistine | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Betahistine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Betahistine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Betahistine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2D6 mediated DDI |
Biperiden | Bupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Clomipramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Biperiden | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI |
Biperiden | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Biperiden | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Biperiden | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Biperiden | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI |
Biperiden | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Biperiden | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Brivaracetam | Clomifene | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Bupivacaine | Efavirenz | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Bupivacaine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Bupivacaine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Bupivacaine | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Bupivacaine | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Bupivacaine | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Bupivacaine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Bupivacaine | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Bupivacaine | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Bupivacaine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Bupivacaine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Bupivacaine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Bupivacaine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Bupivacaine | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carmustine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP3A4 mediated DDI |
Chlorpromazine | Diphenhydramine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Chlorpromazine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Chlorpromazine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Chlorpromazine | Loratadine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypotension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Chlorpromazine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Chlorpromazine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Chlorpromazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Chlorpromazine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Chlorpromazine | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Clomifene | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Clomifene | Levamisole | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | |
Clomifene | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Clomifene | Loratadine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Clomifene | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Clomifene | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Clomifene | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Clomifene | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Clomifene | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Clomifene | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clomifene | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clomipramine | Diphenhydramine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing tachycardia | CYP2D6 mediated DDI |
Clomipramine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Clomipramine | Solifenacin | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | |
Clomipramine | Tamoxifen | 3 | CLASS 1 (from 3); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomipramine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Clomipramine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Clomipramine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Clomipramine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Clomipramine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Clomipramine | Oxaliplatin | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | |
Clopidogrel | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Diazepam | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Diazepam | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dimethyl fumarate | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Dimethyl fumarate | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Dimethyl fumarate | Desflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Dimethyl fumarate | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Diphenhydramine | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Diphenhydramine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Diphenhydramine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Diphenhydramine | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Diphenhydramine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Diphenhydramine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2D6 mediated DDI |
Diphenhydramine | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI; CYP3A4 mediated DDI |
Diphenhydramine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Diphenhydramine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Dydrogesterone | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Dydrogesterone | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Efavirenz | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Efavirenz | Levobupivacaine | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Efavirenz | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Efavirenz | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Efavirenz | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Efavirenz | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ethosuximide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | CYP2C19 mediated DDI |
Ethosuximide | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Fentanyl | Fluoxetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fentanyl | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Fentanyl | Ketamine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Fentanyl | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fentanyl | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Fentanyl | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fentanyl | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Fentanyl | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fentanyl | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fentanyl | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Fentanyl | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Fentanyl | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | |
Fentanyl | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Fentanyl | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C9 mediated DDI |
Fentanyl | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Fentanyl | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Fentanyl | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fentanyl | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Finasteride | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Finasteride | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Finasteride | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Fluorouracil | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Fluoxetine | Ibuprofen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Fluoxetine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fluoxetine | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Fluoxetine | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Fluoxetine | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Fluoxetine | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Fluoxetine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Fluoxetine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Fluoxetine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Fluoxetine | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Hydroxyurea | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP3A4 mediated DDI |
Hydroxyurea | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP3A4 mediated DDI |
Ibuprofen | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C8 mediated DDI | |
Ibuprofen | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ibuprofen | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ibuprofen | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ibuprofen | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Ibuprofen | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI |
Ibuprofen | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Imipramine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Imipramine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Imipramine | Vinpocetine | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing hypertension | CYP2D6 mediated DDI |
Imipramine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Imipramine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Ketamine | Leflunomide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Ketamine | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI |
Ketamine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Ketamine | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Leflunomide | Levamisole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Levetiracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Leflunomide | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI | |
Leflunomide | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Leflunomide | Lipoic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Leflunomide | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Loratadine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Midazolam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP3A4 mediated DDI | |
Leflunomide | Nandrolone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Leflunomide | Norethisterone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Leflunomide | Oxcarbazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Leflunomide | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Leflunomide | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Progesterone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Pyrantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Leflunomide | Rivastigmine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Leflunomide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Leflunomide | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Leflunomide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Leflunomide | Valproic acid | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI | |
Leflunomide | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Leflunomide | Xylometazoline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C9 mediated DDI | |
Leflunomide | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Leflunomide | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C19 mediated DDI | |
Leflunomide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP3A4 mediated DDI | |
Leflunomide | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Leflunomide | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2C9 mediated DDI | |
Leflunomide | Protionamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2C8 mediated DDI | |
Leflunomide | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI | |
Leflunomide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Leflunomide | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Methimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Leflunomide | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Levamisole | Lomustine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Levamisole | Rivastigmine | 3 | CLASS 1 (from 3) | DDI causing hypertension; DDI causing bradycardia | |
Levamisole | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Levamisole | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Levamisole | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Levamisole | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2D6 mediated DDI |
Levamisole | Desflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Levamisole | Propofol | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | CYP1A2 mediated DDI |
Levamisole | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Levetiracetam | Levobupivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Levetiracetam | Lidocaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Levetiracetam | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Levetiracetam | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Levetiracetam | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Levetiracetam | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Levetiracetam | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Levobupivacaine | Ondansetron | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Levobupivacaine | Praziquantel | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypotension | |
Levobupivacaine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Levobupivacaine | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI | |
Levobupivacaine | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Levobupivacaine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Levobupivacaine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Levobupivacaine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Levobupivacaine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Levobupivacaine | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Lidocaine | Nicotinamide | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Lidocaine | Piracetam | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Lidocaine | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Lidocaine | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Lidocaine | Solifenacin | 3 | CLASS 1 (from 3); Major DDI | DDI causing hypertension | |
Lidocaine | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP1A2 mediated DDI |
Lidocaine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Lidocaine | Pirfenidone | 3 | CLASS 1 (from 3) | DDI causing qt_interval_prolongation; DDI causing arrhythmia | CYP1A2 mediated DDI |
Lomustine | Benzyl benzoate | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Lomustine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2D6 mediated DDI | |
Lomustine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2D6 mediated DDI |
Lomustine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | |
Loratadine | Ropivacaine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Midazolam | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nandrolone | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Nicotinamide | Phenytoin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Nicotinamide | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Nicotinamide | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Nicotinamide | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Nicotinamide | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Nicotinamide | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Nicotinamide | Carbamazepine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI | |
Nicotinamide | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C8 mediated DDI |
Nicotinamide | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI; CYP2C8 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Nicotinamide | Desflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP1A2 mediated DDI | |
Norethisterone | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Ondansetron | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ondansetron | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Ondansetron | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Phenytoin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Piracetam | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Piracetam | Tamoxifen | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Piracetam | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Piracetam | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Piracetam | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Praziquantel | Sertindole | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Praziquantel | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Praziquantel | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Praziquantel | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Rivastigmine | Tapentadol | 3 | CLASS 1 (from 5) | DDI causing tachycardia; DDI causing bradycardia | |
Rivastigmine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Ropivacaine | Solifenacin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Ropivacaine | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Ropivacaine | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Ropivacaine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Ropivacaine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Ropivacaine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Sertindole | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sertindole | Amitriptyline | 3 | CLASS 1 (from 5); Major DDI | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Sertindole | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Sertindole | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2B6 mediated DDI; CYP2C19 mediated DDI |
Sertindole | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2B6 mediated DDI |
Sertindole | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Sertindole | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Solifenacin | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2D6 mediated DDI | |
Solifenacin | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Tamoxifen | Tapentadol | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tamoxifen | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tamoxifen | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Tamoxifen | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Tapentadol | Thioridazine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Tapentadol | Trihexyphenidyl | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Tapentadol | Vinpocetine | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | |
Tapentadol | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Tapentadol | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Thioridazine | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2D6 mediated DDI |
Thioridazine | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Thioridazine | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Thioridazine | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Tretinoin | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Trihexyphenidyl | Amitriptyline | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | |
Trihexyphenidyl | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Trihexyphenidyl | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI; CYP3A4 mediated DDI |
Trihexyphenidyl | Desflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2C19 mediated DDI |
Trihexyphenidyl | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP2B6 mediated DDI |
Trihexyphenidyl | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing tachycardia | CYP1A2 mediated DDI; CYP2B6 mediated DDI |
Trihexyphenidyl | Sevelamer | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing bradycardia | CYP1A2 mediated DDI |
Trihexyphenidyl | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Trihexyphenidyl | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP2C19 mediated DDI |
Valproic acid | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI; CYP2D6 mediated DDI | |
Vinpocetine | Cinacalcet | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Vinpocetine | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Vinpocetine | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Xylometazoline | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | |
Amitriptyline | Clotrimazole | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Amitriptyline | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing qt_interval_prolongation | CYP1A2 mediated DDI; CYP2D6 mediated DDI |
Amitriptyline | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Amitriptyline | Sertraline | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI; CYP2D6 mediated DDI | |
Amitriptyline | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Benzyl benzoate | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cinacalcet | Pirfenidone | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2D6 mediated DDI |
Cinacalcet | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C9 mediated DDI; CYP2D6 mediated DDI |
Cinacalcet | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2C19 mediated DDI | |
Cinacalcet | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Cinacalcet | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Clotrimazole | Desflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP3A4 mediated DDI |
Clotrimazole | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI; CYP3A4 mediated DDI |
Clotrimazole | Mitotane | 3 | CLASS 1 (from 3); Major DDI | DDI causing tachycardia | CYP2B6 mediated DDI; CYP2C19 mediated DDI; CYP3A4 mediated DDI |
Desflurane | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI |
Ethanol | Halothane | 3 | Major DDI | DDI causing qt_interval_prolongation; DDI causing arrhythmia | |
Pirfenidone | Propofol | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP1A2 mediated DDI; CYP2C19 mediated DDI; CYP2C9 mediated DDI |
Pirfenidone | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Propofol | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing hypertension | CYP2C19 mediated DDI |
Protionamide | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sertraline | Sevoflurane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sertraline | Carboplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sertraline | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | CYP2B6 mediated DDI | |
Sevoflurane | Vitamin A | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sevoflurane | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Sevoflurane | Oxaliplatin | 3 | CLASS 1 (from 3); CLASS 1 (from 5) | DDI causing arrhythmia | CYP2C19 mediated DDI |
Vitamin A | Halothane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI | ||
Carboplatin | Mitotane | 3 | CLASS 1 (from 3); CLASS 1 (from 5); Major DDI |